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Abstract
The incidence of cannabis use disorder is increasing across the United States as a function of
increased cannabis use (Hasin et al., 2015); accordingly, it is critical that mental healthcare
professionals be able to accurately identify cannabis use disorder. In light of this imperative, the
current study explored potential barriers to diagnosing cannabis use disorder among doctoral
psychology trainees. Participants (N = 123) were doctoral students in clinical psychology,
counseling psychology, and related disciplines. Utilizing a quasi-experimental analogue design,
the study examined whether doctoral psychology trainees’ personal cannabis use predicted their
perceptions of the risks of cannabis use and attitudes toward substance use. Additionally, the
study explored whether doctoral psychology trainees’ personal cannabis use histories,
perceptions of cannabis’ risks, and attitudes toward substance use would predict accurate
diagnosis of cannabis use disorder. A series of t-tests revealed that trainees’ beliefs about the
risks of cannabis use and attitudes toward substance use varied with history and recency of
personal cannabis use. Additionally, partial correlation analyses revealed that doctoral
psychology trainees’ perceptions of cannabis’ risks were negatively correlated with select
attitudes toward substance use. Despite these findings, the study found that none of the attitudes
explored significantly predicted diagnostic decisions among trainees. Additionally, contrary to
study hypotheses, current cannabis use among doctoral psychology trainees increased the
likelihood that trainees would accurately make a diagnosis of cannabis use disorder. Implications
for graduate training, clinical practice, and public health are considered and recommendations for
future research are provided.
Keywords: cannabis, marijuana, cannabis use disorder, psychology training, cognitive
dissonance, bias, clinical judgment, diagnosis, assessment
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CHAPTER I
Introduction
According to the Substance Abuse and Mental Health Services Administration
(SAMHSA; 2013b), cannabis is the most commonly used illicit substance in the United States.
National statistics indicate that 18.9 million, or 7.3 percent of Americans ages 12 and older
report that they used cannabis within the past month, compared to cocaine users (0.6 percent of
the population), heroin users (0.3 percent of the population), methamphetamine users (0.2
percent of the population), and recreational prescription drug users (2.6 percent of the
population; SAMHSA, 2013b). In addition to being the most commonly used illicit substance,
data suggests that recreational cannabis use is on the rise among individuals 12 and older;
SAMHSA (2013b) reports that recreational cannabis use increased from 14.5 million users (5.8
percent of the population) to 18.9 million users between 2007 and 2012. According to the Pew
Research Center (2013), 48 percent of adults report that they have used cannabis at least once,
the highest percentage of United States adults to ever endorse a history of cannabis use.
Increases in the prevalence of recreational cannabis use in the United States in recent
years accompany a larger shift in cultural attitudes and beliefs about cannabis use, not only
among those who report current or past use of cannabis, but among those who have never tried
the drug (Galston & Dionne Jr., 2013). According to the Pew Research Center (2013), support
for the legalization of cannabis has increased among “all demographic and political groups” (p.
4) in the United States, including men and women; individuals who identify as Caucasian, Black,
and Hispanic; adults in every age bracket (18-29, 30-49, 50-64, and 65+); individuals of all
education levels; and among members across every major political group. Although this shift
cannot be entirely accounted for by changing beliefs about the harmfulness of cannabis (e.g.,
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many Americans, despite harboring concerns about the safety of cannabis use, may support the
legalization of recreational cannabis because they believe that criminalization of cannabis is
ineffective or discriminatory, or because legal cannabis sales would produce tax revenue;
Galston & Dionne Jr., 2013), it appears that the perceived risk of cannabis use is declining
among Americans. Fifty-eight percent of Americans disagree with the gateway hypothesis, the
notion that cannabis use among adolescents leads to use of more dangerous illicit substances
(Pew Research Center, 2013). Additionally, according to Galston and Dionne Jr. (2013), recent
surveys have indicated that a “slim majority” (p. 1) of Americans now believe that cannabis is
less dangerous than alcohol. In one such survey of 1,000 American adults, conducted by NBC
News and The Wall Street Journal (2014), when asked which substance – tobacco, alcohol,
cannabis, or sugar – is the most harmful to a person’s health, 49 percent said tobacco, 24 percent
said alcohol, and 15 percent said sugar, compared to eight percent who selected cannabis. A
second survey, conducted by the Pew Research Center (2014), found that 69 percent of the
public believes that alcohol is more harmful to individuals’ health than cannabis, while 63
percent view alcohol as more harmful to society than cannabis. Indeed, in a January 2014
interview in The New Yorker, even President Barack Obama was quoted as saying “I don’t think
[cannabis] is more dangerous than alcohol,” (Remnick, 2014, para. 76). Although the percentage
of Americans who believe that cannabis use can lead to abuse or dependence is unknown,
anecdotal evidence suggests that many adolescents and adults believe that cannabis is not
addictive (Office of National Drug Control Policy, n.d.; Szalavitz, 2010).
As Americans’ attitudes toward cannabis use have shifted, so too has the legal landscape.
As of February 26, 2014, when the current study was initially proposed, 20 states and the District
of Columbia had passed legislation legalizing the prescription, sale, and use of cannabis to treat
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medical conditions (compared to four states in which medical cannabis legislation failed to pass;
Procon.org, 2014), an additional 13 states were debating pending legislation or ballot measures
which would legalize medical cannabis (Procon.org, 2014), and possession of cannabis had been
decriminalized in 17 states, with decriminalization legislation pending in the District of
Columbia (Selway, 2014). Most notably, in November 2012, two states – Colorado and
Washington – legalized the distribution, sale, and possession of cannabis for recreational use by
adults 21 years of age or older (Healy, 2012). The legalization of recreational cannabis in these
two states marks the first time since 1937, when the federal government passed the Marijuana
Tax Act, that the sale and distribution of marijuana to private citizens for recreational purposes
has effectively been legal (although cannabis use is still prohibited by federal law, the United
States Justice Department has not blocked legislation from taking effect in Colorado or
Washington, and Department of Justice documents indicate that the federal government will not
prosecute cannabis distributors in either state assuming that certain enforcement and regulation
guidelines are met; Cole, 2013; Slaughter, 1988).
There is conflicting evidence on the impact of medical cannabis legalization efforts on
cannabis use among Americans. While some studies (Cerdá, Wall, Keyes, Galea, & Hasin, 2012;
Wall et al., 2011) have demonstrated that recreational cannabis use is more common in states
where medical cannabis has been legalized, select studies exploring the nature of this
relationship have indicated that prevalence of cannabis use precedes and predicts the legalization
of medical cannabis (as opposed to medical cannabis legalization resulting in increased cannabis
use) and that the relationship between medical cannabis legalization and recreational cannabis
use disappears if other factors are controlled (Gorman & Huber Jr., 2007; Harper, Strumpf, &
Kaufman, 2012; Khatapoush & Hallfors, 2004). Conversely, other studies have found that
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cannabis use does increase following the passage of medical cannabis legislation (Cerdá et al.,
2012). A recent study conducted by Pacula, Powell, Heaton and Sevigny (2013) suggests that
these discrepancies may be accounted for by the fact that medical cannabis legislation is not
uniform, and that states in which medical cannabis laws explicitly allow for the creation of
medical cannabis dispensaries, include provisions which provide legal protection for
dispensaries, and/or allow home cultivation of cannabis are associated with increased cannabis
use. Even in studies that have refuted the hypothesized link between medical cannabis
legalization and increased recreational cannabis use, legalization is nonetheless associated with a
decrease in the perceived harmfulness of cannabis (Khatapoush & Hallfors, 2004). Additionally,
although no studies to date have explored the impact of recreational cannabis legalization on use
of the drug in Colorado and Washington, a study which explored the impact of
commercialization of cannabis in the Netherlands on cannabis use found that the de facto
legalization of cannabis led to a steep increase in self-reported cannabis use among 18- to 20year-olds, from 15 percent to 44 percent (MacCoun & Reuter, 2001). According to MacCoun
and Reuter (2001),
Recent experience with legalized gambling [in the United States], as well as the difficulty
of suppressing cigarette promotion, added to the post-World War II erosion of repeal’s
liquor controls, all suggest legal commercial interests are likely to weaken regulatory
efforts… If, even with relatively tight regulation, The Netherlands saw a large increase in
marijuana prevalence, US [legalization] might lead to very high prevalence rates indeed.
(p. 127)
As states legalize medical and recreational cannabis, the accessibility of cannabis has
increased, both through legal channels and illegal or legally dubious channels. Research in
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Colorado following the legalization of medical cannabis, but prior to the legalization of
recreational cannabis, found that approximately 74 percent of adolescents in substance abuse
treatment in the Denver area had obtained cannabis from someone with authorization to use
cannabis for medical purposes, indicating that the diversion of medical cannabis for recreational
use is widespread (Salomonsen-Sautel, Sakai, Thurstone, Corley, & Hopfer, 2012). Additionally,
some reports have indicated that dispensaries in states where medical cannabis is legal are
operating illegally under the guise of this legislation, selling medical cannabis authorization
cards and cannabis itself to individuals who do not need cannabis for medical treatment (Martin,
2009). Indeed, in certain areas of California and Colorado, medical cannabis dispensaries are
believed to outnumber Starbucks coffee shops (Dickinson, 2011; Martin, 2009).
As the belief that cannabis is harmful decreases among Americans and access to and use
of cannabis increases, so too will the incidence of cannabis use disorder. Approximately 7.6
million Americans report that they use cannabis on a daily or near-daily basis (SAMHSA,
2013b). Although not all people who use cannabis at some point in time will eventually meet
criteria for cannabis use disorder, it is estimated that approximately nine percent of individuals
who try cannabis will eventually develop dependence (Anthony, 2006; Anthony, Warner, &
Kessler, 1994); this number increases to 17 percent among individuals who first use cannabis
during adolescence (Anthony, 2006), and between 33 and 50 percent among daily users (Hall &
Pacula, 2003). Lifetime prevalence of cannabis dependence is four percent in the United States
(Anthony et al., 1994). Of the 7.3 million people ages 12 and older who met criteria for
substance abuse or dependence in 2012, 4.3 million (approximately 1.7 percent of the total
population ages 12 and older) met criteria for cannabis use disorder (SAMHSA, 2013b). In 2012,
957,000 people received treatment for cannabis use disorder, more than the number who sought
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treatment for cocaine, tranquilizer, heroin, hallucinogen, or stimulant use disorders, and
approximately equal to the number who sought treatment for pain reliever abuse/dependence
(SAMHSA, 2013b). As cannabis becomes more accessible, both by way of medical and
recreational legalization, it is anticipated that the percentage of Americans who meet criteria for
and require treatment of cannabis use disorders will continue to rise (Cerdá et al., 2012; Pacula et
al., 2013).
Cannabis Use Disorder
According to the Diagnostic and Statistical Manual of Mental Disorders (DSM-5;
American Psychiatric Association, 2013), cannabis use disorder is defined as “a problematic
pattern of cannabis use leading to clinically significant impairment or distress… occurring within
a 12-month period,” (p. 509). Despite the American Psychiatric Association’s inclusion of
cannabis use disorder in the DSM-5, criteria for cannabis use disorder are, for the most part,
subjective. At present, there is no consensus regarding how much cannabis must be consumed, or
how frequently cannabis must be used in order to qualify for a diagnosis of cannabis use disorder
(Alexander, 2003). Without objective criteria to assist healthcare professionals in diagnosing
cannabis use disorder, it is likely that these diagnoses may be influenced by mental health
professionals’ personal judgments about what patterns of behavior indicate problem cannabis
use, especially if clients seeking mental healthcare are in denial about their problem cannabis use
or do not attribute their cannabis use to be the cause of their presenting concerns, which is
common among individuals with cannabis use problems (American Psychiatric Association,
2013).
Among those healthcare professionals who are expected to be competent in the diagnosis
of cannabis use disorder are clinical and counseling psychologists, as well as clinical and
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counseling doctoral psychology trainees. Doctoral psychology trainees frequently complete
practicum and pre-doctoral internships in settings in which they are likely to encounter
individuals with substance use issues, including cannabis use disorder; accordingly, it is
imperative that doctoral psychology trainees are knowledgeable about cannabis use disorder and
able to accurately identify cannabis use disorder among clients. Despite this, research has
repeatedly demonstrated that doctoral psychology trainees in professional psychology fields,
including clinical and counseling psychology, receive minimal to no formal training in substance
use disorder treatment (Aanavi, Taube, Ja, & Duran, 1999; Chiert, Gold, & Taylor, 1994; da
Silva Cardoso, Pruett, Chan, & Tansey, 2006; Lubin, Brady, Woodward, & Thomas, 1986;
Madson, Bethea, Daniel & Necaise, 2008; Selin & Svanum, 1981).
Influence of Personal Attitudes and Behavior on Professional Judgment
In lieu of formalized training on cannabis use disorder or conclusive evidence
documenting the risks and benefits of cannabis use, research has suggested that healthcare
professionals defer to their personal attitudes toward cannabis use and substance use generally
when making professional decisions. To date, no studies have explored the impact of
psychologists’ or doctoral psychology trainees’ personal attitudes toward cannabis, or the impact
that these attitudes may have on their ability to identify cannabis use disorder; however, a small
body of literature has explored this phenomenon among physicians. In one such study, conducted
in 1989 by Linn, Yager, and Leake, physicians’ personal religious and political beliefs, as well as
their perception of the severity of the United States’ “drug problem” (p. 715) were associated
with their attitudes toward the decriminalization and legalization of cannabis for recreational use.
Another study, conducted by Charuvastra, Friedmann, and Stein (2005), found that physicians’
attitudes toward substance use – specifically, their permissiveness and non-moralism toward
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substance use – significantly predicted their support for the legalization of medical cannabis.
Personal attitudes toward cannabis use do not only impact clinical judgment; they also, in
turn, impact provision of services. In a study of family physicians practicing in Colorado, for
example, physicians who had recommended medical cannabis to their patients were more likely
to believe that cannabis use was associated with significant physical health benefits and to
support the legalization of recreational cannabis (Kondrad & Reid, 2013). Likewise, in a study
conducted by Norberg et al. (2012) in Australia, nurses and physicians who believed that
cannabis should not be available for medical use were 2.06 times more likely to report that they
had screened someone for cannabis use in the past month than study participants who supported
the legalization of medical cannabis, suggesting that healthcare professionals’ personal beliefs
about cannabis impact their the provision of services to patients.
Social psychology research has indicated that attitudes are likely to predict behavior
when they are formed through personal experience (Cooke & Sheeran, 2004; Glasman &
Albarracín, 2006; Kraus, 1995). Healthcare professionals are not immune to this phenomenon.
Research has indicated that healthcare professionals who may have alcohol use problems tend to
minimize patients’ problematic alcohol use, resulting in a failure to intervene with patients who
may have substance use disorders (Aalto & Seppa, 2007; Geirsson, Hensing, & Spak, 2009).
As with alcohol use, studies suggest that healthcare professionals’ personal cannabis use
appears to influence professionals’ clinical practices when it comes to assessing for cannabis use,
as well as their judgments of the benefits and harms of cannabis use. In one such study,
physicians who reported current or past use of cannabis were more likely to favor the
legalization or decriminalization of cannabis than those who denied cannabis use (Linn et al.,
1989). Additionally, in a study of Colorado family physicians by Kondrad and Reid (2013),
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physicians who reported personal cannabis use and who indicated that their personal cannabis
use influenced their decision to recommend cannabis to patients were significantly less likely to
believe that cannabis is addictive, that using cannabis poses mental health risks, and that
physicians who prescribe cannabis should have an ongoing relationship with the patients to
whom they prescribe this drug than physician respondents who did not report personal cannabis
use. Using the framework of Festinger’s (1957) Theory of Cognitive Dissonance, the current
study posited that personal cannabis use may lead healthcare professionals – specifically,
doctoral psychology trainees – to minimize signs of cannabis use in clients, resulting in a failure
to recognize cannabis use disorder.
Statement of the Problem
Paradoxically, as cannabis use – and in turn, cannabis use disorder – becomes more
frequent, it is less likely to be seen as a potential problem by the general public. As such, it is
critical that mental healthcare professionals – particularly the next generation of mental
healthcare professionals, who will inevitably see increasing rates of cannabis use disorder – be
able to accurately identify problem cannabis use. Through the use of a vignette depicting
cannabis use disorder in a hypothetical client, the current study explored the impact of doctoral
psychology trainees’ perceptions of cannabis’ risks, attitudes toward substance use, and personal
cannabis use on trainees’ ability to identify cannabis use disorder. Participants were doctoral
students in clinical, counseling, and other applied psychology training programs who read a
vignette which portrayed a hypothetical client who met DSM-5 (American Psychiatric
Association, 2013) criteria for cannabis use disorder and were asked to identify whether, based
on their own judgment, the client met criteria for cannabis use disorder. Participants also
completed a series of questions about their own cannabis use, as well as a screening measure of
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problem cannabis use, an assessment of perceptions of harm related to cannabis use, and a
measure of attitudes related to substance use generally. The goal of the study was twofold: First,
the study sought to identify whether doctoral psychology trainees’ personal cannabis use
predicted their perceptions of the risks of cannabis use and attitudes toward substance use
generally. Second, the study sought to explore whether doctoral psychology trainees’ personal
cannabis use, beliefs about the risk of harm from cannabis, and non-moralistic, permissive, and
non-stereotypical attitudes toward substance use predicted their ability to identify cannabis use
disorder.
Limitations of Existing Studies
To date, no studies have explored psychologists’ or doctoral psychology trainees’
personal use of cannabis, or their beliefs about the risk of harm associated with cannabis use or
attitudes toward substance use more generally. Additionally, of those studies which have been
conducted exploring healthcare professionals’ personal cannabis use, beliefs about the risks of
cannabis use, and attitudes toward substance use generally, none have used analogue
methodology; rather, the majority of studies on this topic have either (a) asked healthcare
professionals about their opinions on the legalization of medical and/or recreational cannabis, or
(b) relied on participants’ self-reported practices in order to gauge how their behaviors and/or
beliefs had impacted their professional judgment. Such methodology may be prone to error (e.g.,
participants’ incorrectly estimating how many referrals for substance abuse treatment they have
made over a specific period of time) or fail to effectively operationalize clinical judgment,
because respondents may support the legalization or decriminalization of cannabis despite
viewing cannabis use as a high-risk behavior, as noted by Galston and Dionne Jr. (2013).
Accordingly, the current study sought to resolve these gaps in the literature and methodological
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flaws by studying doctoral psychology trainees and by utilizing analogue methodology.
Definition of Terms
Attitudes toward substance use are defined as favorable or unfavorable evaluations of
substance use. For the purposes of the current study, attitudes toward substance use were defined
by scores on three subscales of the Substance Abuse Attitude Survey (SAAS; Chappel, Veach, &
Krug, 1985): the Permissiveness (P-SAAS), Non-Moralism (NM-SAAS), and Non-Stereotyping
(NS-SAAS) subscales. (Each of these constructs – permissiveness, non-moralism, and nonstereotyping – will be described individually below).
Cannabis use disorder is defined as “a problematic pattern of cannabis use leading to
clinically significant impairment or distress… occurring within a 12-month period,” (American
Psychiatric Association, 2013, p. 509). For the purposes of the study, cannabis use disorder was
defined by DSM-5 (American Psychiatric Association, 2013) criteria for this disorder.
Current cannabis use is defined as any use of cannabis in the past year (Bashford, Flett,
& Copeland, 2010). For the purposes of the current study, current cannabis use was operationally
defined as participant self-reported past-year cannabis use.
History of cannabis use is defined as lifetime incidence of cannabis use. For the purposes
of the study, history of cannabis use was operationally defined as participant endorsement of
lifetime cannabis use.
Non-moralism is defined as an attitude toward substance use which avoids perceptions of
substance use as morally evil or wrong. For the purposes of the current study, non-moralism was
operationally defined as scores on the NM-SAAS (Chappel et al., 1985).
Non-stereotyping is defined as attitudes suggestive of “non-reliance on popular societal
stereotypes of substance use and substance users,” (Linden, 2010, p. 380). For the purposes of
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the current study, non-stereotyping was operationally defined as scores on the NS-SAAS
(Chappel et al., 1985).
Perception of cannabis’ risks is defined as a set of beliefs congruent with the opinion that
use of cannabis is physically or psychologically harmful, that there are no/few benefits to
cannabis use, and that cannabis is addictive. For the purposes of the study, perception of
cannabis’ risks was defined as scores on the Perceptions of Cannabis Use Risks Questionnaire
(PCURQ), an experimental questionnaire adapted from the work of Kondrad and Reid (2013).
Permissiveness is defined as attitudes indicating “[acceptance of] substance use within a
continuum of normal human behavior,” (Linden, 2010, p. 380). For the purposes of the current
study, permissiveness was operationally defined as scores on the P-SAAS (Chappel et al., 1985).
Problem cannabis use is defined as risk of developing cannabis use disorder or currently
meeting criteria for cannabis use disorder. For the purposes of the current study, problem
cannabis use was operationally defined as scores on the Cannabis Use Problems Identification
Test (CUPIT; Bashford et al., 2010).
Research Questions
1) Does doctoral psychology trainees’ personal cannabis use predict trainees’ perceptions of
cannabis’ risks?
2) Does doctoral psychology trainees’ personal cannabis use predict trainees’ attitudes toward
substance use?
3) Are perceptions of cannabis’ risks associated with attitudes toward substance use?
4) Do personal cannabis use, perceptions of cannabis’ risks, and attitudes toward substance use
predict doctoral psychology trainees’ ability to identify cannabis use disorder from a clinical
vignette?
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Statement of Hypotheses
1) Doctoral psychology trainees who reported current or past use of cannabis would have more
positive attitudes regarding the benefits and risks of cannabis use. Specifically, doctoral
psychology trainees who reported current or past use of cannabis would report (1a) lower
perceptions of cannabis’ risks as compared to individuals who denied cannabis use. (1b)
Doctoral psychology trainees’ perceptions of cannabis’ risks would be lower among those
who endorsed current cannabis use. Additionally, (1c) perceptions of cannabis’ risks would
decrease as trainees’ own risk of problem cannabis use increased.
2) Doctoral psychology trainees who reported current or past use of cannabis would (2a)
endorse more permissive attitudes toward substance use than trainees who denied cannabis
use. Additionally, (2b) doctoral psychology trainees who reported current or past use of
cannabis would endorse more non-moralistic attitudes toward substance use than trainees
who denied cannabis use. Doctoral psychology trainees who reported current or past use of
cannabis would also (2c) endorse more non-stereotyped attitudes toward substance use. (2d)
Non-moralistic, (2e) permissive, and (2f) non-stereotyped attitudes toward substance use
would be higher among those who currently used cannabis than those with a history of prior
use. Additionally, trainees’ risk of problem cannabis use would predict (2g) non-moralistic,
(2h) permissive, and (2i) non-stereotyped attitudes toward substance use.
3) Doctoral psychology trainees’ perceptions of cannabis’ risks would be negatively correlated
with (3a) trainee permissiveness (3b) trainee non-moralism, and (3c) trainee nonstereotyping toward substance use.
4) Trainees’ cannabis use, risk of cannabis use problems, perceptions of cannabis’ risks, and
attitudes toward substance use would predict trainees’ ability to identify cannabis use
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disorder from a clinical vignette.
Delimitations
The current study utilized a quantitative, quasi-experimental, survey design with
analogue methodology. Because this study utilized a quasi-experimental design, participants
could not be randomly assigned to conditions, which may impact the internal validity of the
study; however, this was unavoidable, as it would have been unethical to assign participants to
conditions in which substance use was required. As a result, no causal conclusions can be made
based on the results of the study. Additionally, the current study relied on convenience sampling,
which may limit the generalizability of study findings. It is possible that participants who chose
to take part in the study self-selected into the study due to their interest in the description of the
research, and that those who did not select to participate may have differed in certain ways from
those who participated, in a manner which poses a threat to the ecological validity of the results.
Further, self-report data was used to measure participants’ history of and current cannabis
use. Accordingly, it is possible that participants may have been influenced by social desirability
bias, and may have underreported cannabis use. Although research has indicated that adults
generally report their cannabis use honestly (Darke, 1998), prior studies of healthcare
professionals have indicated that this group may underreport cannabis use due to potential
professional and legal repercussions (Norberg et al., 2012). In an effort to minimize this threat to
study validity, all participant data was collected anonymously.
There is some question regarding the validity of measurements utilized in the current
study to measure perceptions of cannabis’ risks and attitudes toward substance use. There are no
previously validated assessments of perceptions of cannabis use risks; accordingly, the study
used a self-report measure adapted from prior research (Kondrad & Reid, 2013). Additionally,

15
there is limited data on the psychometric properties of the SAAS (Chappel et al., 1985), which
was used to assess participants’ attitudes toward substance use. Despite this, the SAAS is widely
used to assess attitudes toward substance use and abuse and no comparable instruments exist to
measure attitudes toward substance use. Accordingly, the SAAS was selected for the present
study.
Finally, it is important to acknowledge that although the present study sought to identify
the impact of trainees’ attitudes on diagnostic decision-making, a third variable – participants’
competence in diagnosis – may confound this relationship. Efforts were made to control for
variables which were hypothesized to be associated with trainees’ level of clinical competence,
e.g. data on the number of years of training trainees had completed, as well as whether or not
trainees were currently completing or had completed internship; however, it is possible that level
of experience does not entirely account for trainee competence. Consideration was also given to
other methods of controlling for clinical competence, i.e. providing DSM-5 (American
Psychiatric Association, 2013) diagnostic criteria to study participants as they reviewed the
clinical vignette; however, it was ultimately decided that doing so would sacrifice the ecological
validity of the study’s analogue methodology. Although it is beyond of the scope of the present
study, further research exploring the extent to which competence in diagnosis may limit the
impact of trainees’ personal biases is a fruitful area for further research and a recommended
direction of study.
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CHAPTER II
Literature Review
It is estimated that approximately nine percent of individuals who try cannabis will
eventually develop dependence (Anthony, 2006; Anthony, Warner, & Kessler, 1994); this
number increases to 17 percent among individuals who first use cannabis during adolescence
(Anthony, 2006), and between 33 and 50 percent among daily users (Hall & Pacula, 2003).
Lifetime prevalence of cannabis dependence is four percent in the United States (Anthony et al.,
1994). Of the 7.3 million people ages 12 and older who met criteria for substance abuse or
dependence in 2012, 4.3 million (approximately 1.7 percent of the total population ages 12 and
older) met criteria for cannabis use disorder (SAMHSA, 2013b). As cannabis becomes more
accessible, both by way of medical and recreational legalization, it is anticipated that the
percentage of Americans who meet criteria for and require treatment of cannabis use disorder
will continue to rise (Cerdá et al., 2012; Pacula et al., 2013).
Given the prevalence of cannabis use disorder in the United States, and the projected
increase in cannabis use disorder linked to cannabis legalization efforts, it is important that
healthcare professionals and trainees in healthcare related fields, including clinical and
counseling psychology, be able to identify cannabis use disorder in their patients, in order to
ensure prompt and appropriate treatment. Doctoral psychology trainees in particular frequently
complete practicum, internship, and post-doctoral training in settings such as college counseling
centers, hospitals, community mental health centers, and outpatient clinics, in which they are
likely to encounter individuals with substance use issues, including cannabis use disorder;
accordingly, it is imperative that psychology trainees are knowledgeable about cannabis use
disorder and able to accurately identify cannabis use disorder among clients.
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Despite this imperative, there are many barriers which may impede this process. Doctoral
psychology trainees historically have minimal training in substance abuse treatment, which may
result in substance use disorders going unidentified and untreated (Aanavi et al., 1999; Chiert et
al., 1994; da Silva Cardoso et al., 2006; Lubin et al., 1986; Madson et al., 2008; Selin & Svanum,
1981). According to a recent survey of master’s and doctoral students in clinical and counseling
psychology conducted by Madson and colleagues (2008), only 34 percent of participants
reported that they had completed a dedicated course in substance abuse treatment, and only 52
percent reported that they had received any form of substance abuse treatment training at all.
In lieu of formalized training on substance abuse diagnosis and treatment, what criteria
might doctoral psychology trainees – and in turn, psychologists – use in their identification of
substance use disorders? Prevailing evidence from the social psychology literature suggests that
individuals’ attitudes are likely to predict behavior when they are formed through personal
experience (Cooke & Sheeran, 2004; Glasman & Albarracín, 2006; Kraus, 1995). Accordingly,
if we are to understand doctoral psychology trainees’ ability to identify cannabis use disorder, it
is essential that we examine their personal cannabis use, as well as their perceptions about the
risks of cannabis use and attitudes about substance use in general, which may be shaped by their
personal use of cannabis.
The present study rested upon several discrete but related bodies of research. Although
there is little literature which speaks specifically to the variables and population of interest in this
study – doctoral psychology trainees, personal recreational cannabis use, and attitudes toward
recreational cannabis use and substance use generally – previous research has explored other
non-psychologist healthcare professionals’ positions on medical and recreational cannabis use.
Extant literature on healthcare professionals which identified factors that influence clinical
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judgment and professional practices informed the selection of variables explored in the present
study. Festinger’s (1957) Theory of Cognitive Dissonance – which I posited may explain how
healthcare professionals’ personal behaviors bias their attitudes and subsequently, their
professional judgment – served as the theoretical framework for the study.
As noted above, it is important to note that there is little literature which speaks
specifically to the variables and population of interest in this study. To the knowledge of the
author, no studies have explored doctoral psychology trainees’ personal substance use and the
impact of personal substance use on perceptions of cannabis’ risks and attitudes toward
substance use. Additionally, no research has explored licensed psychologists’ attitudes toward or
use of cannabis. Even among healthcare professionals more generally, the research in this area is
sparse; only four studies (Linn et al., 1989; Charuvastra et al., 2005; Norberg et al., 2012; and
Kondrad & Reid, 2013) have explored physicians’ attitudes toward cannabis, of which only one
– conducted 25 years ago (Linn et al. 1989) – explored attitudes toward recreational, as opposed
to medical cannabis use. In lieu of research which directly addressed doctoral psychology
trainees and cannabis use, research which addressed theoretically related groups, such as
physicians and other groups of healthcare professionals, and health-related or substance use
behaviors, such as alcohol use and cigarette smoking, was reviewed where research on cannabis
use and/or psychology trainees specifically was unavailable.
As the current study sought to assess doctoral psychology trainees’ ability to identify
cannabis use problems, I begin by briefly discussing the diagnosis of interest, cannabis use
disorder.
Cannabis Use Disorder
According to the DSM-5 (American Psychiatric Association, 2013), cannabis use disorder
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is defined as “a problematic pattern of cannabis use leading to clinically significant impairment
or distress… occurring within a 12-month period,” (p. 509). In order to meet criteria for cannabis
use disorder, an individual must meet two of the following 11 criteria: (1) “Cannabis is often
taken in larger amounts or over a longer period of time than was intended,” (American
Psychiatric Association, 2013, p. 509); (2) “There is a persistent desire or unsuccessful efforts to
cut down or control cannabis use;” (3) “A great deal of time is spent in activities necessary to
obtain cannabis, use cannabis, or recover from its effects;” (4) “Craving, or a strong desire or
urge to use cannabis;” (5) “Recurrent cannabis use resulting in a failure to fulfill major role
obligations at work, school, or home;” (6) “Continued cannabis use despite having persistent or
recurrent social or interpersonal problems, caused or exacerbated by the effects of cannabis;” (7)
“Important social, occupational, or recreational activities are given up or reduced because of
cannabis use;” (8) “Recurrent cannabis use in situations in which it is physically hazardous;” (9)
“Cannabis use is continued despite knowledge of having a persistent or recurrent physical or
psychological problem that is likely to have been caused or exacerbated by cannabis;” (10)
Tolerance, defined by either “A need for markedly increased amounts of cannabis to achieve
intoxication or desired effect,” or “Markedly diminished effect with continued use of the same
amount of cannabis;” and (11) Withdrawal, as evidenced by symptoms of cannabis withdrawal
syndrome, including but not limited to irritability, anxiety, difficulty sleeping, depressed mood,
and/or somatic symptoms, or by the use of cannabis to relieve or prevent symptoms of
withdrawal.
Identification of Cannabis Use Disorder
Despite the American Psychiatric Association’s (2013) inclusion of cannabis use disorder
in the DSM-5, there is no consensus on objective criteria which can be used to identify cannabis
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use disorder (Alexander, 2003). Unlike other forms of problem substance use, such as binge
drinking, which is defined by an objective standard (the number of drinks consumed within a
specific period of time, with specific standards for men and women; National Institute of
Alcohol Abuse and Alcoholism, 2004), no such criteria exist to identify cannabis use disorder.
As Earlywine (2002) notes, research linking daily or near-daily use of cannabis to the negative
outcomes generally used to identify cannabis use disorder (e.g., decreased social or occupational
functioning, development of dependence, etc.) is inconsistent; on the other hand, Dennis, Babor,
Roebuck, and Donaldson (2002) write that daily or near-daily cannabis use is not necessary in
order for someone to meet criteria for dependence. In lieu of objective criteria which can help
healthcare professionals’ identify cannabis use disorder, such as the amount of cannabis
consumed and the frequency of consumption, diagnoses of cannabis use disorder may rely on a
more subjective standards for diagnosis: clinicians’ judgment that clients’ cannabis use is
impacting their daily functioning. Such judgments may be influenced by mental health
professionals’ personal judgments about what patterns of behavior indicate problem cannabis
use. This is especially the case if clients seeking mental healthcare are in denial about their
problem cannabis use, or do not attribute their cannabis use to be the source of their presenting
concerns, which is common among individuals with cannabis use problems (American
Psychiatric Association, 2013).
Training in Identification of Substance Use Disorders
In addition to the difficulties in diagnosing cannabis use disorder which may arise from a
lack of objective criteria which define the disorder, individuals who are tasked with identifying
cannabis use disorder – healthcare professionals – often have minimal training in the
identification and treatment of substance use disorders. Clinical and counseling psychologists are
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no exception to this. As has been previously noted, although doctoral psychology trainees
frequently complete practicum and pre-doctoral internships in settings in which they are likely to
encounter individuals with substance use issues, including cannabis use disorder, research has
repeatedly demonstrated that doctoral psychology trainees in professional psychology fields,
including clinical and counseling psychology, receive minimal to no formal training in substance
use disorder treatment (Aanavi et al., 1999; Chiert et al., 1994; da Silva Cardoso et al., 2006;
Lubin et al., 1986; Madson, et al., 2008; Selin & Svanum, 1981). This necessarily impairs
psychologists’ and trainees’ ability to identify cannabis use disorder, and may make them more
susceptible to relying on personal attitudes toward cannabis use and personal cannabis use as
barometers of problem cannabis use.
Attitudes
The concept of attitudes as a theoretical construct has been ascribed many definitions
throughout the history of social psychology. Early writers in social psychology described
attitudes as components of cognition which had not only cognitive, but affective, motivational,
and behavioral components (Schwarz & Boehner, 2001). For example, in 1935, Gordon Allport
defined attitudes as “a mental and neural state of readiness, organized through experience,
exerting a directive and dynamic influence upon the individual's response to all objects and
situations with which it is related," (p. 810). Similarly, Krech and Crutchfield (1948) defined
attitudes as “an enduring organization of motivational, emotional, perceptual, and cognitive
processes with respect to some aspect of the individual's world,” (p. 152). Since this era, the
definition of attitudes has shifted somewhat, such that the concept of attitudes now primarily
refers to one’s beliefs about, preferences for, and evaluations of a specific idea or entity; put
most simply by Bem (1970), “Attitudes are likes and dislikes,” (p. 14). Similarly, Eagly and
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Chaiken (1993) write that an attitude is “a psychological tendency that is expressed by evaluating
a particular entity with some degree of favor or disfavor,” (p. 1).
It is generally argued that individuals’ attitudes are predictive of their future behavior; so
ubiquitous is this concept that, in a recent text, Hogg and Vaughan (2005) define attitudes as a
“relatively enduring organization of beliefs, feelings, and behavioral tendencies towards socially
significant objects, groups, events or symbols," (p. 150). Although research has indicated that the
relationship between personally held attitudes and behaviors is not as simple as initial theories
have posited (Glasman & Albarracín, 2006), among those in the healthcare professions, there is a
well-founded concern that personal attitudes will bias clinicians, resulting in inadequate or
otherwise unethical patient care. Within the professional psychology literature, the need to be
aware of one’s personal attitudes and the impact said beliefs may have on one’s professional
judgment has been well documented. For example, the impact of personal beliefs on
psychologists’ professional behavior is addressed by the American Psychological Association
(2010) in its Ethical Principles of Psychologists and Code of Conduct, which states,
“Psychologists [should] exercise reasonable judgment and take precautions to ensure that their
potential biases … do not lead to or condone unjust practices,” (p. 3).
Public Perceptions of Cannabis
Although psychologists’ and doctoral psychology trainees’ attitudes toward cannabis use
have not been documented, the contemporary attitudes of the general public in regards to
cannabis are fairly well established. As noted previously, according to the Pew Research Center
(2013), support for the legalization of cannabis has increased among “all demographic and
political groups” (p. 4) in the United States, including men and women; individuals who identify
as Caucasian, Black, and Hispanic; adults in every age bracket (18-29, 30-49, 50-64, and 65+);
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individuals of all education levels; and among members across every major political group.
Furthermore, it appears that the perceived risk of cannabis use is declining among Americans.
According to Galston and Dionne Jr. (2013), recent surveys have indicated that a “slim majority”
(p. 1) of Americans now believe that cannabis is less dangerous than alcohol. Additionally,
although the percentage of Americans who believe that cannabis use can lead to abuse or
dependence is unknown, anecdotal evidence suggests that many individuals believe that cannabis
is not addictive (Szalavitz, 2010; Office of National Drug Control Policy, n.d.).
Attitudes Toward Cannabis and Substance Use Among Healthcare Professionals
As cultural perceptions of cannabis’ risks shift, it is apt to consider how healthcare
professionals, who will be tasked with identifying cannabis use disorder in patients, feel about
cannabis and substance use generally, and whether these personal beliefs may be biasing their
professional judgments, influencing their professional practices, and – as the current study has
posited – compromising their ability to identify cannabis use disorder.
Research exploring healthcare professionals’ attitudes toward cannabis use is limited. To
date, four studies (Charuvastra et al., 2005; Kondrad & Reid, 2013; Linn et al., 1989; Norberg et
al., 2012) have explored in the impact of healthcare professionals’ personal attitudes toward
cannabis on their professional practices. No research has explored psychologists’ attitudes
toward cannabis, nor doctoral psychology trainees’.
Following the legalization of medical cannabis in Colorado, Kondrad and Reid (2013)
conducted a survey of 520 family physicians practicing in Colorado in order to explore
physicians’ attitudes about medical cannabis. In addition to polling respondents about their
opinions on prescribing cannabis for medical ailments and whether or not they have prescribed
cannabis to patients, Kondrad and Reid (2013) asked respondents about their attitudes regarding
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the legalization of recreational cannabis, as well as their perceptions of cannabis’ risks and
benefits. Chi-square analyses revealed that physicians who had previously prescribed cannabis to
one or more patients were more likely to endorse the statements, “‘Physicians should recommend
marijuana as a medical therapy,’” (p. 58) “‘There are significant physical health benefits to using
marijuana,’” “‘The FDA should reclassify marijuana so that it is no longer a schedule I drug,’”
and, most notably, “‘Marijuana should be legalized for recreational use,’” than those family
physicians who denied recommending cannabis to their patients. Although Kondrad and Reid’s
(2013) use of chi-square analyses, as opposed to regression analyses, limits the interpretation of
their results, their findings suggest, at minimum, that physicians who recommend medical
cannabis to their patients are more likely to hold positive attitudes about cannabis than those who
choose not to prescribe the drug. Regrettably, although Kondrad and Reid (2013) asked
respondents whether they supported the legalization of cannabis for recreational use, the authors
did not conduct any analyses identifying how the attitudes of respondents who supported the
legalization of recreational cannabis differed from those who did not.
A second study, by Charuvastra and colleagues (2005), supports the results of Kondrad
and Reid (2013) and benefits from somewhat more rigorous statistical analysis and nationwide
sampling, improving the generalizability of results. A sample of 960 physicians from a range of
specialties, including family medicine, general medicine, obstetrics-gynecology, general
psychiatry, and addiction medicine/addiction psychiatry, were recruited through the American
Medical Association’s national registry, as part of a larger study. Respondents were asked to
complete the Permissiveness and Non-Moralism subscales from the SAAS (Chappel et al.,
1985), a Likert-style self-report questionnaire. Additionally, participants were asked to respond
to the statement, “‘Doctors should be able to legally prescribe marijuana as medical therapy,’”
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(Charuvastra et al., 2005, p. 89). Results of a forward step-wise logistic regression revealed that
physician permissiveness and non-moralism, as measured by the SAAS, were predictive of
physicians’ opinions on the legalization of medical cannabis; those physicians who were more
permissive of substance use and less moralistic in their attitudes toward substance use were more
likely to support the legalization of medical cannabis. As Charuvastra et al. (2005) conclude, “In
light of the uncertainty and controversy regarding the medical benefits and harms of marijuana
prescription, it is not surprising that personal attitudes regarding substance use might influence
physicians’ views,” (p. 91). Unfortunately, although Charuvastra et al. (2005) utilized regression,
their decision to employ stepwise regression significantly compromises their results; as Field
(2013) writes, stepwise regression “[relies] on the computer selecting variables based upon
mathematical criteria… [taking] many important methodological decisions out of the hands of
the researcher,” (p. 323), and should not be used under virtually any circumstance because the
mathematical models may fail to include certain variables in a regression model which may be
supported by the theoretical model which informs the research.
Additionally, in a widely cited study, and the first known to explore physicians’ personal
cannabis use, Linn et al. (1989) surveyed 303 physicians from various medical specialties about
their personal cannabis use and opinions on the legalization of cannabis. Using one way analyses
of variance (ANOVAs) and chi-square tests, the authors – to their surprise – found that
physicians’ positions on the legalization of cannabis were unrelated to physicians’ specialties,
experience diagnosing substance use disorders or providing substance abuse treatment, or beliefs
about the efficacy of substance abuse treatment. Instead, physicians’ personal characteristics
predicted their attitudes toward the legalization of cannabis. Physicians who were less concerned
with the epidemic of drug use in the United States, and who were younger, less religious, and
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politically liberal, were significantly more likely to favor more lenient cannabis policies
(legalization or decriminalization versus criminalization) than older, more devout, and more
politically conservative physicians. As with the work of Kondrad and Reid (2013), Linn et al.’s
(1989) use of chi-square analyses limits the interpretability of these findings; it may be possible,
for example, that older physicians were also more likely to be more religious and more
politically conservative, and that one of these demographic variables, as opposed to all three,
accounts for the between-group differences observed. Nonetheless, the findings of Linn et al.
(1989) suggest that physicians’ personal opinions, as opposed to their medical experience, are
influencing their attitudes toward cannabis.
To date, only one known study (Norberg et al., 2012) has evaluated the impact of
healthcare professionals’ attitudes toward cannabis use on their provision of screenings and
referral to substance abuse treatment for cannabis users. Utilizing a sample of 664 primary care
physicians and nurses, the study asked participants about their attitudes toward cannabis use and
the legalization of medical cannabis. Utilizing logistic regression, Norberg and colleagues (2012)
found that nurses and physicians who believed that cannabis should not be available for medical
use were 2.06 times more likely to report that they had screened someone for cannabis use in the
past month than study participants who supported the legalization of medical cannabis,
suggesting that healthcare professionals’ personal beliefs about cannabis impact their provision
of services to patients. It must be noted, however, that the use of self-reported service provision
as an outcome variable compromises the validity of the study, as it is likely that healthcare
professionals’ estimates of their past-month service provision are inaccurate, and potentially
biased by their attitudes toward provision of services to cannabis users, such that individuals who
do not approve of cannabis use would be more likely to overestimate their provision of cannabis-
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related screening and intervention services.
Of note, two of the aforementioned studies which have explored the impact of healthcare
professionals’ personal attitudes toward cannabis use have looked at physicians’ attitudes toward
the (medical or recreational) legalization of cannabis as an outcome variable (Linn et al., 1989;
Charuvastra et al., 2005). Needless to say, physicians’ attitudes toward the legalization of
cannabis may have little to do with their clinical judgment or professional practices; as Galston
and Dionne Jr. (2013) note, public opinion about the legalization of cannabis is often related to
many other considerations beyond individuals’ perceptions of cannabis’ risks. Nonetheless, as
Linn and colleagues (1989) note, physicians are considered to be authorities on matters relating
to individuals’ health, including substance use, and as such, their opinions on whether or not
cannabis should be legalized are a form of professional practice, as are the opinions of mental
health professionals. Given that healthcare professionals’ attitudes toward the legalization of
cannabis, as well as their willingness to prescribe cannabis, are related to their personal beliefs
about cannabis, healthcare professionals’ personal attitudes and the impact of these attitudes are
ripe for further exploration, especially at a time of widespread changing cultural attitudes toward
cannabis legalization and use among the general public.
Behavior
The question at the core of the present study was, “Do doctoral psychology trainees’
attitudes toward cannabis impact their clinical judgment in identifying cannabis use disorder?”
Put more simply, this question, at its essence, embodies one of the core inquiries of social
psychology: Do attitudes impact behavior? As I have already demonstrated, prior research
suggests that healthcare professionals’ attitudes toward the legalization of cannabis and the
prescription of cannabis are closely related to their personal attitudes. What remains to be seen is
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what shapes healthcare professionals’ perceptions of the risks of cannabis use.
One factor which appears to influence individuals’ beliefs about cannabis, and their
support for the legalization of cannabis, is their personal cannabis use. According to the Pew
Research Center (2013), 70 percent of individuals who have used cannabis support its
legalization for recreational use, yet strikingly, among those who have never used cannabis, this
percentage is halved, with only 35 percent supporting the legalization of cannabis. Such a
noticeable difference may indicate a role for the theory of cognitive dissonance in explaining
individuals’ attitudes toward cannabis, such that individuals who use cannabis will develop more
positive views toward cannabis in order to reduce the psychological discomfort they would
otherwise experience from using a potentially harmful and addictive substance.
Festinger’s (1957) Theory of Cognitive Dissonance
In the introduction to his book, A Theory of Cognitive Dissonance, Festinger (1957)
writes,
It has frequently been implied… that the individual strives toward consistency within
himself. His opinions and attitudes, for example, tend to exist in clusters that are
internally consistent… There is the same kind of consistency between what a person
knows or believes and what he does. (p. 1-2)
As this passage indicates, the theory of cognitive dissonance, which Festinger goes on to
describe in his text, is based on the premise that individuals seek consistency (a) between their
various attitudes and beliefs and (b) between their attitudes and behavior.
Despite the fact that individuals may prefer consistency between their attitudes and
between attitudes and behavior, individuals may not always act in ways which are consistent
with their attitudes. For example, as Festinger (1957) describes, many individuals smoke
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cigarettes despite knowing that smoking is bad for one’s health. This inconsistency between
individuals’ beliefs – that smoking is a health hazard – and their behavior – continuing to smoke
– is know as cognitive dissonance.
In addition to defining cognitive dissonance, Festinger (1957) makes a second crucial
assertion in his initial description of cognitive dissonance: cognitive dissonance creates
psychological discomfort. As such, cognitive dissonance acts as a negative feedback loop,
compelling the individual to resolve the dissonance, thereby reducing the psychological
discomfort that the inconsistency between opposing cognitions or opposing cognitions and
behavior creates.
When individuals become aware that they have acted in a manner which is inconsistent
with their beliefs, or that they hold two or more logically inconsistent beliefs, what can they do
to reduce this discomfort? As Festinger (1957) theorizes, there are two ways to resolve cognitive
dissonance: (1) the individual may change their future behavior such that it coincides with their
beliefs, or (2) the individual may, as Festinger puts it, “change [their] ‘knowledge’” (p. 6); in
other words, the individual may convince him/herself that they believe something which aligns
with their behavior, or they may intentionally seek out information which confirms an attitude
which supports their behavior.
Cognitive Dissonance and Substance Use
When individuals who use substances experience cognitive dissonance associated with
their substance use, research has demonstrated that they have a tendency to alter their attitudes –
rather than their behaviors – to resolve the dissonance. For example, studies of cognitive
dissonance among individuals who smoke have repeatedly found that cigarette smokers have a
tendency to underestimate the health-related risks associated with smoking; this attitude reduces
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the psychological discomfort which would otherwise arise from the inconsistency between
smokers’ behavior (smoking cigarettes) and their knowledge that smoking has been associated
with adverse health outcomes, including lung cancer, respiratory illnesses, and death (Halpern,
1994; McMaster & Lee, 1991;Tagliacozzo, 1979).
In addition to studies exploring cognitive dissonance among smokers, literature has
indicated that cognitive dissonance may play a critical role in maintaining cannabis use among
those who use this drug. According to Peretti-Watel (2006), in societies in which cannabis use is
viewed by the dominant culture as a social ill and/or risky behavior, as has historically been the
case in the United States, individuals who use cannabis must “‘neutralise’ the social and legal
stigma attached to their practice by convincing themselves that such stigma reflects the opinion
of people who don’t know anything about the matter,” (p. 1035). In order to rationalize their
behavior, Peretti-Watel (2006) argues, individuals who use marijuana
scapegoat “hard drug” users and establish a systematic differentiation between so-called
“hard” and “soft” drugs. Cannabis users also emphasise their ability to control their
consumption personally. Lastly, they tend to consider that cannabis use is not unhealthier
than drinking alcohol or cigarette smoking… Cannabis users… reject the stigmatized
stereotype of the drug addict, they consider their consumption a recreational and
convivial activity, and their belonging to a peer group confirms this opinion. (p. 1035)
A quantitative study of French adolescents conducted by Peretti-Watel (2006) supports the
notion that cannabis users have a tendency to alter their attitudes, rather than their behavior, in
order to rationalize their cannabis use and reduce the psychological discomfort associated with
cognitive dissonance. According to Peretti-Watel (2006), adolescents’ tendency to deny the
riskiness of marijuana use was strengthened by their own use and by peer use. Additionally,

31
Peretti-Watel (2006) found that French adolescents’ tendency to deny risk was positively
correlated with academic achievement, but was not at all correlated with exposure to drug
education provided at school, suggesting, as Peretti-Watel (2006) concludes, that these attitudes
should be viewed as “a learned skill, not a lack of knowledge,” (p. 1045).
Cognitive Dissonance and the Healthcare Professional
Healthcare professionals are not immune to cognitive dissonance; indeed, research on
healthcare professionals, including physicians and nurses, has consistently indicated that
healthcare professionals’ own health-related behavior influences their provision of services to
patients. For example, compared to healthcare professionals who do not smoke cigarettes, a
number of studies have demonstrated that primary care physicians and nurses who smoke are
less likely to ask patients about smoking habits, to recommend that patients quit smoking, to
provide evidence-based smoking cessation interventions to patients, and to have high selfefficacy when it comes to providing smoking cessation interventions (Aboyans, Pinet, Lacroix,
& Laskar, 2009; Barengo, Sandstrom, Jormanainen, & Myllykangas, 2005; Behbehani,
Hamadeh, & Macklai, 2004; Brotons et al., 2005; Gunes, Karaoglu, Genc, Pehlivan, & Egri,
2005; Hall, Vogt, & Marteau, 2005; Heath, Andrews, Kelley, & Sorrell; 2004; Kawahara et al.,
2000; McKenna et al., 2001; Parna et al., 2005; Pipe, Sorensen, & Reid, 2009; Pizzo, Chellini,
Grazzini, Cardone, & Badellino, 2003; Squier, Hesli, Lowe, Ponamorenko, & Medvedovskaya,
2006; Yan et al., 2008); these findings are consistent cross-nationally, and have been replicated
in multiple countries across Asia, Europe, and North America. Similarly, a meta-analysis of 14
American and Chinese studies conducted by Zhu, Norman, & While (2011) concluded that
overweight and obese healthcare professionals were less confident in their ability to provide
weight management education and intervention for overweight or obese patients, perceived more
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barriers to providing weight management interventions, and had more negative outcome
expectations of weight management interventions than their normal-weight colleagues.
Additionally, healthcare professionals’ own fitness behavior has been found to predict their
tendency to provide counseling on physical fitness to their patients (Abramson, Stein, Schaufele,
Frates, & Rogan, 2000; Al-Doghether, Al-Tuwijri, & Khan, 2007; Frank, Bhat Schelbert, &
Elon, 2003; Rogers et al., 2006). These findings have also been replicated among medical
students (Frank, Carrera, Elon, & Hertzberg, 2007). As Lobelo, Duperly, and Frank (2009), in a
review of physician fitness practices, conclude, the association between healthcare professionals’
personal healthcare practices and their professional behavior “is strong and independent of many
demographic, training, and clinical practice factors… [This] relationship is already present at the
beginning of medical training, [and] is evident in students from both developed and developing
nations,” (p. 91). In sum, healthcare professionals who “practice what they preach,” as the saying
goes, provide more effective health-related interventions, while those who do not follow basic
preventive health guidelines in their personal lives demonstrate a bias which has significant
implications for professional practice.
In addition to research which has explored healthcare professionals’ weight management,
physical fitness, and cigarette smoking, multiple studies have explored the impact of healthcare
professionals’ alcohol consumption on their professional practices, including assessment of
alcohol abuse and provision of alcohol-related preventive healthcare interventions. Research on
healthcare professionals’ attitudes toward alcohol use, and the impact of these attitudes on
professional behavior, may provide much insight into how healthcare professionals’ beliefs about
cannabis use may impact their related clinical practice. Whereas recent public health campaigns
and contemporary medical science have emphasized the risks associated with smoking tobacco,
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poor diet and obesity, and poor physical fitness, the matter of alcohol use is unique in that both
the public and healthcare professionals believe that alcohol, when used by adults in moderation,
carries minimal risk and may have some health benefits; in this sense, attitudes toward alcohol
consumption more closely resemble current beliefs about recreational cannabis use. Additionally,
whereas a comparatively small percentage of healthcare professionals in the United States smoke
cigarettes (Frank et al., 1998; Pipe et al., 2009), many more healthcare professionals drink
alcohol, in part due to its widespread social acceptance. Further, in lieu of training on the
diagnostic criteria for alcohol use disorders and national guidelines defining binge drinking,
healthcare professionals may rely on personal standards for identifying alcohol misuse in
patients, which, if healthcare professionals are misusing or abusing alcohol themselves, may
result in a failure to accurately diagnose and provide much needed intervention to patients
abusing alcohol, even if the professionals’ alcohol misuse itself has not resulted in professional
impairment (Frost-Pineda, VanSusteren, & Gold, 2004; Johnson, Booth, & Johnson, 2005). This
may also be the case for cannabis, which for many years was not considered to be an addictive
substance, even within the medical community, a belief that has been perpetuated among those
who support legalization of recreational cannabis in recent years (Szalavitz, 2010).
Multiple studies have supported the notion that healthcare professionals’ personal alcohol
use influences their professional practices. In one such study of 3,193 Finnish primary care
physicians (Aalto & Seppa, 2007), respondents were asked to complete the Alcohol Use
Disorders Identification Test (AUDIT; Saunders, Aasland, Babor, de la Fuente, & Grant, 1993),
a popular Likert-style self-report measure typically used to screen for problem alcohol use, and
to answer the question, “‘How many drinks should a male/female patient drink in a week to
make you advise him/her to drink less?’” (p. 1322). Results suggested that physicians whose
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AUDIT scores indicated that they drank heavily reported higher mean thresholds at which they
would intervene in patients’ alcohol consumption by advising that consumption be reduced.
Similar findings were noted in a study of primary care doctors in Sweden (Geirsson, Hensing, &
Spak, 2009), in which a short-form of the AUDIT, the AUDIT-C (Bush, Kihlavan, McConell,
Fihn, & Bradley, 1998), was used.
In addition to quantitative evidence supporting the notion that healthcare professionals’
own alcohol consumption may influence their perceptions of patients’ alcohol misuse, one
qualitative study, based on a sample of primary care nurses from England, sheds light on the
notion that healthcare professionals’ alcohol use may color their perceptions of their patients’
alcohol use. Using a grounded theory approach, Lock, Kaner, Lamont, & Bond (2002)
interviewed 24 primary care nurses about their “attitudes to alcohol intervention, including
perceived barriers and facilitating factors, which influence their involvement in this area of
work,” (p. 334). As Lock et al. (2002) write, nurses may avoid engaging in discussions about
alcohol use with patients because of their own attitudes toward drinking. As one nurse reported,
I’m fairly lax on what [the patients] drink because I enjoy wine, so from a personal point
of view I wouldn’t actually, unless somebody’s needing alcohol every day, if someone’s
having a bottle at the weekend of wine and maybe one Gin and Tonic I wouldn’t bat an
eye lid at that quite honestly. (p. 339)
Another nurse reported
I know how I feel on a Friday night, I like my 5 brandies, I like to have 5 brandies or 5
gin and tonics on a Friday night because I’ve had enough of Monday to Friday and I need
this thing that relaxes me and says this is the weekend now. (p. 339)
Perhaps most telling, however, is the statement of a third nurse interviewed by Lock et al. (2002)
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when asked about her perceptions of her patients’ alcohol intake: “Oh gosh, I drink much more
than that!” (p. 339).
Healthcare Professionals’ Cannabis Use
Unlike healthcare professionals’ use of legal substances (e.g., tobacco, alcohol), there is
limited information on healthcare professionals’ personal cannabis use and the influence of this
behavior on healthcare professionals’ professional opinions, clinical judgments, and behavior. Of
the four studies which have explored the healthcare professionals’ attitudes toward medical or
recreational cannabis, or their professional behaviors related to patient cannabis use (Charuvastra
et al., 2005; Kondrad & Reid, 2013; Linn et al., 1989; Norberg et al., 2012), only two studies
(Kondrad & Reid, 2013; Linn et al., 1989) have investigated the influence of personal cannabis
use on healthcare professionals’ professional attitudes and practices (a third study, conducted by
Norberg and colleagues (2012) attempted to investigate the role of personal cannabis use, but
only one of the study’s 664 participants admitted to using cannabis and no conclusions could be
drawn). Despite this limited body of research, it is clear that personal cannabis use is related to
healthcare professionals’ opinions about cannabis as these opinions pertain both to the
legalization of cannabis and to their clinical work.
In Linn et al.’s (1989) study of 303 physicians’ attitudes toward the legalization of
cannabis, 55% of those physicians surveyed reported having used cannabis at sometime in their
lives, with nine percent reporting current use. Chi-square analyses revealed that individuals who
had used cannabis at some point in their lives were significantly more likely to support more
lenient penalties for cannabis possession than those who had never used cannabis.
In Kondrad and Reid’s 2013 study of Colorado family physicians, the authors did not
directly ask respondents whether they had ever used cannabis or currently used cannabis;
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however, they did ask respondents whether personal cannabis use was a source of information
which influenced their decision to recommend cannabis to patients. Of those surveyed, 20
participants reported that their cannabis use influenced their professional opinions about
recommending cannabis. Compared to respondents who did not report that their personal
cannabis use was an influence on their recommendation of cannabis to patients, those who
reported that they used cannabis were significantly less likely to believe that cannabis is
addictive and that cannabis poses serious mental health risks than those who did not report
cannabis use. Additionally, physicians who reported cannabis use were significantly less likely to
believe that doctors should be required to have ongoing relationships with patients to whom they
prescribe cannabis than those who did not report cannabis use. Although the results of this
analysis are not generalizable due to the small sample of physicians who endorsed cannabis use,
Kondrad and Reid’s (2013) findings suggest – definitively – that some healthcare professionals’
personal cannabis use is an influence on their professional practices, and also that healthcare
professionals’ personal cannabis use appears to be associated with decreased perceptions of
cannabis’ risks and denial of cannabis use disorder, at least among some.
As the research reviewed demonstrates, healthcare professionals’ personal health-related
behaviors, including cannabis use, appear to bias their judgments of their patients’ own practices
in a manner which may pose a risk to patients whose problem health-related behaviors ultimately
go unnoticed and untreated as a result. Although this bias has not previously been evaluated
through the framework of cognitive dissonance (indeed, this may be methodologically
impossible, as healthcare professionals’ initiation of alcohol use and other health-related
behaviors likely pre-date their careers), it is not unreasonable to conclude that healthcare
professionals who use cannabis may, like the general public, “change [their] ‘knowledge,’”
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(Festinger, 1957, p. 6), to permit their cannabis use to continue, a cognitive tactic which in turn
biases their professional judgment.
Summary and Conclusions
This chapter has identified several important factors which serve as the framework for the
proposed study. First, healthcare professionals’ clinical judgments may be prone to bias.
Research has demonstrated that healthcare professionals’ personal attitudes toward substance use
and their perceptions of risks associated with cannabis use influence their opinions on the
legalization of recreational and medical cannabis, their decisions to recommend cannabis to their
patients, and their provision of cannabis use disorder screening and intervention. Second,
healthcare professionals’ own health-related behaviors and personal substance use may bias their
clinical judgment, which may result in a failure to make appropriate recommendations to patients
at risk for adverse consequences secondary to their poor health-related behavior and/or problem
substance use. Preliminary research has indicated that this bias may also impact healthcare
professionals’ judgments about the risk of harm associated with cannabis use and their tendency
to recommend medical cannabis to patients. In this chapter, I have suggested that the attitudinal
bias seen among healthcare professionals who engage in risky substance use, including cannabis
use, may be a result of cognitive dissonance.
Limitations of Existing Studies
While a substantial body of research has explored healthcare professionals’ legal healthrelated and substance use behaviors, much less research has explored healthcare professionals’
use of illicit substances and how their use of substances such as cannabis may impact their
perceptions of the risks associated with cannabis use or their clinical judgment regarding patient
cannabis use. This is understandable, given that cannabis is an illicit substance and healthcare
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professionals may be hesitant to self-report illegal activity; however, given the changing cultural
landscape around cannabis, which may result in increased cannabis consumption and
subsequently, increased problem cannabis use, it is imperative that researchers assess the role
that healthcare professionals’ personal use of cannabis may play in their assessments of patients’
cannabis use. If, as it has been posited, healthcare professionals who use cannabis subsequently
view cannabis use less seriously, there is a significant risk that patients in need of substance
abuse treatment will go unnoticed.
In addition, of those studies which have been conducted exploring healthcare
professionals’ personal cannabis use, beliefs about the risks of cannabis use, and attitudes toward
substance use generally, none have used analogue methodology; rather, the majority of studies
on this topic have either (a) asked healthcare professionals about their opinions on the
legalization of medical and/or recreational cannabis, or (b) relied on participants’ self-reported
practices in order to gauge how their behaviors and/or beliefs had impacted their professional
judgment. Such methodology may be prone to error (e.g., participants’ incorrectly estimating
how many referrals for substance abuse treatment they have made over a specific period of time)
or fail to effectively operationalize clinical judgment, because respondents may support the
legalization or decriminalization of cannabis despite viewing cannabis use as a high-risk
behavior, as noted by Galston and Dionne Jr. (2013).
Finally, and most notably, to date, no studies have explored doctoral psychology trainees’
personal use of cannabis, their perceptions of the risks associated with cannabis use, or their
attitudes toward substance use more generally. The next generation of mental healthcare
professionals, who will inevitably see increasing rates of cannabis use disorder, must be able to
accurately identify problem cannabis use; accordingly, it is critical that research explore barriers
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which may impede identification of cannabis use disorder.
The Current Study
In order to address gaps in the extant literature, the current study explored the influence
of doctoral psychology trainees’ personal cannabis use, perceptions of cannabis’ risks, and
attitudes toward substance use on their ability to identify cannabis use disorder. In order to
address the limitations of prior research on healthcare professionals’ personal use of and attitudes
toward cannabis, the study was conducted anonymously through a web-based survey platform in
order to reduce participants’ hesitance to self-report illicit substance use. Additionally, the study
utilized analogue methodology to assess trainees’ ability to identify cannabis use disorder, rather
than self-reported service provision or attitudes toward legalization. The goal of the study was
twofold: First, the study sought to identify whether doctoral psychology trainees’ personal
cannabis use predicted their perceptions of cannabis’ risks and attitudes toward substance use
generally. Second, the study sought to explore whether doctoral psychology trainees’ personal
cannabis use, perceptions of cannabis’ risks, and non-moralistic, permissive, and nonstereotypical attitudes toward substance use predicted their ability to identify cannabis use
disorder.
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CHAPTER III
Methodology
The study used a quantitative, quasi-experimental survey design with analogue
methodology. Using a vignette describing a client who met criteria for cannabis use disorder, the
current study explored factors that influence doctoral psychology trainees’ ability to identify
cannabis use disorder in clients. In light of gaps in the extant literature on which factors may
influence doctoral psychology trainees’ clinical judgment, personal factors which have
previously been implicated in clinical judgment among healthcare professionals were explored;
these included (1) personal cannabis use, (2) non-moralistic, permissive, and non-stereotypical
attitudes toward substance use, and (3) perceptions of cannabis’ risks.
The study sought to answer the following questions:
1) Does doctoral psychology trainees’ personal cannabis use predict trainees’
perceptions of cannabis’ risks?
2) Does doctoral psychology trainees’ personal cannabis use predict trainees’ attitudes
toward substance use?
3) Are perceptions of cannabis’ risks associated with attitudes toward substance use?
4) Do personal cannabis use history, perceptions of cannabis’ risks, and attitudes toward
substance use predict doctoral psychology trainees’ ability to identify cannabis use
disorder from a clinical vignette?
Based on these questions, the following hypotheses were examined:
1) Doctoral psychology trainees who reported current or past use of cannabis would
have more positive attitudes regarding the benefits and risks of cannabis use.
Specifically, doctoral psychology trainees who reported current or past use of
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cannabis would report (1a) lower perceptions of cannabis’ risks as compared to
individuals who denied cannabis use. (1b) Doctoral psychology trainees’ perceptions
of cannabis’ risks would be lower among those who endorsed current cannabis use.
Additionally, (1c) perceptions of cannabis’ risks would decrease as trainees’ own risk
of problem cannabis use increased.
2) Doctoral psychology trainees who reported current or past use of cannabis would (2a)
endorse more permissive attitudes toward substance use than trainees who denied
cannabis use. Additionally, (2b) doctoral psychology trainees who reported current or
past use of cannabis would endorse more non-moralistic attitudes toward substance
use than trainees who denied cannabis use. Doctoral psychology trainees who
reported current or past use of cannabis would also (2c) endorse more nonstereotyped attitudes toward substance use. (2d) Non-moralistic, (2e) permissive, and
(2f) non-stereotyped attitudes toward substance use would be higher among those
who currently used cannabis than those with a history of prior use. Additionally,
trainees’ risk of problem cannabis use would predict (2g) non-moralistic, (2h)
permissive, and (2i) non-stereotyped attitudes toward substance use.
3) Doctoral psychology trainees’ perceptions of cannabis’ risks would be negatively
correlated with (3a) trainee permissiveness (3b) trainee non-moralism, and (3c)
trainee non-stereotyping toward substance use.
4) Trainees’ cannabis use, risk of cannabis use problems, perceptions of cannabis’ risks,
and attitudes toward substance use would predict trainees’ ability to identify cannabis
use disorder from a clinical vignette.
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Research Design
Participants and Sample Characteristics
Participants in the current study were 141 doctoral psychology trainees. Participants were
recruited in two ways. Although the author originally planned to distribute recruitment materials
via multiple online mailing lists operated by the American Psychological Association, this was
ultimately not feasible, as the Association prohibits doctoral trainees from soliciting research
participants via its mailing lists. Instead, snowball sampling was employed. Letters of solicitation
were sent to colleagues of the author who were also enrolled in doctoral programs or who were
recent graduates, inviting them to participate in the study if they were eligible and/or pass
information about the study along to any students they believed were eligible to participate
(Appendix A). Additionally, letters of solicitation were distributed to doctoral program training
directors asking them to forward information about the study to their students (Appendix B). In
order to avoid inadvertent coercion, training directors were asked to have a department
administrator, graduate assistant, or an equivalent staff member in a non-evaluative role forward
recruitment materials to students. All recruitment materials clearly stated that the study was
voluntary and anonymous. In return for their participation, all participants were given the option
to enter a drawing for one of six $50 Amazon.com virtual gift cards.
In order to ensure that study participants were doctoral psychology trainees in clinical or
counseling psychology or related fields, participants were required to be currently enrolled in a
Ph.D., Psy.D., or Ed.D. program in clinical psychology, counseling psychology, or other related
professional psychology disciplines at the time of participation. Participants in non-applied
psychology disciplines (e.g., those in experimental psychology doctoral programs) were not
eligible to participate, as clinical work (e.g., assessment and treatment of mental disorders) is not
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a core competency in these disciplines.
According to multiple simulation studies, in order to avoid an overfit model, studies
utilizing logistic regression as the primary analysis, such as the proposed study, should include
10 cases per predictor variable for each dependent variable outcome (Agresti, 2007; Peduzzi,
Concato, Kemper, Holford, & Feinstein, 1996; Stoltzfus, 2011). In the current study, the primary
analysis (Question 4) included six predictor variables: (1) trainee history of cannabis use, (2)
trainee risk of cannabis use problems, (3) trainee perceptions of cannabis’ risks, (4) trainee
permissiveness toward substance use, (5) trainee non-moralism toward substance use, and (6)
trainee non-stereotyping toward substance use, and a dependent variable with two outcomes
(yes/no to diagnosis of cannabis use disorder). Accordingly, the sample size necessary for the
present study was estimated at 120 participants. An a priori power analysis performed using
G*Power (Version 3.1 for Mac; Faul, Erdfelder, Buchner, & Lang, 2009) produced a
recommended sample size of 123, consistent with this estimate. Of the 141 participants who
ultimately completed the survey, 18 responses were flagged for missing data; these participants
were removed from further analysis (see Chapter IV for additional information about this
decision), resulting in a sample size of N = 123.
Participants retained in the current study ranged in age from 22 to 40 years (M = 29.1
years, SD = 4.1). The majority of participants identified as female (77.2%) and White (NonLatino) (74%). Participants represented a range of religious affiliations, and the majority (53.7%)
reported that they identified as democrats. Participants’ cannabis use history was approximately
evenly split among the sample, with 43 participants (35%) reporting that they had never used
cannabis, 36 (29%) endorsing past cannabis use, and 44 (36%) endorsing current (past year)
recreational cannabis use. Table 3.1 presents the demographic characteristics of the overall
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sample, as well as broken down by reported cannabis use history.
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Table 3.1
Means, Standard Deviations, Frequencies, and Percentages of Participant Demographics
Characteristic
Age (Myears ± SDyears)
Sex (Frequency)
Male
Female
Other
Race/Ethnicity (Frequency)
African American, Caribbean
American, or Black
Asian American
Latina/Latino
Native American
White (Non-Latino)
Biracial/Multiracial
International Student
Other
Religious Affiliation (Frequency)
Buddhist
Catholic/Christian
Jewish
Native American
Pagan
Sikh
Spiritualist
Unitarian/Universalist
Atheist
Agnostic
Humanist
No religion
Multifaith
Other
Political Affiliation (Frequency)
Democrat
Republican
Independent
Other

Overall Sample
(N = 123)
29.1 ± 4.1

Current Cannabis Users
(n = 44)
29.0 ± 3.7

Past Cannabis Users
(n = 36)
30.0 ± 4.1

Denied Cannabis Users
(n = 43)
28.5 ± 4.4

27 (22.0%)
95 (77.2%)
1 (0.8%)

14 (31.8%)
30 (68.2%)
0 (0.0%)

7 (19.4%)
28 (77.8%)
1 (2.8%)

6 (14.0%)
37 (86.0%)
0 (0.0%)

5 (4.1%)
6 (4.9%)
6 (4.9%)
1 (0.8%)
91 (74.0%)
8 (6.5%)
4 (3.3%)
2 (1.6%)

1 (2.3%)
1 (2.3%)
3 (6.8%)
1 (2.3%)
32 (72.7%)
4 (9.1%)
1 (2.3%)
1 (2.3%)

2 (5.6%)
2 (5.6%)
3 (8.3%)
0 (0.0%)
25 (69.4%)
3 (8.3%)
0 (0.0%)
1 (2.8%)

2 (4.7%)
3 (7.0%)
0 (0.0%)
0 (0.0%)
34 (79.1%)
1 (2.3%)
3 (7.0%)
0 (0.0%)

3 (2.4%)
42 (34.1%)
18 (14.6%)
1 (0.8%)
1 (0.8%)
1 (0.8%)
4 (3.3%)
1 (0.8%)
15 (12.2%)
13 (10.6%)
4 (3.3%)
13 (10.6%)
2 (1.6%)
5 (4.1%)

1 (2.3%)
10 (22.7%)
9 (20.5%)
1 (2.3%)
1 (2.3%)
1 (2.3%)
0 (0.0%)
0 (0.0%)
6 (13.6%)
5 (11.4%)
0 (0.0%)
7 (15.9%)
1 (2.3%)
2 (4.5%)

1 (2.8%)
11 (30.%)
4 (11.1%)
0 (0.0%)
0 (0.0%)
0 (0.0%)
2 (5.6%)
1 (2.8%)
3 (8.3%)
4 (11.1%)
3 (8.3%)
3 (8.3%)
1 (2.8%)
3 (8.3%)

1 (2.3%)
21 (48.8%)
5 (11.6%)
0 (0.0%)
0 (0.0%)
0 (0.0%)
2 (4.7%)
0 (0.0%)
6 (14.0%)
4 (9.3%)
1 (2.3%)
3 (7.0%)
0 (0.0%)
0 (0.0%)

66 (53.7%)
9 (7.3%)
26 (21.1%)
22 (17.9%)

30 (68.2%)
1 (2.3%)
7 (15.9%)
6 (13.6%)

15 (41.7%)
3 (8.3%)
8 (22.2%)
10 (27.8%)

21 (48.8%)
5 (11.6%)
11 (25.6%)
6 (14.0%)
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In regards to doctoral training, the majority of participants in the current study reported
that they were enrolled in Ph.D. programs (83.7%). Nearly half of the sample reported that they
hailed from counseling psychology programs (49.6%). Participants varied in the years of training
they reported, with slightly more reporting that they were in their fourth year of training or
beyond (58.5%); the majority reported that they had yet to start internship (79.7%). Table 3.2
presents the graduate training characteristics of the overall sample, as well as broken down by
reported cannabis use history.
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Table 3.2
Frequencies and Percentages of Sample Training Characteristics

Characteristic
Degree Type
Ph.D.
Psy.D.
Discipline
Clinical Psychology
Counseling Psychology
School Psychology
Other
Standing in Doctoral Program
1st Year
2nd Year
3rd Year
4th Year
5th Year
6th Year
7th Year or Beyond
Internship Status
Currently
Completing/Completed
Not yet started

Overall Sample
(N = 123)

Current Cannabis
Users
(n = 44)

Past Cannabis
Users
(n = 36)

Denied Cannabis
Users
(n = 43)

103 (83.7%)
20 (16.3%)

34 (77.3%)
10 (22.7%)

32 (88.9%)
4 (11.1%)

37 (86.0%)
6 (14.0%)

53 (43.1%)
61 (49.6%)
4 (3.3%)
5 (4.1%)

25 (56.8%)
17 (38.6%)
1 (2.3%)
1 (2.3%)

15 (41.7%)
19 (52.8%)
0 (0.0%)
2 (5.6%)

13 (30.2%)
25 (58.1%)
3 (7.0%)
2 (4.7%)

20 (16.3%)
9 (7.3%)
22 (17.9%)
34 (27.6%)
21 (17.1%)
15 (12.2%)
2 (1.6%)

8 (18.2%)
1 (2.3%)
9 (20.5%)
12 (27.3%)
9 (20.5%)
5 (11.4%)
0 (0.0%)

2 (5.6%)
4 (11.1%)
7 (19.4%)
8 (22.2%)
6 (16.7%)
7 (19.4%)
2 (5.6%)

10 (23.3%)
4 (9.3%)
6 (14.0%)
14 (32.6%)
6 (14.0%)
3 (7.0%)
0 (0.0%)

25 (20.3%)
98 (79.7%)

7 (15.9%)
37 (84.1%)

11 (30.6%)
25 (69.4%)

7 (16.3%)
36 (83.7%)
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In addition to collecting general information on participants’ doctoral training
experiences, participants were also asked whether they had received specialized training in the
diagnosis and treatment of substance use disorders. Contrary to previous literature which has
indicated that doctoral psychology trainees receive minimal to no formal training in substance
use disorder treatment (e.g., see Aanavi et al., 1999; Chiert et al., 1994; da Silva Cardoso et al.,
2006; Lubin et al., 1986; Madson et al., 2008; Selin & Svanum, 1981), the majority of
participants in the current study (78.9%) reported that they had received some training in
substance use disorders over the course of graduate school. Table 3.3 presents the substance use
disorder training characteristics of the overall sample, as well as broken down by reported
cannabis use history.
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Table 3.3
Participants’ Substance Use Disorder Training Characteristics as Frequencies and Percentages
Overall Sample
(N = 123)

Current Cannabis Users
(n = 44)

Past Cannabis Users
(n = 36)

Denied Cannabis Users
(n = 43)

97 (78.9%)

38 (86.4%)

29 (80.6%)

30 (69.8%)

"I have taken a graduate-level course (or
multiple courses) on addiction or
substance use disorder treatment."

41 (33.3%)

20 (45.5%)

12 (33.3%)

9 (20.9%)

"I have attended a workshop or conference
on addiction or substance use disorder
treatment."

44 (35.8%)

19 (43.2%)

11 (30.6%)

14 (32.6%)

"I am currently completing, or have
previously completed an externship,
internship, or similar clinical training
experience in which substance use
disorders treatment was a primary
focus."

42 (34.1%)

18 (40.9%)

13 (36.1%)

11 (25.6%)

"I have worked with clients with problem
substance use or substance use disorder
diagnoses."

83 (67.5%)

33 (75.0%)

25 (69.4%)

25 (58.1%)

"I have conducted research on substance
use/addiction."

13 (10.6%)

8 (18.2%)

3 (8.3%)

2 (4.7%)

8 (6.5%)

3 (6.8%)

2 (5.6%)

3 (7.0%)

26 (21.1%)

6 (13.6%)

7 (19.4%)

13 (30.2%)

Substance Use Disorder Training
Endorsed

"I have completed training toward
certification as a substance abuse
counselor, or am certified as a
substance abuse counselor."
Denied
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Participants who identified as current cannabis users completed the Cannabis Use
Problems Identification Test (CUPIT), a screening measure (Bashford et al., 2010; discussed
further below). Of the 44 participants who endorsed current cannabis use, eight (18.2%) received
scores of 12 or higher on this measure, considered a positive screen for problem cannabis use on
the CUPIT; of these eight, two participants from this group received scores greater than 20,
indicating that they met criteria for cannabis use disorder. Participants’ responses to Item 1 of the
CUPIT revealed that of the 44 participants who endorsed current cannabis use, 28 (63.6%)
reported that they used cannabis less than once per month during the past year, five (11.4%)
reported that they had used cannabis approximately once monthly during the past year, eight
(18.2%) reported that they had used cannabis approximately 2-3 days/month over the past year,
one (2.3%) reported that she had used cannabis weekly over the past year, and two (4.5%)
reported that they had used cannabis at least 5-6 days/week over the past year. Given that only 44
participants endorsed current cannabis use, separating current users into subgroups based on the
frequency of their use would have resulted in low sample sizes for each subgroup and threatened
the effect size of subsequent analyses; accordingly, participants who identified as current users
were maintained as a single group for subsequent analyses.
Procedures
Prior to beginning study recruitment, approval from the author’s dissertation committee
and the Seton Hall University Institutional Review Board (IRB) was obtained.
Potential participants received letters of solicitation through the aforementioned avenues
of recruitment. Letters included an overview of the study, as well as a description of
requirements of participation, time commitment required to participate, and potential benefits
and risks associated with participation. Data was collected anonymously in order to protect the
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identity of individuals who endorsed cannabis use, which may have personal, professional, and
legal repercussions. Recipients of recruitment materials were informed in the letter of solicitation
that they would not be asked for any identifying information in the survey. Additionally,
participants were informed that the survey would employ anonymization features, ensuring that
IP addresses were not collected; this ensured that all data collected was anonymous and could
not be traced to respondents. Prospective participants were informed that their personal
information would be stored confidentially on a USB memory key, which would be kept in a
locked drawer at a secure physical site. Finally, participants were advised that they could print
the letter of solicitation for their personal records. Interested parties who had questions or
concerns about the study were advised to contact the principal investigator or the Seton Hall
University IRB with any questions. After reviewing the letter of solicitation, those who wished to
complete the study were directed to Qualtrics, an online, secure server-based survey platform.
Those who agreed to participate demonstrated consent by completing the survey.
After being directed to Qualtrics via a link in the letter of solicitation, participants were
presented with a brief set of demographic questions (Appendix C). Additionally, participants
were asked for basic information about their doctoral program (e.g., whether they were enrolled
in a Ph.D., Psy.D., or Ed.D program; the specialty of their program – e.g., clinical psychology,
counseling psychology, etc.; and how far they had progressed in their doctoral studies), in order
to confirm that they met inclusionary criteria for the study. Of note, in an effort to protect
participant anonymity, participants were not asked to identify their doctoral program or state of
residence. Although the decision not to collect demographic data related to residence restricted
the ability of the current study to assess differences in attitudes and diagnostic ability among
students in states where medical and/or recreational cannabis use is legal versus illegal – an
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interesting and timely vantage point from which to evaluate study data – given the possibility
that collecting this information in addition to other identifying demographics may have posed a
risk to participant anonymity, and the fact that such analyses were not central to the study’s
purpose, this omission was deemed suitable.
After completing the demographic questions, participants were presented with a vignette
about a college student named “John” (Appendix D). In the vignette, participants were told that
John presented for a mandatory drug and alcohol use assessment at the college counseling center
where they were an extern. In the vignette, John endorsed symptoms consistent with a diagnosis
of cannabis use disorder of moderate severity as defined by the DSM-5 (American Psychiatric
Association, 2013). The vignette was constructed by the principal investigator, and reviewed by
three licensed psychologists considered experts in the field of substance use disorders, as well as
the author’s dissertation advisor and committee members, all psychologists themselves.
Following the vignette, participants were asked to answer the question “Does John have cannabis
use disorder?” (yes/no). Once participants completed this question and progressed to the next
page of the survey, they were unable to return to the vignette, in order to prevent participants
from altering their initial answers.
After reviewing the vignette and responding to the associated question, participants were
asked to provide information about their personal cannabis use (Appendix E). Participants were
first asked to identify whether they currently used or had previously used cannabis. Participants
who reported current cannabis use (defined as use in the past 12 months) were asked to complete
the CUPIT (Bashford et al., 2010; Appendix F). Those who did not endorse current cannabis use
were directed to complete the PCURQ (adapted from Kondrad & Reid, 2013; Appendix G) and
the SAAS (Chappel et al., 1985; Appendix H). Individuals who were asked to complete the
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CUPIT completed these measures following their completion of the CUPIT. All measures are
described further below.
After completing the PCURQ and SAAS, participants were asked a final demographic
question regarding their histories of graduate training in the diagnosis and treatment of substance
use disorders (Appendix I). Individuals who endorsed having received specialized training in
substance use disorder assessment and/or treatment were prompted to identify what form(s) this
training took (e.g., coursework, practicum or internship experiences, etc.) Participants were
asked to select all types of training in which they had participated.
Following their completion of the survey, subjects were thanked for their participation
and asked not to discuss the purpose of the study with other potential participants, in order to
avoid biasing subsequent participants’ responses.
At the end of the study, participants were again provided with contact information for
Ms. Stratyner, as well as the Seton Hall University IRB should they have had any questions
about the study. Additionally, participants were invited to click on a hyperlink which directed
them to a separate survey where they were able to enter a raffle for one of six $50 Amazon.com
e-gift cards. Participation in the raffle was completely voluntary. In order to protect participant
anonymity, participants were only required to enter their email addresses in order to enter the
raffle, and could, if they so chose, use an email address that did not identify them. Furthermore,
as email addresses were provided in a separate survey, it was impossible to associate
participants’ study data with their email addresses. Finally, utilization of Amazon.com e-gift
cards as incentives maintained participant anonymity, as these gift cards can be delivered via
email (rather than by mail) and recipients’ names are not required to purchase/send gift cards.
Participants who did not complete all study items did not forfeit these benefits, and were able to
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proceed to the end of the study, click the link to the separate raffle survey, and enter the raffle.
Mean survey response time was 37 minutes; however, when respondents who took more than 10
hours to complete the survey (suggesting that they may have unintentionally left the survey open
in their internet browsers) were removed, mean response time was reduced to 18 minutes. The
majority of participants (63.83%) completed the survey in 8-16 minutes.
Instruments
Cannabis Use Problems Identification Test. The CUPIT (Bashford et al., 2010) is a 16item self-report screening instrument that measures current and potential problem cannabis use.
The CUPIT includes 2 subscales: Impaired Control (over cannabis use) and Problems (caused by
cannabis use). As the titles of these subscales imply, Impaired Control measures individuals’
consumption of and difficulty controlling their cannabis use (e.g., “On how many days have you
used cannabis during the past 12 months?” and “Have you felt you needed cannabis?”), while the
Problems subscale measures participants’ experiences of detrimental consequences attributed to
cannabis use (e.g., “Did your use of cannabis ever interfere with your work at school, job, or
your home life?”). Despite the two-factor structure of the CUPIT, total scores are used to
calculate problem cannabis use. Item scoring varies by item, with higher total scores indicating
increased risk of problem cannabis use. The measure utilizes a cutoff score of 12 or above as an
indication that individuals who complete the measure are at risk of developing cannabis use
disorder; scores of 20 or above indicate that individuals meet criteria for cannabis use disorder
(Bashford et al., 2010).
The CUPIT demonstrates strong internal consistency; in an initial validation study
utilizing a sample of 74 adults, Chronbach’s alphas were .92 for the Impaired Control subscale
and .90 for the Problems subscale (Bashford et al., 2010). In the current study, Chronbach’s
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alphas were .88 for the Impaired Control subscale and .72 for the Problems subscale. One-week
item test-retest reliability estimates are also strong, ranging from .89 to .99 in initial validation
studies of the measure, indicating that respondents’ scores on the CUPIT remain stable over time
(Bashford et al, 2010).
Concurrent validity of CUPIT scores is demonstrated by moderate to strong correlations
between CUPIT scores and number of Diagnostic and Statistical Manual of Mental Disorders,
Fourth Edition (DSM-IV; American Psychiatric Association, 1994) and International
Classification of Diseases, Tenth Edition (ICD-10; World Health Organization, 1992) symptoms
of cannabis use disorder endorsed, as well as with a previously validated measure of problem
cannabis use, the Cannabis Problems Questionnaire (Bashford et al., 2010; Copeland, Gilmour,
Gates, & Swift, 2005).
Perceptions of Cannabis Use Risks Questionnaire. To date, there are no standardized
assessments which exist to assess individuals’ perceptions of the risks of cannabis use;
accordingly, in order to assess individuals’ perceptions of the risk of harm from cannabis use, the
present study utilized an adapted version of a questionnaire developed in a previous study of
family physicians’ attitudes toward medical cannabis (Kondrad & Reid, 2013). The original
survey is a 17-item measure that assesses attitudes ranging from physicians’ views on the
legalization of recreational cannabis to their opinions on Colorado’s medical cannabis policy.
Items are answered using a 5-point Likert-style scale, ranging from 1 (strongly disagree) to 5
(strongly agree). Items included on the survey were evaluated for construct validity by six
family physicians and a psychologist; additionally, survey items were pilot-tested by 18 family
physicians and a psychiatrist (Kondrad & Reid, 2013). Despite these procedures, to date, there
are no published studies of validity or reliability for this measure.
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For the purposes of the current study, a revised version of the questionnaire utilized by
Kondrad and Reid (2013) was utilized in order to evaluate participants’ perceptions of risk
associated with cannabis use. In order to adapt Kondrad and Reid’s (2013) measure for these
purposes, items which inquired about physicians’ roles in the prescription of cannabis and the
medical utility of cannabis (e.g., “Training about medical marijuana should be incorporated into
medical school curricula,”) and items referring to Colorado’s medical cannabis legislation (e.g.,
“Medical marijuana should be included in the Colorado Prescription Drug Monitoring Program
(PDMP), which tracks prescribing and dispensing of controlled substances,”) were removed.
Additionally, as it has been suggested that individuals’ attitudes toward the legalization of
recreational and medical cannabis do not necessarily equate with individuals’ perceptions of
cannabis as a harmful substance (Galston, & Dionne Jr., 2013), items intended to assess
individuals’ attitudes toward Food and Drug Administration regulation or legalization of
cannabis were removed. The subsequent questionnaire includes five items which assess
individuals’ perceptions of the physical and mental health risks of cannabis, physical and mental
health benefits of cannabis, and the addictive properties of cannabis (Appendix G). Items on this
questionnaire have high face validity. In order to calculate a total score for this questionnaire,
reverse scoring was applied to items describing the benefits of cannabis use, and item scores
were added to create a continuous total score variable. Higher scores on the Perceptions of
Cannabis Use Risks Questionnaire (PCURQ) indicate greater perceived risk associated with
cannabis use. In order to evaluate the reliability of the PCURQ, Chronbach’s alpha was
calculated. The resulting statistic, α = .66, suggests that the PCURQ demonstrated acceptable
reliability in the current sample.
Substance Abuse Attitude Survey. The SAAS (Chappel et al., 1985) is a 50-item self-
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report measure of attitudes toward drug and alcohol misuse. The SAAS includes five subscales:
(1) Permissiveness, (2) Treatment Intervention, (3) Non-Stereotyping, (4) Treatment Optimism,
and (5) Non-Moralism. Items are answered using a 5-point Likert-type scale ranging from 1
(strongly disagree) to 5 (strongly agree), with higher scores indicating higher levels of
agreement with the value indicated by each subscale.
Permissiveness measures attitudes toward substance use which imply that respondents
view substance use as a component of normal human behavior (e.g., “Daily use of one marijuana
cigarette is not necessarily harmful.”). Treatment Intervention measures respondents’ tendency to
perceive substance misuse as a behavior which requires clinical attention (e.g., “Long-term
outpatient treatment is necessary for the treatment of drug addiction.”). Non-Stereotyping
measures respondents’ tendency to disagree with commonly held stereotypes of substance users
(e.g., “Recreational drug use precedes drug misuse.”). Treatment Optimism measures
respondents’ outlook on substance use disorder treatment (e.g., “An alcohol or drug dependent
person who has relapsed several times probably cannot be treated.”). Finally, Non-Moralism
measures respondents’ avoidance of perceptions of substance use as wrong or evil (e.g.,
“Alcoholism is associated with a weak will.”) It should be noted that hypotheses were only
generated for three of the five SAAS subscales: Permissiveness (P-SAAS) and Non-Moralism
(NM-SAAS), which have previously been associated with positive attitudes toward medical
cannabis among physicians (Charuvastra et al., 2005), and Non-Stereotyping (NS-SAAS), which
was hypothesized to be associated with personal cannabis use based on prior literature
suggesting that individuals who use cannabis reject stereotypical notions of the drug addict
(Peretti-Watel, 2006); however, in order to preserve instrument validity, the entire instrument
was administered, and only the three subscales of interest were analyzed.
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The subscales of the SAAS have previously demonstrated acceptable levels of internal
consistency; data from the initial publication of the SAAS indicated that Chronbach’s alphas for
the P-SAAS, NM-SAAS, and NS-SAAS subscales were .77, .81, and .67, respectively (Chappel
et al., 1985). Additionally, according to Chappel et al. (1985), the factor structure of the SAAS
has shown “considerable stability” (p. 51) over the course of multiple factor analyses. In the
current study, Chronbach’s alphas for the P-SAAS, NM-SAAS, and NS-SAAS were .72, .60, and
.64, respectively.
Unfortunately, data on the validity of the SAAS is limited; Chappel et al. (1985) do not
report any validity data on the NM-SAAS, NS-SAAS, and P-SAAS subscales. Additionally, the
SAAS, originally developed in 1985, has not been revised since its initial publication;
accordingly, it is possible that some items on the SAAS may reflect outdated beliefs about
substance use and misuse by contemporary cultural standards. Despite these limitations, the
SAAS remains the definitive assessment of attitudes toward substance use, and continues to be
utilized in studies assessing attitudes toward substance use. In the past 10 years, the SAAS has
been cited in at least 56 studies, according to estimates produced by Google Scholar.
Additionally, the SAAS has been used in two of the three studies of physician attitudes toward
cannabis (Charuvastra et al., 2005; Linn et al., 1989).
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Chapter IV
Results
The purpose of the current study was (a) to assess whether doctoral psychology trainees’
personal cannabis use predicted their perceptions of the risks of cannabis use and attitudes
toward substance use, and (b) to explore whether doctoral psychology trainees’ personal
cannabis use histories, perceptions of cannabis’ risks, and attitudes toward substance use
predicted whether they would correctly diagnose cannabis use disorder. Based on the hypotheses
generated for the present study, the following statistical analyses were planned:
1a) Doctoral psychology trainees who reported current or past use of cannabis would
report lower perceptions of cannabis’ risks as compared to individuals who denied
cannabis use. This hypothesis was to be tested using an independent samples t-test to
compare two groups’ (those who endorsed cannabis use history versus those who
denied cannabis use history) scores on the PCURQ.
1b) Doctoral psychology trainees’ perceptions of cannabis’ risks would be lower among
those who endorsed current cannabis use. This hypothesis was to be tested using an
independent samples t-test to compare two groups’ (current cannabis users and past
cannabis users) scores on the PCURQ.
1c) Perception of cannabis’ risks would decrease as trainees’ own risk of problem
cannabis use increased. This hypothesis was to be tested using linear regression
analysis of the scores on the CUPIT and the PCURQ.
2a) Doctoral psychology trainees who reported current or past use of cannabis would
endorse more permissive attitudes toward substance use than trainees who denied
cannabis use. This hypothesis was to be tested using an independent samples t-test to
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compare two groups’ (those who endorsed cannabis use history versus those who
denied cannabis use history) scores on the P-SAAS.
2b) Doctoral psychology trainees who reported current or past use of cannabis would
endorse more non-moralistic attitudes toward substance use than trainees who did not
use cannabis. This hypothesis was to be tested using an independent samples t-test to
compare two groups’ (those who endorsed cannabis use history versus those who
denied cannabis use history) scores on the NM-SAAS.
2c) Doctoral psychology trainees who reported current or past use of cannabis would
endorse more non-stereotyped attitudes toward substance use than trainees who did
not use cannabis. This hypothesis was to be tested using an independent samples t-test
to compare two groups’ (self-reported cannabis users and denied cannabis users)
scores on the NS-SAAS.
2d) Non-moralistic attitudes toward substance use would be higher among those who
endorsed current cannabis use than those with a history of prior use. This hypothesis
was to be tested using an independent samples t-test to compare two groups’ (current
cannabis users and past cannabis users) scores on the NM-SAAS subscale.
2e) Permissive attitudes toward substance use would be higher among those who
currently used cannabis than those with a history of prior use. This hypothesis was to
be tested using an independent samples t-test to compare two groups’ (current
cannabis users and past cannabis users) scores on the P-SAAS subscale.
2f) Non-stereotyped attitudes toward substance use would be higher among those who
currently used cannabis than those with a history of prior use. This hypothesis was to
be tested using an independent samples t-test to compare two groups’ (current
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cannabis users and past cannabis users) scores on the NS-SAAS.
2g) Trainees’ risk of problem cannabis use would predict non-moralistic attitudes toward
substance use. This hypothesis was to be tested using linear regression of scores on
the CUPIT and the NM-SAAS.
2h) Trainees’ risk of problem cannabis use would predict permissive attitudes toward
substance use. This hypothesis was to be tested using linear regression of scores on
the CUPIT and the P-SAAS.
2i) Trainees’ risk of problem cannabis use would predict non-stereotyped attitudes
toward substance use. This hypothesis was to be tested using linear regression of
scores on the CUPIT and the NS-SAAS.
3a) Doctoral psychology trainees’ perceptions of cannabis’ risks would be negatively
correlated with trainee permissiveness toward substance use. This hypothesis was to
be tested using correlation between scores on the P-SAAS and the PCURQ.
3b) Doctoral psychology trainees’ perceptions of cannabis’ risks would be negatively
correlated with trainee non-moralism toward substance use. This hypothesis was to be
tested using correlation between scores on the NM-SAAS and the PCURQ.
3c) Doctoral psychology trainees’ perceptions of cannabis’ risks would be negatively
correlated with trainee non-stereotyping toward substance use. This hypothesis was to
be tested using correlation between scores on the NS-SAAS and the PCURQ.
4) Trainees’ cannabis use, risk of cannabis use problems, perceptions of risk associated
with cannabis use, and attitudes toward substance use would predict trainees’ ability
to identify cannabis use disorder from a clinical vignette. This hypothesis was to be
tested using multiple hierarchical logistic regression. Demographic information was
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to be entered in Step 1, endorsement of past cannabis use was to be entered in Step 2,
endorsement of current cannabis use and risk of cannabis use problems were to be
entered as Step 3, and perceptions of cannabis’ use risks (scores on the PCURQ) and
attitudes toward substance use (scores on the P-SAAS, NM-SAAS, and NS-SAAS)
were to be entered in Step 4. The outcome measure was to be respondents’
assessment of cannabis use disorder – a binary categorical variable – in the clinical
vignette.
Data Screening and Preliminary Analyses
Prior to initiating analyses to evaluate the proposed hypotheses, a series of data screening
procedures were conducted. First, data was evaluated for accuracy of entry by generating
frequency tables for each of the survey items. Having automated data collection and entry via
Qualtrics, no inaccuracies were discovered.
Next, missing data was analyzed. As described in Chapter III, of 141 total participants, 18
responses were flagged for missing data. Chi-square analyses, Fisher exact tests (in instances in
which chi squares were unable to be computed due to low sample size within specific
categories), and independent samples t-tests (for continuous demographic variables, i.e. age)
were conducted in order to evaluate group differences between participants who provided
incomplete responses and those who completed the survey in its entirety. No statistically
significant demographic differences were found between those who completed the study and
those who provided incomplete responses (p values ranged from .05 to 1.00); accordingly,
incomplete responses were excluded from further analysis, resulting in a sample size of N = 123.
Alternative strategies for handling missing data, such as imputing data or employing higher order
statistical models that accommodate missing data were rejected as unnecessary and superfluously

63
cumbersome.
Normality tests were conducted to evaluate the distributions of scores for all continuous
variables. Results of these tests indicated that the P-SAAS, NM-SAAS, NS-SAAS, and PCURQ
data were normally distributed. Univariate outlier analysis was conducted using the procedure
proposed by Hoaglin and Iglewicz (1987). No outliers were found in any of the SAAS subscale
data. Two outliers were discovered in the PCURQ data. Subsequent case-by-case investigation of
both response sets suggested that in both instances, outliers were not obviously attributable to
random responding. Accordingly, it is reasonable to believe that outliers in the data represent
true variation within the sample. As normality tests indicated that data for the PCURQ were
normally distributed, it was decided that these outliers would be maintained in the dataset.
Descriptive statistics for each of the four aforementioned measures, and correlations between
these measures, are presented in Table 4.1.
Table 4.1
Means, Standard Deviations, and Correlations for Scores on the PCURQ, P-SAAS, NM-SAAS,
and NS-SAAS
Measure
1. PCURQ
2. P-SAAS
3. NM-SAAS
4. NS-SAAS

M
16.19
31.56
34.85
39.18

SD
3.09
5.13
3.72
4.02

1
–
-.34*
-.14
-.26*

2
-.34*
–
.37*
.43*

3
-.14
.37*
–
.54*

4
-.26*
.43*
.54*
–

Note. N = 123.
*
p < .01

Unlike scores on the PCURQ, P-SAAS, NM-SAAS, and NS-SAAS, tests of normality
revealed that the distribution of scores on the CUPIT (M =8.41, SD = 5.70) was positively
skewed (skewness = 2.82) and leptokurtic (kurtosis = 11.70). While non-normal, this distribution
is not surprising. Only 44 participants of 123 (specifically, those who endorsed current cannabis
use) received the CUPIT; the remaining 79 automatically received scores of 0 on this measure, as
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responses on the measure are based on past-year cannabis use. This explains the disproportionate
number of 0-value scores, resulting in the leptokurtic distribution observed. Additionally, among
those 44 respondents who did complete the CUPIT, the majority of scores were quite low (mode
= 5; skewness for distribution of current cannabis users’ scores = 2.94, kurtosis = 10.94); this too
would be expected, given that higher scores on the CUPIT indicate greater risk of problem
cannabis use (a characteristic which one would not expect to be prevalent among doctoral
psychology trainees). As the CUPIT was originally developed as a screening measure, the
decision was made to dichotomize scores on this measure utilizing the identified cutoff score of
12 (see Bashford et al., 2010), rather than transform the data in order to correct for the nonnormal distribution; accordingly, participants who scored 12 or above were categorized as
“positive” for problem cannabis use, and those with scores 11 or under categorized as
“negative.” Upon deciding to utilize the CUPIT as a categorical variable, proposed linear
regression analyses were replaced by independent samples t-tests in the statistical analysis plan
as methods of analysis for Hypotheses 1c, 2g, 2h, and 2i, improving the ability to make direct
comparisons between the results of these hypotheses and Hypotheses 1a, 1b, and 2a through 2f,
all of which were to be tested with independent samples t-tests as per the a priori analysis plan.
Following data screening, demographic data were examined for between-group
differences. A series of independent samples t-tests, chi-square analyses and Fisher exact tests
revealed no significant between-group differences between individuals who denied history of
lifetime cannabis use versus those who endorsed history of cannabis use (p = .07 to .80),
individuals who endorsed past use versus current use (p = .09 to .98), and current cannabis users
who screened positive on the CUPIT (indicating problem cannabis use) versus those whose
CUPIT scores were unremarkable (p = .16 to .79).
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After assessing the distribution of demographic variables across cannabis use history
conditions, data reduction techniques were implemented to remove variables empirically found
to lack association with perceptions of cannabis’ risks and attitudes toward substance use, and to
group sparse demographic categories into more meaningful subsets. The association of
demographic factors with perceptions of cannabis’ risks and attitudes toward substance use was
examined in order to focus the remaining analyses on only those demographics that were
associated with the variables of interest. Prior to conducting these analyses, demographic and
training characteristic variables that included less than 10 percent of the sample (less than 12
members) were, when possible, combined into meaningful groupings of sufficient size. As no
study hypotheses explored demographic differences among the variables of interest, in instances
in which more than three categories in a given variable had more than 12 participants, categories
were collapsed based on conceptual similarities between groups when possible, such that
demographic variables had no more than three categories per variable; this level of coding detail
was deemed sufficient to address the question of whether each of the demographic dimensions
surveyed were exerting influence on study results. All categorical demographic variables were
subsequently dummy coded, and two-factor interaction terms were generated for all possible
combinations of demographic variables. (See Appendix J for a taxonomy demonstrating how
demographic variables were collapsed and dummy coded, as well as how interaction terms were
generated).
To evaluate the influence of demographic variables on perceptions of cannabis’ risks and
attitudes toward substance use, a systematic sequence of linear regression models was conducted.
In order to increase the likelihood that demographic variables which were potentially influential
would be retained as controls, those variables and interaction terms that were significantly
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related to PCURQ, P-SAAS, NM-SAAS, and NS-SAAS scores at p < .2 (rather than p < .05)
were retained from each analysis, as per Hosmer, Lemeshow, and Sturdivant’s (2013)
recommendations; variables which were not significant at p < .2 were dropped from further
analysis. Regression analyses were sequenced as follows: First, a series of linear regressions with
partial and semipartial correlations were performed with all dummy coded variables entered as
predictors; as noted, demographic variables with p < .2 were retained. Next, a series of four
linear regressions with partial and semipartial correlations were conducted with all two-factor
interaction terms entered as predictors, with interaction terms with p < .2 retained. Last, the
combined list of retained demographic variables and interaction terms were entered as predictors
in order to understand the influence of each of the previously retained factors on perceptions of
cannabis’ risks and attitudes toward substance use; factors with p < .2 were again retained.
Finally, collinearity diagnostics were utilized to identify those retained demographic variables
that were linear combinations of other variables; these factors were subsequently removed, in
accordance with Hosmer et al.’s (2013) recommendations, resulting in a finalized list of
demographic controls to be retained in subsequent analyses. Driven by findings suggesting that
select demographic variables may be associated with perceptions of cannabis’ risks and attitudes
toward substance use, partial correlation was selected in place of bivariate correlation for
Hypothesis 3 in order to isolate the unique correlations between the PCURQ, P-SAAS, NMSAAS, and NS-SAAS while controlling the influence of demographic factors.
Hypothesis 1
A series of t-tests were utilized to evaluate the relationship between participants’
cannabis use history and their perceptions of cannabis’ risks, as defined by scores on the
PCURQ. Each of these analyses is described below.

67

Hypothesis 1a
An independent samples t-test was conducted to evaluate the hypothesis that doctoral
psychology trainees who reported history of cannabis use would report lower perceptions of
cannabis' risks compared to individuals who denied history of cannabis use. The test was
significant, t(121) = 3.04, p < .01. Results indicate that individuals with no lifetime history of
cannabis use (M = 17.30, SD = 2.38) on average associated greater physical and psychological
risks with cannabis use then those who endorsed history of cannabis use (M = 15.59, SD = 3.27).
The eta square index indicated that seven percent of the variance in PCURQ scores was
accounted for by whether or not someone endorsed history of cannabis use, a medium to large
effect. This is a nine percent difference between groups across the range of scores (a 0.56-SD
difference).
Hypothesis 1b
An independent samples t-test was conducted to evaluate the hypothesis that doctoral
psychology trainees’ perceptions of cannabis’ risks would be lower among those who currently
used cannabis than among past users. The test was significant, t(78) = 2.63, p < .05. Results
indicated that individuals who endorsed current cannabis use (M = 14.75, SD = 3.52) perceived
recreational cannabis use to carry less risk than those who endorsed history of cannabis use but
denied current use (M = 16.61, SD = 2.62). The eta square index indicated that eight percent of
the variance in PCURQ scores was accounted for by endorsement of current cannabis use among
participants. This is a 10% difference between groups across the range of scores (a 0.59-SD
difference).
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Hypothesis 1c
An independent samples t-test was conducted to evaluate the hypothesis that doctoral
psychology trainees who screened positive for problem cannabis use would endorse lower
perceptions of cannabis’ risks than those current users who screened negative for problem
cannabis use on the CUPIT. The test was not significant, t(42) = -1.00, p = .32. Results indicated
that individuals who screened positive for problem cannabis use (M = 15.88, SD = 3.23) were no
less likely to associate risk with cannabis use then those users whose CUPIT scores were
unremarkable (M = 14.50, SD = 3.58).
Hypothesis 2
Additional t-tests were utilized to evaluate the relationship between participants’ cannabis
use history and their attitudes toward substance use, as defined by scores on the P-SAAS, NMSAAS, and NS-SAAS. Each of these analyses is described below.
Hypothesis 2a
An independent samples t-test was conducted to evaluate the hypothesis that doctoral
psychology trainees with histories of cannabis use would endorse more permissive attitudes
toward substance use than trainees who denied lifetime history of cannabis use. The test was
significant, t(121) = -5.15, p < .001. Results indicate that individuals who have used cannabis (M
= 33.15, SD = 4.62) are more permissive of substance use than those who deny history of
cannabis use (M = 28.60, SD = 4.75). The eta square index indicated that 18% of the variance in
P-SAAS scores was accounted for by whether or not someone endorsed history of cannabis use,
a large effect. This is a 17% difference between groups across the range of scores (a 0.98-SD
difference).
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Hypothesis 2b
An independent samples t-test was conducted to evaluate the hypothesis that doctoral
psychology trainees who reported history of cannabis use would endorse less moralistic attitudes
about substance use than trainees who denied history of cannabis use. The test was significant,
t(121) = -2.37, p < .05. Results indicated that individuals who have used cannabis (M = 35.43,
SD = 3.50) were less likely to view substance use as immoral than participants who denied
history of cannabis use (M = 33.79, SD = 3.94). The eta square index indicated that four percent
of the variance in NM-SAAS scores was accounted for by whether or not someone endorsed
history of cannabis use, a small to medium effect. This is a nine percent difference between
groups across the range of scores (a 0.45-SD difference).
Hypothesis 2c
An independent samples t-test was conducted to evaluate the hypothesis that doctoral
psychology trainees who reported history of cannabis use would endorse less stereotyped
attitudes toward substance use than trainees who denied lifetime history of cannabis use. The test
was significant, t(121) = -2.49, p < .05. Results indicated that individuals who have used
cannabis (M = 39.83, SD = 3.98) are less likely to hold stereotypical views of substance use and
those who use substances than participants who deny history of cannabis use (M = 37.98, SD =
3.85). The eta square index indicated that five percent of the variance in NS-SAAS scores was
accounted for by whether or not someone endorsed history of cannabis use, a small to medium
effect. This is a 10% difference between groups across the range of scores (a 0.47-SD
difference).
Hypothesis 2d
An independent samples t-test was conducted to evaluate the hypothesis that non-
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moralistic attitudes toward substance use would be higher among current cannabis users than
those with a history of prior use. The test was not significant, t(78) = -.02, p = .99. Results
indicate that current cannabis users (M = 35.43, SD = 3.71) are no more non-moralistic in their
attitudes toward substance use than past cannabis users (M = 35.42, SD = 3.26).
Hypothesis 2e
An independent samples t-test was conducted to evaluate the hypothesis that current
cannabis users would endorse more permissive attitudes toward substance use than past users.
The test was significant, t(78) = -4.00, p < .001. Results indicate that individuals who currently
used cannabis (M = 34.86, SD = 4.49) were more permissive of substance use than past cannabis
users (M = 31.06, SD = 3.91). The eta square index indicated that 17% of the variance in PSAAS scores was accounted for by whether participants endorsed past or current cannabis use, a
large effect. This is a 14% difference between groups across the range of scores (a 0.90-SD
difference).
Hypothesis 2f
An independent samples t-test was conducted to evaluate whether past cannabis users
would hold more stereotyped beliefs toward substance use than current users. The test was
significant, t(78) = -2.24, p < .05. Results indicate that current cannabis users (M = 40.70, SD =
4.16) were less likely to hold stereotypical views of substance use and individuals who use
substances than past cannabis users (M = 38.75, SD = 3.51). The eta square index indicated that
six percent of the variance in NS-SAAS scores was accounted for by whether participants
endorsed past or current cannabis use, a medium effect. This is a 10% difference between
groups across the range of scores (a 0.50-SD difference).
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Hypothesis 2g
An independent samples t-test was conducted to evaluate the hypothesis that problem
cannabis users would endorse higher non-moralism toward substance use than current users
whose CUPIT scores were unremarkable. Levene’s test was violated for this analysis;
accordingly, results of a test not assuming homogeneity of variance are reported. Results of this
test were not significant, t(8.18) = .57, p = .57. Results indicated that individuals who screened
positive for problem cannabis use (M = 34.50, SD = 5.42) were no more non-moralistic than
those users whose CUPIT scores were unremarkable (M = 35.64, SD = 3.29).
Hypothesis 2h
An independent samples t-test was conducted to evaluate the hypothesis that trainees with
problem cannabis use would endorse more permissive attitudes toward substance use than those
whose patterns of cannabis use were not indicative of problem use. Results of this test were not
significant, t(42) = .25, p = .80. Results indicated that individuals who screened positive for
problem cannabis use (M = 34.50, SD = 5.88) were no more permissive of substance use than
current cannabis users whose CUPIT scores were unremarkable (M = 34.94, SD = 4.22).
Hypothesis 2i
A final independent samples t-test was utilized to evaluate the hypothesis that doctoral
psychology trainees with problem cannabis use would endorse higher non-stereotyping toward
substance use than current users whose CUPIT screens were negative. Results of this test were
not significant, t(42) = .62, p = .54. Results indicate that individuals who screened positive for
problem cannabis use (M = 39.88, SD = 4.94) were no less likely to hold stereotypical beliefs
about substance use and substance users than those users whose CUPIT scores were
unremarkable (M = 40.89, SD = 4.03).
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Hypothesis 3
Partial correlation was utilized to examine the relationship between perceptions of
cannabis use risks (operationalized by scores on the PCURQ) and attitudes toward substance use
(operationalized by P-SAAS, NM-SAAS, and NS-SAAS scores). It was hypothesized that
doctoral psychology trainees’ perceptions of cannabis’ risks would be negatively correlated with
trainee permissiveness, non-stereotyping, and non-moralism. Table 4.2 presents the partial
correlation coefficients for Hypotheses 3a through 3c, along with the results of exploratory
correlation analyses among the three subscales of the SAAS (P-SAAS, NM-SAAS, and NSSAAS), after controlling for relevant demographic variables. As indicated on the table,
participants’ perceptions of cannabis’ risks were negatively and significantly correlated with
scores on the P-SAAS and NS-SAAS. PCURQ scores were not significantly correlated with
scores on the NM-SAAS. Results suggest that psychology trainees who associate cannabis use
with greater psychological/physical risk also tend to be less permissive of substance use
generally and more likely to hold stereotypical beliefs related to substance use and substance
users, though perceptions of cannabis’ risks are unrelated to the belief that substance use is
morally evil or wrong among doctoral psychology trainees. Results of exploratory partial
correlation analyses between scores on the P-SAAS, NM-SAAS, and NS-SAAS revealed that all
three of the SAAS subscales explored in the current study were positively and significantly
correlated, such that respondents who endorsed more permissive attitudes toward substance use
also had more non-moralistic and non-stereotypical beliefs about substance use and users.
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Table 4.2
Summary of Partiala Correlation Results for Scores on the PCURQ, P-SAAS, NM-SAAS, and NSSAAS
Measure
1. PCURQ
2. P-SAAS
3. NM-SAAS
4. NS-SAAS

1
–
-.27*
-.04
-.26*

2
-.27*
–
.30**
.32**

3
-.04
.30**
–
.55***

4
-.26*
.32**
.55***
–

Note. N = 123.
a
Controlled variables included Age, Sex, Race, Non-Religious, Other Religious Affiliation, Republican, Other Political
Affiliation, Degree Type, Clinical Psychology, Other Discipline, Years of Training, and Internship. Controlled interactions
included Age*Sex, Age*Degree Type, Age*Republican, Sex*Non-Religious, Sex*Republican, Sex*Other Political
Affiliation, Sex*Years of Training, Race*Internship, Other Religious Affiliation*Republican, Other Religious
Affiliation*Degree Type, Non-Religious*Degree Type, Non-Religious*Years of Training, Other Political
Affiliation*Degree Type, Republican*Years of Training, Republican*Internship, Other Political Affiliation*Internship,
Degree Type*Years of Training, Degree Type*Internship, and Other Discipline*Internship.
*
p < .05
**
p < .01
***
p < .001

Hypothesis 4
In order to test the hypothesis that cannabis use history, perceptions of cannabis’ risks,
and attitudes toward substance use would predict trainees’ ability to identify cannabis use
disorder, a series of hierarchical logistic regression analyses were conducted. Of the 123
participants included in the study, 95 (77.2%) correctly diagnosed the hypothetical client
portrayed in the vignette with cannabis use disorder, while 28 (22.8%) failed to correctly
diagnose the client.
Although the original statistical analysis plan indicated that demographic information was
to be entered in Step 1, endorsement of past cannabis use in Step 2, endorsement of current
cannabis use and risk of cannabis use problems (scores on the CUPIT) in Step 3, and perceptions
of cannabis use risks (scores on the PCURQ) and attitudes toward substance use (scores on the
P-SAAS, NM-SAAS, and NS-SAAS) in Step 4, it was ultimately determined that the
organizational structure of this model would prevent conclusions from being drawn about the
applicability of the Theory of Cognitive Dissonance (Festinger, 1957) as a framework for the
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influence of personal behaviors and beliefs on diagnostic decision-making. Accordingly, the a
priori logistic regression plan was replaced by a series of three hierarchical logistic regression
analyses, which better simulated cognitive dissonance. The first of these analyses (Model 1)
models the prediction of diagnostic decision based upon perceptions of cannabis’ risks and
attitudes toward substance use (scores on the PCURQ, P-SAAS, NM-SAAS, and NS-SAAS).
The second logistic model tests the cognitive dissonance hypothesis which has served as the
framework for this study; by entering history of cannabis use into the model following scores on
the PCURQ, P-SAAS, NM-SAAS, and NS-SAAS, this model will demonstrate whether or not
individuals’ cannabis use accounted for variation in diagnostic decision above and beyond the
influence of perceptions of cannabis’ risks and attitudes toward substance use. Finally, in the
third logistic model, demographic variables were entered in Step 1 – in advance of perceptions of
cannabis’ risks and attitudes toward substance use (Step 2), as well as cannabis use history (Step
3) – in order to evaluate whether the predictive model is altered by controlling for these factors.
Given the low number of participants who endorsed patterns of problem cannabis use (n
= 8), in advance of the logistic regression analyses, a Fisher’s exact test was conducted to assess
whether the diagnostic decisions of current problem cannabis users differed significantly from
those of current cannabis users whose CUPIT screens were unremarkable. Results of this
analysis were non-significant (p = 1.00); accordingly, cannabis users whose CUPIT scores
evidenced problem use and those whose scores were unremarkable were combined for all
subsequent regression analyses (n = 44).
Model 1
A hierarchical logistic regression analysis was conducted to predict accurate diagnosis of
cannabis use disorder using perceptions of cannabis’ risks and attitudes toward substance use as
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predictors. Scores on the PCURQ, P-SAAS, NM-SAAS, and NS-SAAS were entered
simultaneously as predictors. Diagnostic decision – whether participants did or did not diagnose
cannabis use disorder in the hypothetical client portrayed in the vignette – was entered as the
outcome variable. A test of the model versus a constant only model was not statistically
significant, χ2model (4, N = 123) = 4.83, p = .31. Statistical significance of the Wald criteria for the
PCURQ, P-SAAS, NM-SAAS, and NS-SAAS ranged from p = .17 to p = .95, indicating that
none of the individual predictors made a statistically significant contribution to the predictive
ability of the model. Results indicate that perceptions of cannabis’ risks and attitudes toward
substance use do not predict participants’ diagnostic decisions. Nagelkerke’s R2 of .06 indicated
that the model explained six percent of the variance in diagnostic decisions among participants.
Prediction success overall was 76% (94/123 participants correctly identified), with Model 1
correctly identifying 99% of participants (94/95 participants) who correctly diagnosed cannabis
use disorder, but failing to accurately identify any respondents who failed to diagnose the client
portrayed in the vignette. Table 4.3 summarizes the analysis results for Model 1.
Table 4.3
Results of Logistic Regression Analysis for Hypothesis 4, Model 1 (Prediction of Diagnostic
Decision by Perceptions of Cannabis’ Risks and Attitudes Toward Substance Use)

Predictor
PCURQ
P-SAAS
NM-SAAS
NS-SAAS

a

β
-.01
.04
-.10
-.07

SE
.07
.05
.07
.07

Wald Statistic
.05
.72
1.92
.88

b

OR
1.00
1.04
.90
.94

95% CI
Lower
Upper
.86
1.15
.95
1.15
.78
1.04
.82
1.07

Note. N = 123. None of the variables entered were significant predictors of diagnostic decision.
β values represent estimated unstandardized regression coefficients. bOR represents the likelihood of correct
diagnosis (a response of “yes” to the question “Does John have cannabis use disorder?”).

a

Model 2
A second hierarchical logistic regression analysis was conducted to evaluate the extent to
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which cannabis use history accounted for variance in diagnostic decision-making above the
impact of perceptions of cannabis’ risks and attitudes toward substance use alone. Scores on the
PCURQ, P-SAAS, NM-SAAS, and NS-SAAS were entered simultaneously in Step 1. History of
cannabis use (three levels: denied, past, or current) was entered as a categorical predictor into
Step 2. Diagnostic decision was again entered as the outcome variable.
A test of the full model versus a constant only model was not statistically significant,

χ2model (6, N = 123) = 10.41, p = .11, indicating that cannabis use history, perceptions of
cannabis’ risks, and attitudes toward substance use were unable to account for variation in
diagnostic decision-making among participants. Likewise, a test of the full model versus Model
1 (including perceptions of cannabis’ risks and attitudes toward substance use only, see above)
was not significant, χ2block (2, N = 123) = 5.58, p = .06, suggesting that the addition of cannabis
use history to the logistic model did not significantly improve predictive ability of the model as a
whole. Nagelkerke’s R2 of .12 indicated that the model including cannabis use history explained
12% of the variance in diagnostic decisions among participants. Although overall prediction
success in Model 2 remained at 76% (94/123 participants), true positive and true negative
prediction success shifted, with the new model accurately identifying 98% of participants (93/95
participants) who accurately diagnosed cannabis use disorder and four percent of participants
(1/28 participants) who failed to diagnose cannabis use disorder.
While the overall model was not statistically significant, further examination of the
component predictors included in Model 2 revealed that one of seven predictors – current
cannabis use – made a statistically significant contribution to the predictive ability of the model,
Wald criterion = 4.61, p < .05. Contrary to study hypotheses, however, rather than reduce the
odds of correctly identifying cannabis use disorder, individuals who endorsed current cannabis
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use were 4.52 times more likely to correctly identify cannabis use disorder than those who
denied history of cannabis use, 95% CI [1.14, 17.93]. While it remains the case that Model 2 was
not statistically significant, this finding is intriguing, as it suggests the possibility that other
factors may be masking the influence of current cannabis use. Table 4.4 summarizes the analysis
results for Model 2.
Table 4.4
Results of Hierarchical Logistic Regression Analysis for Hypothesis 4, Model 2 (Prediction of
Diagnostic Decision by Perceptions of Cannabis’ Risks, Attitudes Toward Substance Use, and
Cannabis Use Historya)

Predictor
PCURQ
P-SAAS
NM-SAAS
NS-SAAS
Denied cannabis useb
Past cannabis use
Current cannabis use

c

β
.03
-.01
-.09
-.09
–
.26
1.51

SE
.08
.06
.07
.07
–
.54
.70

Wald Statistic
.17
.03
1.45
1.52
4.99
.22
4.61*

d

OR
1.03
.99
.91
.92
–
1.29
4.52

95% CI
Lower
Upper
.88
1.21
.89
1.11
.79
1.06
.80
1.05
–
–
.45
3.75
1.14
17.93

Note. N = 123.
a
Cannabis use history (three levels: denied history, past history, current use) was entered on PCURQ, P-SAAS, NMSAAS, and NS-SAAS in Step 2 (PCURQ, P-SAAS, NM-SAAS, and NS-SAAS were entered in Step 1, equivalent
to Model 1 as presented in Table 4.3). bDenied cannabis use was utilized as a reference group for cannabis use
history. cβ values represent estimated unstandardized regression coefficients. dOR represents the likelihood of a
correct diagnosis (a response of “yes” to the question “Does John have cannabis use disorder?”).
*
p < .05

Model 3
A final hierarchical logistic regression analysis was conducted to predict diagnostic
decisions using cannabis use history, perceptions of cannabis’ risks, and attitudes toward
substance use as predictors, with relevant demographic variables controlled. The combined
demographic variables were entered in Step 1. Subsequent variables were entered in the same
order described in Model 2, with perceptions of cannabis’ risks and attitudes toward substance
use entered in Step 2, and cannabis use history entered as a categorical predictor in Step 3.
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Diagnostic decision was entered as the outcome variable.
A test of the model represented in Step 1 was not significant, χ2 (31, N = 123) = 37.65, p
= .19, indicating that the demographic variables were not independently predictive of diagnostic
decision.
After controlling for demographic variables in Step 1, a test of the model with PCURQ,
P-SAAS, NM-SAAS, and NS-SAAS scores entered as predictors was conducted to predict
diagnostic decisions from perceptions of cannabis’ risks and attitudes toward substance use,
controlling for demographic variables. A test of the full model against a constant only model was
not significant, χ2model (35, N = 123) = 41.21, p < .22, as was a test of the revised model against
the previous model, χ2block (4, N = 123) = 3.56, p = .47, indicating that including perceptions of
cannabis’ risks and attitudes toward substance use in the model neither predicted diagnostic
decisions not improved model fit substantially. Statistical significance of the Wald criteria for
perceptions of cannabis’ risks and each of the attitudes toward substance use ranged from p = .35
to p = .91, indicating that none of these predictors individually made a statistically significant
contribution to the predictive ability of the model.
A test of the full model including PCURQ, P-SAAS, NM-SAAS, and NS-SAAS scores,
cannabis use history, and demographic variables was conducted to evaluate whether perceptions
of cannabis’ risks, attitudes toward substance use, and cannabis use behavior predicted
diagnostic decisions, controlling for demographic factors. A test of the full model against a
constant only model was significant, χ2model (37, N = 123) = 56.89, p < .05. Further, results
indicated that the addition of cannabis use history significantly improved model fit, χ2block (2, N
= 123) =15.68, p < .001. Nagelkerke’s R2 of .56 indicated that the model including cannabis use
history explained 56% of the variance in diagnostic decisions among participants. Prediction
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success overall was 87% (107/123 participants), with the model illustrated by Step 3 correctly
identifying 61% of participants who failed to make the correct diagnosis (17/28 participants) and
95% of participants (90/95 participants) who correctly diagnosed cannabis use disorder.
Although none of the demographic factors controlled for in the model made statistically
significant contributions to the model independently (p values ranged from .12 to 1.00 in Step 1,
.08 to 1.00 in Step 2, and .07 to 1.00 in Step 3), controlling these variables strengthened the
relationship between history of personal cannabis use and diagnostic decision; specifically, when
demographic variables were accounted for within the model, the odds that individuals who
endorsed current cannabis use would correctly identify cannabis use disorder in the vignette as
compared to individuals who denied cannabis use history rose over eleven times, with
individuals who endorsed current cannabis use now 51.03 (versus 4.52, as in Model 2) times
more likely to correctly identify cannabis use disorder in the vignette than those who denied
lifetime history of recreational cannabis use, 95% CI [3.94, 660.64]. Results suggest that
controlling for demographic factors unmasked the effect of current cannabis use in predicting
participants’ diagnostic decisions. Table 4.5 summarizes the analysis results for Model 3.
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Table 4.5
Results of Hierarchical Logistic Regression Analysis for Hypothesis 4, Model 3 (Prediction of
Diagnostic Decision by Perceptions of Cannabis’ Risks, Attitudes Toward Substance Use, and
Cannabis Use Historya, with Demographic Variables Controlledb)

Predictor
Step 1
Control variables
Step 2e
Control variables
PCURQ
P-SAAS
NM-SAAS
NS-SAAS
Step 3f
Control variables
PCURQ
P-SAAS
NM-SAAS
NS-SAAS
Denied cannabis useg
Past cannabis use
Current cannabis use

c

d

95% CI
Lower
Upper

β

SE

Wald Statistic

OR

–

–

–

–

–

–

–
.01
.02
-.09
-.08

–
.11
.08
.10
.10

–
.01
.07
.89
.62

–
1.01
1.02
.91
.93

–
.82
.89
.75
.76

–
1.25
1.17
1.10
1.12

–
.16
-.09
-.06
-.11
–
.18
3.93

–
.14
.09
.11
.12
–
.81
1.31

–
1.23
.99
.33
.94
9.77*
.05
9.06*

–
1.71
.92
.94
.89
–
1.20
51.03

–
.89
.77
.76
.71
–
.25
3.94

–
1.55
1.09
1.16
1.21
–
5.83
660.64

Note. N = 123.
Cannabis use history included three levels: denied history, past history, current use. bControlled variables included
Age, Sex, Race, Non-Religious, Other Religious Affiliation, Republican, Other Political Affiliation, Degree Type,
Clinical Psychology, Other Discipline, Years of Training, and Internship. Controlled interactions included Age*Sex,
Age*Degree Type, Age*Republican, Sex*Non-Religious, Sex*Republican, Sex*Other Political Affiliation,
Sex*Years of Training, Race*Internship, Other Religious Affiliation*Republican, Other Religious
Affiliation*Degree Type, Non-Religious*Degree Type, Non-Religious*Years of Training, Other Political
Affiliation*Degree Type, Republican*Years of Training, Republican*Internship, Other Political
Affiliation*Internship, Degree Type*Years of Training, Degree Type*Internship, and Other Discipline*Internship; p
values were non-significant. cβ values represent estimated unstandardized regression coefficients. dOR represents
the likelihood of a correct diagnosis (a response of “yes” to the question “Does John have cannabis use disorder?”).
e
PCURQ, P-SAAS, NM-SAAS, and NS-SAAS were entered on demographic controls in Step 2. fCannabis use
history was entered on PCURQ, P-SAAS, NM-SAAS, NS-SAAS, and demographic controls in Step 3. gDenied
cannabis use was utilized as a reference group for cannabis use history.
*
p < .01
a
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Post Hoc Analyses
After concluding all hypothesis-testing analyses, a final question remained: What is the
influence of doctoral psychology trainees’ training in the diagnosis and treatment of substance use
disorders specifically on the likelihood that they will accurately diagnose cannabis use disorder?
Although personal experiences and beliefs might understandably influence trainees’ clinical
judgments in lieu of formalized training in the assessment and treatment of substance use
disorders, if doctoral students had completed training – whether didactic or experiential – on
substance use disorders, trainees, graduate faculty, and practicum/internship supervisors might
reasonably assume that these experiences would inform and improve trainees’ ability to identify
and diagnose cannabis use disorder.
To evaluate the impact of substance use disorder training on diagnosis of cannabis use
disorder, two post hoc hierarchical logistic regression analyses were conducted. In the first,
demographic controls as determined in prior analyses were entered in Step 1 in order to control
the effects of these variables. Substance use disorder training history (whether or not trainees
endorsed any history of graduate training in substance use disorders specifically) was entered as a
bivariate predictor in Step 2. Consistent with the order of predictors in prior models, perceptions
of cannabis’ risks and attitudes toward substance use were entered into Step 3, and cannabis use
history was entered in Step 4. Diagnostic decision – whether participants did or did not diagnose
cannabis use disorder in the hypothetical client portrayed in the vignette (the same outcome
variable used in previous logistic models) – was entered as the outcome variable. (Note: Results
of this analysis will be reported beginning with Step 2, as the results of Step 1 have been reported
in prior analyses.)
After entering demographic variables in Step 1, a test of the model with endorsement of
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substance use disorder training was conducted to predict accurate diagnosis of cannabis use
disorder from history of graduate training in addiction. A test of this model against a constant
only model was not significant, χ2model (32, N = 123) = 37.77, p = .22, nor was a test of the revised
model against the previous model, which included demographic controls only, χ2block (1, N = 123)
= .12, p = .73, indicating that endorsement of training in substance use disorders did not reliably
distinguish between participants who correctly diagnosed cannabis use disorder and those who
failed to diagnose cannabis use disorder. Nagelkerke’s R2 of .40 indicated that the model
explained 40% of the variance in diagnostic decisions among participants. Prediction success
overall was 81% (99/123 participants), with the model illustrated by Step 2 correctly identifying
96% of participants who correctly diagnosed cannabis use disorder (91/95 participants) and 29%
of respondents who failed to diagnose the client portrayed in the vignette (8/28 participants).
Next, a test of the model with PCURQ, P-SAAS, NM-SAAS, and NS-SAAS entered in
Step 3 was conducted. A test of the full model against a constant only model was not significant,

χ2model (36, N = 123) = 41.46, p = .25, nor was a test of the revised model against the previous
model, χ2block (4, N = 123) = 3.69, p = .45. Statistical significance of the Wald criteria for the
PCURQ, P-SAAS, NM-SAAS, and NS-SAAS ranged from p = .38 to .94, indicating that the
predictive ability of these variables was neither significantly reduced nor enhanced by the
addition of substance use disorder training to the model. Nagelkerke’s R2 of .44 indicated that the
model explained 44% of the variance in diagnostic decisions among participants. Prediction
success overall was 80% (98/123 participants), with the model illustrated by Step 3 correctly
identifying 95% of participants who correctly diagnosed cannabis use disorder (90/95
participants) and 29% of respondents who failed to diagnose the client portrayed in the vignette
(8/28 participants).
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Last, a test of the model with cannabis use history entered in Step 4 was conducted. A
test of the full model against a constant only model was significant, χ2model (38, N = 123) = 57.81,
p < .05, as was a test of the revised model against the previous model, χ2block (2, N = 123) =
16.36, p < .001. As in Model 3 (Prediction of Diagnostic Decision by Perceptions of Cannabis’
Risks, Attitudes toward Substance Use, and Cannabis Use History, with Demographic Variables
Controlled), a review of the Wald criteria revealed that current cannabis use was the only
significant predictor of diagnostic decision, Wald criterion = 9.60, p < .01. Nagelkerke’s R2 of
.57 indicated that the model explained 57% of the variance in diagnostic decision among
participants. Prediction success overall was 85% (105/123 participants), with the model
illustrated by Step 4 correctly identifying 95% of participants who correctly diagnosed cannabis
use disorder (90/95 participants) and 54% of respondents who failed to diagnose the client
portrayed in the vignette (15/28 participants). Although substance use disorder training in and of
itself was not a significant predictor of diagnostic judgments among doctoral psychology
trainees, it is apparent that inclusion of this variable in the logistic model enhanced the effect of
current cannabis use slightly; review of the odds ratio for current cannabis use in this model
indicates that current cannabis users were 58.57 times more likely to correctly identify cannabis
use disorder than those who denied lifetime history of recreational cannabis use (compared to
51.03 in Model 3), 95% CI [4.46, 769.14]. Table 4.6 summarizes the descriptive statistics and
analysis results for this model.
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Table 4.6
Results of Hierarchical Logistic Regression for Post Hoc Analysis 1(Influence of Substance Use
Disorder Training History on the Predictive Ability of Logistic Regression Model 3)

Predictor
Step 1
Control variablesc
Step 2d
Control variables
Training
Step 3e
Control variables
Training
PCURQ
P-SAAS
NM-SAAS
NS-SAAS
Step 4f
Control variables
Training
PCURQ
P-SAAS
NM-SAAS
NS-SAAS
Denied cannabis useg
Past cannabis use
Current cannabis use

95% CI
Lower
Upper

βa

SE

Wald Statistic

ORb

–

–

–

–

–

–

–
.25

–
.71

–
.12

–
1.28

–
.32

–
5.13

–
.37
.01
.02
-.09
-.09

–
.75
.11
.07
.10
.10

–
.25
.01
.05
.78
.74

–
1.45
1.01
1.02
.92
.92

–
.34
.82
.88
.76
.76

–
6.25
1.25
1.17
1.11
1.12

–
.83
.13
-.09
-.05
-.15
–
.19
4.07

–
.86
.15
.09
.11
.12
–
.82
1.31

–
.93
.74
1.13
.17
1.49
10.28*
.06
9.60*

–
2.30
1.14
.91
.96
.86
–
1.21
58.57

–
.42
.85
.77
.77
.68
–
.25
4.46

–
12.47
1.52
1.08
1.19
1.10
–
6.01
769.14

Note. N = 123.
a
β values represent estimated unstandardized regression coefficients. bOR represents the likelihood of a correct
diagnosis (a response of “yes” to the question “Does John have cannabis use disorder?”). cControlled variables
included Age, Sex, Race, Non-Religious, Other Religious Affiliation, Republican, Other Political Affiliation, Degree
Type, Clinical Psychology, Other Discipline, Years of Training, and Internship. Controlled interactions included
Age*Sex, Age*Degree Type, Age*Republican, Sex*Non-Religious, Sex*Republican, Sex*Other Political
Affiliation, Sex*Years of Training, Race*Internship, Other Religious Affiliation*Republican, Other Religious
Affiliation*Degree Type, Non-Religious*Degree Type, Non-Religious*Years of Training, Other Political
Affiliation*Degree Type, Republican*Years of Training, Republican*Internship, Other Political
Affiliation*Internship, Degree Type*Years of Training, Degree Type*Internship, and Other Discipline*Internship.
d
Substance use disorder training (endorsed) was entered on demographic controls in Step 2. ePCURQ, P-SAAS, NMSAAS, and NS-SAAS were entered on substance use disorder training (endorsed) and demographic controls in Step
3. fCannabis use history (three levels: denied, past, and current) was entered on demographic controls, substance use
disorder training (endorsed), PCURQ, P-SAAS, NM-SAAS, and NS-SAAS in Step 3. gDenied cannabis use was
utilized as a reference group for cannabis use history.
*
p < .01
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After determining that substance use disorder training was not a significant predictor of
diagnostic accuracy among study participants, a final logistic regression analysis was conducted
to determine whether more intensive forms of training in substance use disorder treatment might
predict increased diagnostic accuracy among study participants. While the initial post hoc
analysis included participants whose training in substance use disorders was potentially limited
to having completed a graduate-level course on substance use disorder treatment or attended a
workshop or conference this topic (among other didactic or less intensive training experiences),
the current analysis limited the definition of training to (a) training toward certification or
completion of certification as a substance abuse counselor, and/or (b) externship, internship, or
similar clinical training experiences in which substance use disorder treatment was a primary
focus. These two categories of training were retained because they represent two of the most
intensive forms of clinical training in substance use disorders available to doctoral psychology
trainees. Although requirements vary by state, substance abuse counselors are typically required
to complete thousands of clinical hours (e.g., in New Jersey, Certified Alcohol and Drug
Counselors must complete 3,000 supervised clinical hours in substance use disorder treatment
settings; New Jersey Department of Human Services, 2012), while doctoral psychology trainees
who select to complete externships in addiction treatment settings would be expected to
accumulate at least 480 hours of addiction treatment experience over the course of a training year
(e.g, see Seton Hall University, 2009).
To evaluate the impact of intensive substance use disorder training (to be referred to
subsequently as “intensive training”) on diagnosis of cannabis use disorder, demographic controls
as determined in prior analyses were entered in Step 1 in order to control the effects of these
variables. Endorsement of history of intensive training was entered as a bivariate predictor in Step
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2. Consistent with the order of predictors in previous logistic models, perceptions of cannabis’
risks and attitudes toward substance use were entered into Step 3, and cannabis use history was
entered in Step 4. Diagnostic decision was entered as the outcome variable. (Note: Results of this
analysis will be reported beginning with Step 2, as the results of Step 1 have been reported in
prior analyses.)
After entering demographic variables in Step 1, a test of the model with endorsement of
intensive training was conducted to predict accurate diagnosis of cannabis use disorder from
history of specialized training in addiction. A test of this model against a constant only model was
not significant, χ2model (32, N = 123) = 37.73, p = .22, nor was a test of the revised model against
the previous model, which included demographic controls only, χ2block (1, N = 123) = .08, p = .78,
indicating that endorsement of intensive training did not reliably distinguish between participants
who correctly diagnosed cannabis use disorder and those who failed to correctly diagnose
cannabis use disorder. Nagelkerke’s R2 of .40 indicated that the model explained 40% of the
variance in diagnostic decisions among participants. Prediction success overall was 80% (98/123
participants), with the model illustrated by Step 2 correctly identifying 96% of participants who
correctly diagnosed cannabis use disorder (91/95 participants), and 25% of respondents who
failed to diagnose the client portrayed in the vignette (7/28 participants).
Next, a test of the model with PCURQ, P-SAAS, NM-SAAS, and NS-SAAS entered in
Step 3 was conducted. A test of the full model against a constant only model was not significant,

χ2model (36, N = 123) = 41.43, p = .25, nor was a test of the revised model against the previous
model, χ2block (4, N = 123) = 3.71, p = .45. Statistical significance of the Wald criteria for the
perceptions of cannabis’ risks and attitudes toward substance use variables ranged from p = .33 to
.86, indicating that the predictive ability of these variables was neither significantly reduced nor
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enhanced by the addition of intensive training to the model. Nagelkerke’s R2 of .44 indicated that
the model explained 44% of the variance in diagnostic decisions among participants. Prediction
success overall was 80% (98/123 participants), with the model illustrated by Step 3 correctly
identifying 95% of participants who correctly diagnosed cannabis use disorder (90/95
participants), and 29% of respondents who failed to diagnose the client portrayed in the vignette
(8/28 participants).
Last, a test of the model with cannabis use history entered in Step 4 was conducted. A
test of the full model against a constant only model was significant, χ2model (38, N = 123) = 58.90,
p < .05, as was a test of the revised model against the previous model, χ2block (2, N = 123) =
17.46, p < .001. As in Model 3 (Prediction of Diagnostic Decision by Perceptions of Cannabis’
Risks, Attitudes Toward Substance Use, and Cannabis Use History, with Demographic Variables
Controlled) and the previously described post hoc logistic model (Influence of Substance Use
Disorder Training History on the Predictive Ability of Logistic Regression Model 3), a review of
the Wald criteria revealed that current cannabis use was the only significant predictor of
diagnostic decision, Wald criterion = 9.47, p < .01. Nagelkerke’s R2 of .58 indicated that the
model explained 58% of the variance in diagnostic decisions among participants. Prediction
success overall was 86% (106/123 participants), with the model illustrated by Step 4 correctly
identifying 93% of participants who correctly diagnosed cannabis use disorder (88/95
participants) and 64% of respondents who failed to diagnose the client portrayed in the vignette
(18/28 participants). Although intensive training in and of itself was not determined to be a
significant predictor of diagnostic judgments among doctoral psychology trainees, it is apparent
that inclusion of this variable in the logistic model enhanced the effect of current cannabis use;
review of the odds ratio for current cannabis use in this model indicated that current cannabis
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users were 73.98 times more likely to correctly identify cannabis use disorder than those who
denied history of cannabis use (compared to 58.57 in the prior post hoc model), 95% CI [4.77,
1146.37]. Table 4.7 summarizes the descriptive statistics and analysis results for this model.
Table 4.7
Results of Hierarchical Logistic Regression for Post Hoc Analysis 2 (Influence of Intensive
Substance Use Disorder Training History on the Predictive Ability of Logistic Regression Model
3)
Predictor
Step 1
Control variablesc
Step 2d
Control variables
Intensive training
Step 3e
Control variables
Intensive training
PCURQ
P-SAAS
NM-SAAS
NS-SAAS
Step 4f
Control variables
Intensive training
PCURQ
P-SAAS
NM-SAAS
NS-SAAS
Denied cannabis useg
Past cannabis use
Current cannabis use

a

b

95% CI
Lower
Upper

β

SE

Wald Statistic

OR

–

–

–

–

–

–

–
.18

–
.65

–
.08

–
1.20

–
.34

–
4.24

–
.32
.02
.02
-.10
-.07

–
.69
.11
.07
.10
.10

–
.22
.03
.04
.95
.57

–
1.38
1.02
1.02
.91
.93

–
.36
.82
.88
.75
.77

–
5.37
1.26
1.17
1.10
1.13

–
1.20
.16
-.10
-.07
-.13
–
-.01
4.30

–
.89
.15
.09
.11
.12
–
.84
1.40

–
1.83
1.18
1.28
.44
1.17
10.33*
< .001
9.47*

–
3.32
1.18
.90
.93
.88
–
.99
73.98

–
.58
.88
.75
.75
.70
–
.19
4.77

–
18.86
1.58
1.08
1.16
1.11
–
5.12
1146.37

Note. N = 123.
a
β values represent estimated unstandardized regression coefficients. bOR represents the likelihood of a correct diagnosis (a
response of “yes” to the question “Does John have cannabis use disorder?”). cControlled variables included Age, Sex, Race, NonReligious, Other Religious Affiliation, Republican, Other Political Affiliation, Degree Type, Clinical Psychology, Other
Discipline, Years of Training, and Internship. Controlled interactions included Age*Sex, Age*Degree Type, Age*Republican,
Sex*Non-Religious, Sex*Republican, Sex*Other Political Affiliation, Sex*Years of Training, Race*Internship, Other Religious
Affiliation*Republican, Other Religious Affiliation*Degree Type, Non-Religious*Degree Type, Non-Religious*Years of
Training, Other Political Affiliation*Degree Type, Republican*Years of Training, Republican*Internship, Other Political
Affiliation*Internship, Degree Type*Years of Training, Degree Type*Internship, and Other Discipline*Internship. dIntensive
training (endorsed) was entered on demographic controls in Step 2. ePCURQ, P-SAAS, NM-SAAS, and NS-SAAS were entered
on intensive training (endorsed) and demographic controls in Step 3. fCannabis use history (three levels: denied, past, and
current) was entered on demographic controls, intensive training (endorsed), PCURQ, P-SAAS, NM-SAAS, and NS-SAAS in
Step 4. gDenied cannabis use was utilized as a reference group for cannabis use history.
*
p < .01
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Chapter V
Discussion
Paradoxically, as cannabis use – and in turn, cannabis use disorder – becomes more
frequent, it is less likely to be seen as a potential problem by the general public. As such, it is
critical that mental healthcare professionals – particularly the next generation of mental
healthcare professionals, who will inevitably see increasing rates of cannabis use disorder – be
able to accurately identify problem cannabis use. The present study was developed to explore the
impact of doctoral psychology trainees’ personal cannabis use histories on their perceptions of
cannabis’ risks and attitudes toward substance use. Additionally, the study sought to explore
whether doctoral psychology trainees’ personal cannabis use, beliefs about the risk of harm from
cannabis, and non-moralistic, permissive, and non-stereotypical attitudes toward substance use
predicted their identification of cannabis use disorder in a hypothetical client.
Results of Hypotheses
Hypothesis 1
Hypothesis 1 examined differences in perceptions of cannabis’ risks among individuals
with varying histories of cannabis use. Consistent with the findings of Kondrad and Reid’s 2013
study of family physicians, individuals who denied lifetime history of cannabis use associated
greater risk with cannabis use (as defined by scores on the PCURQ) than those who endorsed
some period of use, as predicted in Hypothesis 1a. Similarly, participants who identified
themselves as past cannabis users associated greater risk with cannabis use than current cannabis
users, as predicted by Hypothesis 1b.
Although the current study posits that individuals’ attitudes toward cannabis use are
biased by their personal cannabis use histories, methodological limitations inherent in cross-
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sectional, non-experimental research limit the extent to which causal inferences may be drawn
from the findings of Hypothesis 1a. As such, although it is possible that individuals who have
used cannabis are less likely to associate medical and mental health risks with cannabis use
because doing so would result in psychological discomfort, one could equally argue that
individuals who ultimately choose to use cannabis recreationally do so because they believe it to
be a low-risk behavior, and conversely, that those who have abstained from cannabis use have
done so because of underlying beliefs about the risks associated with cannabis use.
Whereas the results of Hypothesis 1a cannot be utilized to infer that individuals’ cannabis
use influences their beliefs about the risks of cannabis use, the results of Hypothesis 1b indicate
that perceptions of cannabis use’s risks vary based on recency of personal cannabis use, lending
weight to the proposed cognitive dissonance model. Although the present study cannot
definitively rule out the possibility that past and current cannabis users held different attitudes
about cannabis’ risks prior to the onset of their cannabis use, in light of literature supporting the
role of cognitive dissonance in the relationship between substance use and beliefs about
substance use (e.g., see Halpern, 1994; McMaster & Lee, 1991; Peretti-Watel, 2006;
Tagliacozzo, 1979), it is reasonable to conclude that the variation in beliefs about cannabis use’s
risks among past versus current cannabis users is evidence that individuals who use cannabis
recreationally alter their attitudes toward cannabis in order to align these attitudes with their use,
in doing so neutralizing the discomfort of behaving in ways inconsistent with one’s beliefs.
Contrary to the prediction put forward in Hypothesis 1c, current cannabis users who
screened positive for problem cannabis use did not differ in their perceptions of cannabis use’s
risks from those who screened negative. Viewed within the context of the cognitive dissonance
model which serves as the theoretical foundation of the present study, this finding suggests that
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neutralizing or altering one’s beliefs about the risks of cannabis use may perpetuate cannabis use,
but not in and of itself support the development and maintenance of problem use. While problem
cannabis use likely has many other adverse impacts on doctoral psychology trainees’ personal
and professional lives (as might any other form of problem substance use), results of the current
study do not suggest that problem cannabis use places a unique burden on beliefs about
cannabis’ risks above and beyond that of current cannabis use behavior generally.
While the present study found statistically significant differences in beliefs about the
risks associated with cannabis use among doctoral psychology trainees based on trainees’ history
and recency of cannabis use, it is arguably of greater importance to consider the practical
significance of such findings. Trainees who denied history of cannabis use versus those who
endorsed lifetime cannabis use demonstrated only a 1.71-point difference in mean PCURQ
scores, equivalent to nine percent of the total observed range of scores. Similarly, the difference
in mean PCURQ scores between past and current cannabis users was only 1.86 points, equivalent
to 10% of the observed range of scores. Whether these arguably slight differences between
groups have any meaningful bearing on trainees’ clinical work or client outcomes – e.g., via
influence on diagnostic decision-making, provision of clinical interventions, etc. – is unknown;
this will be considered to some extent further below.
Hypothesis 2
Hypothesis 2 theorized that doctoral psychology trainees’ attitudes toward substance use
– specifically, whether they held moralistic, stereotypical, or permissive attitudes toward
substance use – would vary systematically based on trainees’ personal cannabis use histories.
Hypotheses 2a through 2c explored attitudinal differences between individuals who denied
lifetime history of cannabis use and those who endorsed history of use. Hypotheses 2d through 2f
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examined differences in these three attitudes among current versus past cannabis users.
Hypotheses 2g through 2i examined differences between current users with negative CUPIT
screens versus problem cannabis users.
Consistent with study hypotheses, statistical analyses for Hypotheses 2a through 2c
revealed that individuals who endorsed history of cannabis use held more permissive, nonmoralistic, and non-stereotyped attitudes toward substance use than participants who denied
history of use.
Surprisingly, the results of statistical analyses for Hypotheses 2d through 2f varied by
attitude. While current cannabis users were more permissive of substance use and held less
stereotypical beliefs about substances users than past cannabis users, past and current cannabis
users did not differ significantly on non-moralism.
Lastly, consistent with the findings of Hypothesis 1c, results of Hypotheses 2g through 2i
suggest that current cannabis users tended to have similar attitudes toward substance use,
regardless of whether their personal cannabis use patterns were indicative of problem use.
Although Hypotheses 2a through 2i were originally grouped by independent variable, as
shown above (with 2a through 2c examining differences in the three attitudes among denied
versus endorsed lifetime cannabis users, 2d through 2f examining differences in past versus
current users, and 2g through 2i differences in current users with negative versus positive CUPIT
screens), for ease of interpretation, they will subsequently be grouped and discussed by
dependent variable.
Influence of Cannabis Use History on Permissiveness – Hypotheses 2a, 2e, and 2h.
As previously noted, the results of Hypothesis 2a indicated that individuals who endorsed history
of cannabis use held more permissive attitudes toward substance use than those who denied
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history of cannabis use. Likewise, the results of Hypothesis 2b indicated that individuals who
identified as current cannabis users endorsed higher permissiveness toward substance use than
those who identified as past cannabis users. This pattern of findings parallels the results of
Hypotheses 1a and 1b, described above; similar to those results, the findings for trainee
permissiveness suggest that variation in the belief that “substance use [exists] within a
continuum of normal human behavior” (Linden, 2010, p. 380) among trainees varies by trainee
cannabis use history. This in turn indicates that permissive attitudes are maintained by the
maintenance of cannabis use, as non-permissiveness toward substance use would be akin to the
belief that one’s own behavior was abnormal, a contradiction which would likely result in
marked cognitive dissonance.
Likewise, results of Hypothesis 2h, which indicated that trainee permissiveness did not
significantly differ among those current users who screened positive versus negative on the
CUPIT, parallel the findings of Hypothesis 1c. Consistent with the proposed interpretation of
findings for the former hypothesis, the results of Hypothesis 2h suggest that increasing one’s
permissiveness toward substance use may perpetuate cannabis use, but not in and of itself
support the development and maintenance of problem cannabis use.
Influence of Cannabis Use History on Non-Stereotyping – Hypotheses 2c, 2f, and 2i.
The findings of Hypotheses 2c, 2f, and 2i replicate the pattern of results found for both trainee
perceptions of cannabis use risks (Hypothesis 1) and trainee permissiveness (Hypotheses 2a, e,
and h). As with these findings, the results of Hypothesis 2c indicated that individuals who had
never used cannabis held more stereotypical beliefs about substance use than those who endorsed
history of cannabis use. Likewise, the results of Hypothesis 2f indicated that individuals who
reported past cannabis use were more stereotyping in their attitudes toward individuals who use
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substances than those who endorsed current cannabis use. Once again, there are no differences in
stereotyping between those with positive CUPIT screens and those with negative CUPIT screens.
Thus far, the current study has discussed the impact of doctoral psychology trainees’
cannabis use as a risk factor for biased clinical judgment. However, it must be acknowledged
that those trainees who have used cannabis may, in fact, possess select attitudes that could
reasonably be described as beneficial in the context of clinical work, perhaps largely due to their
personal experiences with substance use. The observed group differences in stereotyping seen
among individuals who have and have not used cannabis may, for example, indicate that
individuals who have used cannabis – particularly if they are current cannabis users – are less
likely to make assumptions about individuals’ substance use based on their appearance (a
frequent theme in items on the NS-SAAS). The implications of this difference will be explored
further below.
Influence of Cannabis Use History on Non-Moralism – Hypotheses 2b, 2d, and 2g.
Diverging from the pattern of results seen in trainee scores on the PCURQ, P-SAAS, and NSSAAS, the results of scores on the NM-SAAS varied by history of cannabis use, but not by
recency of use. Specifically, while individuals who endorsed history of cannabis use were less
likely to agree with statements that described substance use as morally wrong or evil than those
who denied cannabis use history, there were no significant differences in moralism between past
and current cannabis users.
It is unclear why non-moralism, but not permissiveness, non-stereotyping, or beliefs
about the risks associated with cannabis use, appears not to be influenced by whether participants
currently use cannabis. In keeping with the line of reasoning put forth above, which posits that
attitudes which vary by recency of cannabis use may be motivated by cognitive dissonance, non-
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moralism may represent an attitude which preceded the onset of cannabis use in the current
sample. It is also possible that moralistic attitudes are not logically inconsistent with cannabis
use, and therefore, do not activate cognitive dissonance (and subsequent neutralization of
moralistic beliefs). Lastly, it is possible that the observed results of the present study indicate that
moralistic attitudes are influenced by history of cannabis use behavior, but that in contrast to the
other attitudes explored in the current study, are maintained regardless of whether cannabis use is
discontinued. Methodological limitations of the present study impede confirmation of any of
these causal theories; however, to the extent that moralism among doctoral psychology trainees
may potentially influence their work, further exploration of moralism/non-moralism among
future psychologists is warranted. Were it the case that history of cannabis use influenced
moralistic attitudes, it is possible, as noted above with regard to non-stereotyping attitudes, that
history of cannabis use may carry certain benefits for doctoral psychology trainees in their
clinical work. The possibility that identifying as someone who has used cannabis – with the
unique attitudinal profile such an identity appears to be accompanied by – may have advantages
will be explored further later in this chapter.
Additional considerations for Hypothesis 2: Statistical versus practical significance.
As with Hypothesis 1, it is apt to consider the practical significance of the findings associated
with Hypothesis 2. As described in Chapter III, between-group differences ranged from nine
percent of the range of scores (1.64 points) for the difference between the mean score of denied
cannabis users versus those with cannabis use histories on the NM-SAAS, to 17% of the range of
scores (4.55 points) for the difference between the mean score of denied cannabis users versus
those with histories of cannabis use on the P-SAAS. Whether the magnitude of these differences
may have any meaningful bearing on clinical judgment or patient care will be explored to some
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extent later in this chapter.
Hypothesis 3
Hypothesis 3 examined the relationship between perceptions of cannabis use risks and
attitudes toward substance use among doctoral psychology trainees. Results indicated that
psychology trainees who associated cannabis use with greater risk also tended to be less
permissive of substance use and more likely to hold stereotypical beliefs related to substance use
and substance users, though perceptions of cannabis’ risks were unrelated to the belief that
substance use is morally evil or wrong.
Although the correlational analyses utilized prevent causal inferences from being drawn,
the associations between scores on the PCURQ and P-SAAS, as well as the PCURQ and NSSAAS are notable, as they suggest that doctoral psychology trainees’ beliefs about the
psychological and physical health risks associated with cannabis use are linked in some manner
to their value judgments of substance users, including both (a) whether the trainees believe that
substance use at some level exists on a continuum of normal human behavior (or conversely,
whether all substance use is pathological), and (b) whether the trainees make assumptions about
individuals’ substance use based on their physical appearance and other common stereotypes.
The implications of this finding should raise concern among mental healthcare professionals: On
one hand, these findings suggest that individuals who hold liberal attitudes toward substance use
may underestimate the risks associated with their clients’ cannabis use, and could in turn fail to
provide sufficient psychoeducation or other interventions to cannabis users in treatment. On the
other hand, and equally concerning, these findings may indicate that individuals who do
associate cannabis use with physical and psychological risk may hold stigmatizing attitudes
toward substance users that might harm the relationship between clinician and patient in ways
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that prevent the provision and receipt of effective treatment. The link between personal beliefs
about substance use/users and acknowledgement of the risks associated with cannabis use among
clinicians in training is a concerning one, as it suggests that subjective opinions may be tied to
perceptions about the medical risks associated with cannabis use. More optimistic is the lack of
significant association between scores on the PCURQ and NM-SAAS, which suggests that
doctoral psychology trainees’ beliefs about the risks of cannabis use are unrelated to their belief
that individuals who use substances are morally corrupt.
Hypothesis 4
While the findings of the previous three hypotheses arguably have implications for
clinical practice, Hypothesis 4 – which posited that doctoral psychology trainees’ perceptions of
cannabis use’s risks, attitudes toward substance use, and cannabis use histories would predict
participants’ diagnoses of cannabis use disorder in a hypothetical client portrayed in a vignette –
is the sole hypothesis which directly examined the impact of trainees’ personal beliefs and
behavior on the provision of clinical services, namely diagnostic assessment.
A series of three hierarchical logistic models resulted in the following conclusions: (a)
none of the attitudes examined in the current study – including permissiveness toward substance
use, non-stereotyping toward substance use, non-moralizing toward substance use, and
perceptions of the risks of cannabis use – were predictive of participants’ diagnostic decisions;
and (b) current cannabis use – but not past cannabis use – significantly predicted accurate
diagnosis of cannabis use disorder in the presented vignette. Additionally, results of two post-hoc
analyses indicated that while graduate training in substance use disorders was not, in and of
itself, a significant predictor of diagnostic accuracy, it may modify the relationship between
cannabis use history and diagnostic decision-making. Consideration will be given to each of
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these findings below.
Role of perceptions of cannabis’ risks and attitudes toward substance use in the
prediction of cannabis use disorder diagnosis. In contrast to Hypothesis 4, none of the
attitudes measured in the present study were found to predict participants’ diagnostic decisions,
whether accurate (operationally defined by diagnosis of the hypothetical client described in the
vignette) or inaccurate (operationally defined as failure to diagnose the hypothetical client
described). While these results contradicted the predictions initially proposed in the current
study, failure to reject the null hypothesis is arguably a positive finding, as it suggests that
neither personal beliefs about the risks of cannabis use, nor permissive, non-stereotyping, or nonmoralistic attitudes toward substance use are significantly influencing trainees’ diagnostic
decisions.
While the findings of the current study suggest that trainees’ beliefs about the risks of
cannabis use (as defined by PCURQ scores), permissiveness (P-SAAS scores), non-moralism
(NM-SAAS scores), and non-stereotyping (NS-SAAS scores) appear not to be significant
predictors of diagnostic decision, the scope of such results is rather limited. It remains possible
that attitudes not measured in the current study, or even variations of attitudes measured in the
present study, may indeed influence doctoral psychology trainees’ diagnostic decisions.
Identifying what such attitudes may bias diagnostic decisions among trainees is a worthwhile
undertaking. Given the possibility that an alternative attitude or set of attitudes may be predictive
of trainees’ diagnostic decisions, the current study is unable to conclusively state that trainees’
personal attitudes and beliefs as a whole are unrelated to their diagnostic decisions.
Role of current cannabis use in the prediction of cannabis use disorder diagnosis.
Arguably the most surprising result of the current study is the finding that endorsement of
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current cannabis use among doctoral psychology trainees increased the likelihood that trainees
would accurately make a diagnosis of cannabis use disorder by 4.52 times. Further, rather than
reduce the predictive ability of current cannabis use, when demographic variables were entered
into the model as controls of perceptions of cannabis use’s risks and attitudes toward substance
use, current cannabis use became more predictive of accurate decision-making among trainees,
with those endorsing current cannabis use now 51.03 times more likely to accurately diagnose
cannabis use disorder. Certainly, such findings demonstrate that Festinger’s (1957) Theory of
Cognitive Dissonance fails to account for the mechanisms underlying diagnostic decisionmaking in doctoral psychology trainees.
The finding that individuals who have never used cannabis were significantly less likely
to correctly diagnose cannabis use disorder is particularly striking in light of the number of
diagnostic criteria required to make this diagnosis. In order to make a diagnosis of cannabis use
disorder of mild severity (the lowest severity level at which a diagnosis can be made; American
Psychiatric Association, 2013), a client must demonstrate two diagnostic criteria at minimum;
however, review of the vignette indicates that the hypothetical client met criteria for moderate
cannabis use disorder, meeting four criteria. Given the abundance of symptoms portrayed in the
vignette – double the number required to make a positive diagnosis – it is notable that doctoral
trainees with no history of cannabis use still demonstrated a consistent deficit in their
identification of cannabis use disorder.
Notably, the results of the present study contradict the body of previous literature which
has concluded that healthcare professionals’ personal health-related behaviors – including
cannabis use – appear to bias their clinical judgments of related behaviors in their patients (e.g.,
see Aalto & Seppa, 2007; Geirsson et al., 2009; Lock et al., 2002). Unfortunately, while the
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current study is the first to suggest that doctoral psychology trainees’ diagnoses of cannabis use
disorder are predicted by whether or not they themselves endorse current cannabis use, the study
offers little in the way of explaining why doctoral psychology trainees demonstrate this
discrepancy. In lieu of data-driven explanations for the finding that current cannabis users are
more likely to accurately diagnose cannabis use disorder, theoretical explanations for these
findings warrant consideration. Several such theories are offered below.
“Personal experience as professional advantage” hypothesis. The current study initially
hypothesized that doctoral psychology trainees may be biased by their personal substance use.
This was in line with the extant literature on the impact of personal substance use on clinical
judgment among healthcare professionals. However, the opposite notion – that mental health
professionals’ personal experiences may make them more adept clinicians – is also commonly
discussed among psychotherapists and the writers and researchers who study psychotherapy;
their work suggests that personal experience may enhance psychologists’ and other mental health
professionals’ sensitivity to similar experiences among their patients. The argument that personal
experience may be professionally advantageous is frequently found in writings on the concept of
wounded healing, as well as multicultural psychology. The benefits of personal experience as
discussed in both of these bodies of literature will be considered below.
Within the context of psychology, the term “wounded healer” is used to describe mental
health professionals who have themselves faced adversity, typically in the form of personal
mental illness, addiction, or trauma. The introduction of the concept to contemporary theories of
psychotherapy is generally credited to Carl Jung, who wrote, referring to psychotherapists in his
work Memories, Dreams, Reflections: “only the wounded physician heals,” (Jung, 1963, p. 134).
As Jung’s words speak to, wounded healers are theorized to possess unique characteristics that
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may inform the process of psychotherapy and facilitate the therapeutic alliance.
Although the majority of research on the wounded healer paradigm has examined how
personal experiences with mental illness inform vocational choice among mental health
professionals (e.g., see Barnett, 2007; Farber, Manevich, Metzger, & Saypol, 2005), a smaller
body of literature has investigated the benefits of woundedness on psychotherapeutic processes.
As Zerubavel and O’Dougherty Wright (2012), in a recent review of wounded healer literature,
write:
Commonly cited positive effects include a greater ability to empathize with clients, a
deeper understanding of painful experiences, heightened appreciation for how difficult
therapy can be, more patience and tolerance when progress is slow, and greater faith in
the therapeutic process (Gelso & Hayes, 2007; Gilroy, Carroll, & Murra, 2001). Although
the therapist’s own wounds may be activated during psychotherapy sessions, they can
potentially be used to promote self-healing within the client (Miller & Baldwin, 2000;
Sedgwick, 2001). Research indicates that the wounded healer’s countertransference can
have a positive influence on therapy (Fauth, 2006; Gelso & Hayes, 2007; Sedgwick,
1994). Briere (1992) emphasizes that sufficiently recovered wounded healers may make
uniquely talented therapists. (p. 483-484)
Of particular relevance to the current study, the concept of wounded healer as uniquely skilled
practitioner is perhaps nowhere more popular than in the field of addiction. As White (2000a,
2000b) notes, individuals in recovery from alcohol or other substance use disorders have
historically played critical roles in the development and operation of substance use disorder
treatment programs, as well as self-help recovery organizations (e.g., Alcoholics’ Anonymous);
indeed, many practicing addiction treatment providers continue to come to the field by way of
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their own recovery today. Speaking specifically of the theorized benefits of woundedness when
treating addiction, White (2000b) notes that, among other things, individuals who have
personally experienced addiction may benefit from “a knowledge of the physiology, psychology,
and culture of addiction that is derived from direct experience,” (p. 17). Applying this logic to
cannabis use, it is possible that individuals who have used cannabis themselves may be uniquely
adept at identifying problem use, as they may be able to use their personal experiences of
cannabis use as a barometer when assessing others’ use for evidence of addiction.
While the benefits of woundedness as described above have long been suggested,
research to substantiate these claims is very limited (see Zerubavel and O’Dougherty Wright
[2012] for an extensive consideration of barriers to dialogue and research on psychologists as
wounded healers). A review of the research on woundedness suggests that what little research
does exist typically utilizes survey and/or qualitative methodology, with studies exploring
therapists’ own perceptions of the benefits of personal experience, rather than examining
objective differences in the course and outcomes of treatment (e.g, see Gilroy, Carroll, & Murra,
2001). Those studies which do compare the therapy outcomes of “wounded” therapists to
“unwounded” therapists are prone to their own methodological limitations, which prevent
generalization. For example, studies comparing recovering addiction treatment providers to those
without personal histories of addiction are typically confounded by the fact that therapists in
recovery tend to have less education than those who are not in recovery, suggesting that any
differences in efficacy of provided treatment may be attributable to level of education (Gelso &
Hayes, 2007). Perhaps most importantly for the purposes of the current study, to the knowledge
of the author, no studies have examined the impact of woundedness on diagnostic accuracy or
clinical judgment; thus, it is unclear whether the benefits of woundedness described in the
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literature are generalizable to the process of assessment and diagnosis.
While no studies to date have explored the impact of woundedness on diagnostic
accuracy, clinician factors and their relationship to diagnostic accuracy and clinical judgment
have been examined somewhat more within the multicultural psychology literature. A widely
cited meta-analysis by López (1989) revealed evidence of biased diagnosis resulting in either
under- or over-diagnosis of psychiatric disorders based on socioeconomic status, race, cognitive
ability, and sex. Following López’s (1989) work, a large-scale analogue study by Russell, Fujino,
Sue, Cheung, and Snowden (1996) concluded that therapists who were racially/ethnically
matched to clients judged these clients as having higher levels of functioning than non-matched
therapists, suggesting that “therapists who are ethnically similar with their clients are better able
to understand the behaviors and verbalizations of clients within an appropriate cultural context,”
(p. 612-13). Were one to think of cannabis use as a subculture, one might reasonably theorize
that the same conclusions formulated by Russell et al. (1996) might apply to the cannabis users
in the current study, such that the current users, having developed a sense of what constitutes
“normal” versus “abnormal” cannabis use through personal experience, would correctly identify
someone with cannabis use disorder as differing from the norms of the recreational, casual use
cannabis “culture.”
Although literature on wounded healers and therapist matching may shed some light on
the findings for doctoral psychology trainees in the current study, these three groups – cannabis
using psychology trainees, wounded healers, and culturally diverse therapists – have some
notable differences which must be considered. For one, as Zerubavel and O’Dougherty Wright
(2012) note in their discussion of woundedness, the concept of the wounded healer implies that
the therapist has experienced distress from which he or she has “healed, or at least understood
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and processed sufficiently,” (p. 482). Contrary to this definition, the majority of trainee
participants in the current study – despite endorsing current illicit substance use – did not meet
criteria for problem use, nor is it evident (due to study limitations) that the trainees have
“processed sufficiently” their use. Indeed, drawing upon the wounded healer paradigm, one
might be compelled to hypothesize that past cannabis users would have demonstrated superior
diagnostic accuracy to current users and/or those without histories of cannabis use, given their
history of cannabis use (providing a diagnostic “barometer,” as described earlier) coupled with
current abstinence, which may reduce the potential bias that active use might elicit, as
hypothesized based on cognitive dissonance theory. However, this was not the case. Similarly,
although it is possible that one may consider their cannabis use an important part of their
identity, particularly given the recent politicization of cannabis use, it would seem an
oversimplification to liken the identity of cannabis user to components of identity such as race,
ethnicity, or sex (indeed, were it the case that participants’ cannabis use played a critical role in
their sense of self, this might reasonably be pointed to as an indicator of problem use).
Nonetheless, in lieu of research or theory which directly addresses the findings of the present
study, both the wounded healer literature and writings in multicultural psychology suggest
potential explanations for the results obtained.
Latent variable hypothesis. While it is possible that current cannabis use in and of itself
predicts diagnostic accuracy among doctoral psychology trainees – perhaps, as suggested above,
because of increased sensitivity to problem cannabis use among current users – it may be the
case that current cannabis use serves as a proxy for a latent variable not explicitly measured by
the current study.
In an exploratory study such as the current project, it is impractical to identify and
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examine all potential predictors of a given outcome; accordingly, the current study selected five
variables (cannabis use history, and scores on the PCURQ, P-SAAS, NM-SAAS, and NS-SAAS)
supported in the literature to examine as predictors of diagnostic judgment. Nonetheless, it is
reasonable to suggest that other variables may influence diagnostic decision-making. For
example, the present study gathered data on participants’ cannabis use histories, but did not ask
participants about other substances used, personal history of substance use disorder, or whether
participants had family members or friends with addiction histories. It is possible that one of
these variables, a combination of these variables, or perhaps variables yet to be identified might
be present at a greater frequency in participants who report current cannabis use. For example,
one could reasonably hypothesize that participants who themselves use cannabis may be more
likely to have friends who have used cannabis or other substances, and in turn, more likely to
have friends who have met criteria for substance use disorders, which might make current
cannabis users more sensitive to indicators of problem substance use. Unfortunately, the current
study lacks the data to support this theory. Further research on variables which may co-occur
with current cannabis use among doctoral psychology trainees is warranted in order to identify
alternate factors which may modify the relationship between current cannabis use and increased
accuracy in diagnosis of cannabis use disorder.
Minimizing bias hypothesis. Thus far, the findings of the current study have been
conceptualized as evidence of enhanced diagnostic ability among current cannabis users.
However, it is possible that the inconsistency in diagnostic accuracy between current cannabis
users and those who have never used cannabis may instead indicate impaired clinical judgment
in those with no history of cannabis use.
What might lead individuals who deny personal history of cannabis use to fail to
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correctly diagnose cannabis use disorder? Unlike doctoral psychology trainees who report
current cannabis use, those who deny history of cannabis use have no clear personal incentive to
minimize evidence of problem cannabis use in a client, as making a diagnosis of cannabis use
disorder would not result in cognitive dissonance for this group of trainees.
Perhaps the answer to this question is good intentions. In his work on multicultural
psychology and clinical bias, López (1989) – cited above in discussion of personal therapist
characteristics which may be advantageous to clinical work – reported that clinicians may be
prone to more than one type of bias:
Investigators in general have assumed that biased evaluations can only occur in one
direction, toward the perception of greater disturbance. This assumption may have served
as a barrier in finding bias in clinical judgment. In addition to overpathologizing actual
symptoms, practitioners may also minimize symptoms of actual pathology; that is, they
may judge actual symptoms as representing normative behavior, when in fact the
symptoms represent abnormal behavior. Depressive symptomatology, for example, may
be judged as normative behavior for mothers of young children (Ginsberg & Brown,
1982), and psychotic symptomatology may be judged as more normative for mentally
retarded individuals than for individuals of normal intellectual functioning (Reiss,
Levitan, & Szyszko, 1982). Borrowing from Chess, Clark, and Thomas (1953), López
(1983b) referred to this type of bias as the minimizing bias. Few clinical investigators
have acknowledged this bias in clinical judgment. In fact, evidence in support of the
minimizing bias is sometimes interpreted as pro-Black or pro-woman findings and is not
interpreted as possible error. (p. 186)
As Snowden (2003) writes in a review of the literature on clinical bias, minimizing bias is likely
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“well-intentioned,” (p. 242); in a discipline which has historically pathologized women; racial
and ethnic minorities; members of the lesbian, gay, bisexual and transgender (LGBT)
community; and others members of non-privileged groups and classes, contemporary clinicians’
may be overly cautious when evaluating members of these groups. Although such minimization
is arguably driven by a desire not to marginalize individuals by attributing normal distress and
other lived experiences to pathology, such caution may, as López (1989) and Snowden (2003)
have argued, have unintentional repercussions, including a failure to diagnose individuals who
do meet criteria for mental disorders, resulting in an exacerbation of prevailing mental health
treatment disparities in these communities.
In the current political and cultural landscape of which doctoral psychology trainees and
their clients are a part, much has been made of the notion that recreational cannabis use has long
been wrongly pathologized. As discussed at length in Chapter II of this dissertation, recent
surveys have demonstrated that a majority of Americans have begun to dispute cannabis’ risks
(e.g., see Galston & Dionne Jr., 2013; Pew Research Center, 2013). In this context, when faced
with the task of diagnosing someone with cannabis use disorder, individuals who have never
used cannabis might reasonably be influenced by minimizing bias. Fearful that diagnosing a
recreational cannabis user with cannabis use disorder might be over-pathologization of normal
behavior, these trainees may, to use López’s (1989) words, “judge actual symptoms as
representing normative behavior, when in fact the symptoms represent abnormal behavior,” (p.
186). In contrast, current cannabis users would not interpret their decision to make a diagnosis of
cannabis use disorder as over-pathologizing recreational cannabis use, as their personal
experiences of cannabis use support the argument that recreational cannabis use can exist on a
continuum of normal behavior.
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As previously noted, the explanations offered for the finding that current cannabis use is
predictive of correctly diagnosing cannabis use disorder are not supported with data from the
present study. The interpretations which have been offered – including the “personal experience
as professional advantage” hypothesis, latent variable hypothesis, and minimizing bias
hypothesis – are all theoretical. Additional research examining these hypotheses is essential in
verifying any of these theories, and to clarify the nature of the relationship between cannabis use
and diagnostic decision-making among doctoral psychology trainees.
Influence of Graduate Training in Substance Use Disorders. After identifying current
cannabis use as the only significant predictor of diagnostic decisions in a series of logistic
regression analyses, training in substance use disorders was examined as a predictor in a series of
post hoc analyses; as previously noted, these analyses revealed that although training in
substance use disorders in and of itself was not a significant predictor of diagnostic decisions
among trainees, when training was accounted for in the logistic model, the influence of current
cannabis use as a predictor was unmasked. When the definition of substance use disorders
training was limited to intensive training experiences (operationalized as endorsement of (a)
training toward certification or completion of certification as a substance abuse counselor, and/or
(b) externship, internship, or similar clinical training experiences in which substance use disorder
treatment was a primary focus), this effect was magnified. The findings of these analyses are
critical, as they suggest that training in substance use disorders may modify the relationship
between diagnostic judgment and history of cannabis use; in other words, training in substance
use disorders – particularly experiential training – either reduces the diagnostic advantage
associated with current cannabis use, or increases non-current users’ diagnostic skill.
Accordingly, by accounting for the variance associated with substance use disorder training,
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current cannabis use became more predictive of diagnostic decisions.
It is unclear why substance use disorders training (non-intensive or intensive) is not in
and of itself a predictor of diagnostic decision-making among doctoral psychology trainees. One
possibility which has already been suggested is that unexamined variations of variables measured
in the present study be stronger predictors of doctoral psychology trainees’ diagnostic decisions
than the variables selected. In line with this theory, although the present study requested
information from participants regarding whether they had received certain forms of training in
substance use disorder diagnosis and treatment, it did not assess participants’ competence in
these domains of clinical work. It remains possible that operationalizing training using measures
of competency, rather than the more basic operationalization utilized in the present study
(endorsed versus denied) may have yielded significant results.
Implications
Although the present study is unable to explain the etiology of the discrepancy in
diagnosing cannabis use disorder observed among trainees based on their personal history of
cannabis use, that a discrepancy at all was observed should be cause for concern. Since the
current study was initially proposed in May 2014, epidemiologists have reported that the
prevalence of cannabis use in the United States has increased from 4.1% to 9.5% (based on a
nationally representative sample of Americans; Hasin et al., 2015). Within the same time period,
the prevalence of cannabis use disorder nearly doubled, increasing from 1.5% of the population
to 2.9%, with nearly three in 10 cannabis users meeting criteria for cannabis use disorder in
2012-13, an increase which data suggest is attributable not to increased risk of developing
cannabis use disorder among those already using cannabis (e.g., due to increasing potency of the
cannabis crop), but simply to increased cannabis use in the population (Hasin et al., 2015).
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Indeed, as predicted when the current study was initially proposed, Hasin and colleagues (2015)
conclude, “the clear risk for marijuana use disorders among users (approximately 30%) suggests
that as the number of US users grows, so will the number of those experiencing problems related
to such use,” (p. 1240). Without question, if clinician factors, including personal cannabis use (or
lack thereof, as the current study suggests) limit accurate identification of cannabis use disorder
in even a portion of the nearly three percent of the United States population who meets criteria
for cannabis use disorder, the potential impact on public health is substantial.
Thus far, the current study has emphasized that accurate identification of cannabis use
disorder is important insofar as the expedient and accurate identification of any medical or
psychiatric diagnosis is important: diagnosis leads to intervention, which in turn may reduce or
prevent further deterioration of patients’ mental and physical health. Although treating cannabis
use disorder and the direct impact it has on those individuals affected by it is, in and of itself, a
sufficient rationale for the current study’s interest in identifying barriers to its diagnosis, there
are indeed many other reasons that the accurate identification of cannabis use disorder matters;
addiction does not occur in a vacuum, and undiagnosed and/or untreated substance use disorders
have wide-ranging public health implications. As Hasin et al. (2015) note in their review of this
literature, “use or early use of marijuana is associated with increased risk for many outcomes,”
(p. 1236). Recent research (as cited by Hasin et al., 2015) has shown associations between
cannabis use and reduced educational attainment (Lynskey & Hall, 2000); unemployment
(Compton, Gfroerer, Conway, & Finger, 2014); adverse cognitive and neuropsychological
outcomes (Meier et al., 2012); reduced quality of life (Lev-Ran et al., 2012); substance-related
motor vehicle accidents (Brady & Li, 2014; Hartman & Huestis, 2013; Lenné et al., 2010;
Ramaekers, Berghaus, van Laar, & Drummer, 2004); emergency room visits (SAMHSA, 2013a);
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psychosis liability (Davis, Compton, Wang, Levin, & Blanco, 2013; Di Forti et al., 2015);
comorbid psychiatric disorders, including personality disorders (Stinson, Ruan, Pickering, &
Grand, 2006); and progression to other illegal substance use (Secades-Villa, Garcia-Rodriguez,
Jin, Wang, & Blanco, 2015). Accordingly, failure to diagnose cannabis use disorder and engage
clients in treatment has implications not only for those individuals, but for their families and
communities; for healthcare systems; for local, state, and federal governments which designate
funding for emergency services, public assistance, and health insurance programs; and for a
range of other systems of which those individuals impacted by cannabis use disorder are
inherently a part as members of society.
Although the accurate diagnosis of cannabis use disorder is a critical step involved in
helping those with cannabis use disorder access treatment, it is ultimately only one of many
processes involved in the treatment of problem cannabis use. While the attitudinal variables
explored in the current study – permissiveness, non-stereotyping, non-moralizing, and
perceptions of cannabis’ risks – were not significant predictors of clinical judgment in the
present study, statistically significant differences in attitudinal variables among doctoral
psychology trainees based on trainees’ cannabis use histories may have impacts on other clinical
behaviors. As described in Chapter II, the work of Charuvastra and colleagues (2005) has
previously suggested that physicians who held more non-moralistic and permissive attitudes
toward substance use were more likely to support the legalization of medical cannabis, a finding
which suggests, as the study’s authors write, “that personal attitudes regarding substance use
might influence physicians’ views,” (p. 91). Likewise, the work of Norberg et al. (2012, also
reviewed in Chapter II of the current dissertation) found that nurses and physicians who believed
that cannabis should not be available for medical use were significantly more likely to report that
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they had screened someone for cannabis use disorder in the past month than study participants
who supported the legalization of medical cannabis, suggesting that healthcare professionals’
personal beliefs about cannabis impact their provision of services to patients. Although the
current study focused on the impact of personal beliefs about substance use on diagnostic
decisions specifically, it is possible that trainees’ attitudes about substance use and perceptions of
cannabis’ risks might influence other critical components of treatment such as referral to
specialty substance use treatment services and provision of motivational interviewing
interventions to individuals who evidence problem cannabis use. Clinician stigma toward
substance use – as evidenced by endorsement of stereotypical or moralistic beliefs on the NMSAAS and NS-SAAS – may also have deleterious impacts on the course of treatment for
cannabis users, as such biases would be expected to harm the development of therapeutic
alliance between provider and client, a factor which has repeatedly been demonstrated to play a
key role in studies of psychotherapy efficacy (Horvath, Del Ray, Flückiger, and Symonds, 2011).
Having discovered that psychology trainees’ attitudes toward substance use and perceptions of
cannabis’ risks vary with their personal cannabis use histories, future research evaluating the
practical significance of these group differences – specifically, whether such differences have
implications for clinical practice – is called for.
In addition to the impact that attitudes toward substance use and perceptions of cannabis’
risks may have on the treatment of cannabis use disorder, research published since the current
study was initially proposed suggests that cannabis use in general (in other words, use which
does not necessarily meet criteria for cannabis use disorder), may have implications for the
treatment of other psychiatric diagnoses. A 2015 study by Wilkinson, Stefanovics, and
Rosenheck based on data from 2, 276 veterans in posttraumatic stress disorder (PTSD) treatment
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between 1992 and 2011 found that cannabis use was associated with worse symptom severity
and treatment outcomes, as well as violent behavior. The results of this study suggest that
cannabis use may, as the authors write, “worsen PTSD symptoms or nullify the benefits of
specialized, intensive treatment,” (p. 1179). Although the current study did not examine the
impact of trainees’ attitudes on assessment of non-disordered cannabis use, Wilkinson et al.’s
(2015) findings highlight the possibility that cannabis use may have a significant influence on the
presentation of other psychiatric disorders, and on the efficacy of standard psychotherapeutic
treatments for these disorders. Were trainees’ personal beliefs about the risks associated with
cannabis use or permissiveness toward substance use to bias professional judgments regarding
the safety and/or efficacy of cannabis use for individuals with other mental health concerns –
resulting, for example, in failure to address cannabis use with patients being evaluated for PTSD
treatment – the time- and cost-intensive treatments psychologists provide might be in vain, and
cannabis-using recipients of these treatments might ultimately not receive adequate care.
Finally, although this section has thus far emphasized the implications of the current
study’s findings, given the nature of these findings it is equally important to address conclusions
which should not be drawn from the reported results. Although the present study suggests that
current cannabis users may be more accurate in their assessment of cannabis use disorder, such
data should not be misinterpreted as an endorsement of cannabis use for doctoral psychology
trainees. Cannabis remains an illegal substance under federal law, and recreational cannabis use
remains illegal in most states (“State marijuana laws map,” 2015). Additionally, doctoral
psychology trainees are not immune to the risks of cannabis use identified in the general
population. The personal and professional consequences of illicit substance use certainly
outweigh the possible benefit to diagnostic decision-making evidenced in the current study;
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indeed, chronic, recreational cannabis use may have adverse consequences for other areas of
clinical practice, though these were not examined in the present study. Further, as this chapter
has suggested, it is likely that cannabis use may serve as a proxy for a latent variable not
measured in the current study which might better explain improved diagnostic accuracy among
current cannabis users, and which may be able to be developed through targeted graduate
training experiences, as suggested by the study’s findings on the impact of substance use
disorder training. Although the current study suggests that many doctoral psychology trainees
may choose to use cannabis during their training – a decision which warrants the attention of
researchers and graduate training programs to the extent that this decision may have implications
for trainees’ clinical work – the current study should not be viewed as an endorsement of
cannabis use.
Strengths and Limitations
As previously described, the most notable strength of the current study is that it is the
first known to examine the influence of doctoral psychology trainees’ personal cannabis use,
beliefs about the risks of cannabis use, and attitudes toward substance use on diagnosis of
cannabis use disorder. Despite the fact that diagnosis is a core competency for psychologists in
clinical settings, to date, no studies have examined the impact of psychologists’ or doctoral
trainees’ personal health-related behaviors or beliefs on clinical judgment, including diagnostic
assessment. By exploring how the next generation of psychologists’ personal cannabis use,
perceptions of cannabis’ risks, and attitudes toward substance use may impact their clinical
judgment, the current study sought to identify factors which may promote or serve as barriers to
accurate diagnosis of cannabis use disorder, a substance use disorder which is projected to
become increasingly prevalent in the United States as cannabis use itself rises (Hasin et al.,
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2015). While the current study was unable to definitively identify a variable or set of variables
which predict correct versus incorrect diagnosis of cannabis use disorder with total accuracy, the
finding that current cannabis use was a significant predictor of correct diagnosis of cannabis use
disorder may be a crucial first step in identifying factors which are (a) associated with improved
diagnostic accuracy among trainees, and (b) responsive to training, with the ultimate aim of
increasing competency in the diagnosis of cannabis use disorder via targeted graduate training
interventions.
Methodologically, the study has several strengths. As Heppner, Wampold, and Kivlighan
(2008) report, analogue studies have several benefits, some of which the present study took
advantage. For example, by utilizing a vignette devised specifically for the present study – as
opposed to transcripts, audiotapes, or video of actual diagnostic interviews – the study was able
to control for extraneous and confounding variables which may have threatened its internal
validity. This is particularly important in the present study, as individuals with cannabis use
disorder often meet criteria for co-occurring substance use and other psychiatric diagnoses
(Stinson et al., 2006), which may have imposed unique diagnostic challenges for participants and
increased the likelihood that participants’ ultimate diagnostic decisions may have been
influenced by factors outside of the scope of the present study. Additionally, by utilizing a
vignette depicting a hypothetical client, the study was able to evaluate trainees’ diagnostic
abilities without risking violating the privacy of real-life clients.
One of the primary concerns when the initial study was proposed was that doctoral
psychology trainees would be reluctant to report illicit substance use. To reduce participants’
hesitation to participate in the study or honestly report their cannabis use, the current study
employed anonymous, online-based data collection. While the current study relies on self-report
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to measure history and recency of cannabis use (versus objective measures, e.g., urinalysis), and
therefore cannot guarantee that participants were truthful in their reporting of cannabis use, it
appears that that collecting data anonymously encouraged participants to report their cannabis
use candidly, with approximately two-thirds of the current sample endorsing lifetime cannabis
use. Although it is possible that endorsing cannabis use is not viewed as a liability by current
doctoral psychology trainees, prior studies of healthcare professionals have indicated that this
group may underreport cannabis use due to potential professional and legal repercussions
(Norberg et al., 2012); accordingly, it is reasonable to conclude that collecting data anonymously
increased participants’ willingness to be forthcoming in their responses. Given the success of this
study’s recruitment and data collection procedures, future researchers examining substance use
among healthcare professionals and trainees may wish to consider employing the same methods
utilized in the current study.
In spite of the study’s strengths, it is not without its limitations. Although the current
study benefits from the increased internal validity afforded by analogue methodology, this
benefit may come at the expense of reduced external validity (Heppner et al., 2008). In other
words, while crafting a vignette which depicted cannabis use disorder in the absence of any cooccurring diagnoses strengthens internal validity, this depiction is inherently contrived,
potentially reducing the generalizability of study findings to real-world clinical assessment
scenarios, in which diagnostic decision-making may be complicated by the fact that individuals
with cannabis use disorder may have co-occurring disorders with confounding diagnostic
criteria. Additionally, while use of anonymous data collection procedures may have increased
participants’ willingness to honestly describe their cannabis use, because data was collected
anonymously, there is no way to ensure – however unlikely – that participants did not complete
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the study more than once, or exit and restart the study to alter their responses once they realized
the aims of the study. Accordingly, one might imagine a scenario in which a participant who had
strong opinions about cannabis use exited the study upon realizing that the study was exploring
the relationship between personal cannabis use and diagnostic judgments in order to change their
answer to the question on diagnosis in such a way that would distort the findings relating
cannabis use behavior to diagnosis of cannabis use disorder (although the odds of this scenario
occurring seem highly unlikely). Similarly, although the study’s use of convenience sampling
undoubtedly increased the rate of data collection, as noted in Chapter I, the selected data
collection method may limit the generalizability of study findings. It is possible that participants
who chose to take part in the study self-selected into the study due to their interest in the
description of the research, and that those who did not select to participate may differ in certain
ways from those who do participate, in a manner which poses a threat to the validity of the
results.
In addition to methodological limitations routinely associated with convenience sampling
and anonymous data collection, the current study suffered from a lack of respondents whose
responses on the CUPIT evidenced problem cannabis use. Of the 123 participants retained
following data screening, only eight endorsed patterns of cannabis use resulting in positive
CUPIT screens, compared to 36 current cannabis users whose scores on the CUPIT failed to
suggest evidence of problem cannabis use. Although it is neither concerning nor surprising that
few doctoral psychology trainees met criteria for problem cannabis use, it is possible that
statistical analyses which compared individuals with negative screens to those with positive
screens were underpowered, and as such were unable to detect hypothesized differences between
these groups. Unfortunately, it was neither practical nor possible to gather additional data from
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trainees who met criteria for problem cannabis use alone. If recruitment was reopened, many
participants who inevitably would not have screened positive for problem cannabis use would
have completed the survey, placing an undue burden on the population from which the study
sampled. On the other hand, if alternative recruitment methods were implemented to request
participation from only trainees who identified as current problem cannabis users, trainees who
consented to participate may have selected into the study based on information which was not
available to other participants making up the sample; such a change in procedure may ultimately
have introduced confounding factors, posing a risk to study validity. In the end, it was felt that
the ramifications of reopening data collection outweighed the benefits of increasing the sample
of participants who screened positive for problem cannabis use, particularly as it is likely that
this is an unusual phenomenon among individuals enrolled in demanding doctoral training
programs.
There is little data on the psychometric properties of measures selected to assess trainees’
attitudes in the current study – the P-SAAS, NM-SAAS, and NS-SAAS (Chappel et al., 1985),
and PCURQ, an experimental questionnaire adapted from the work of Kondrad & Reid (2013);
ultimately, these scales were selected based on their use in previous studies of beliefs about
cannabis use and substance use among healthcare professionals. More psychometrically robust
measures of healthcare professionals’ attitudes toward substance use and beliefs about cannabis’
risks – while desirable – remain elusive; accordingly, the use of these measures is considered a
notable but unavoidable limitation of the present study.
The current study’s primary aim was to test a specific hypothesis: that doctoral
psychology trainees’ histories of cannabis use would impair their diagnostic judgments when
tasked with assessing for cannabis use disorder. As previously discussed, this hypothesis was
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informed by Festinger’s (1957) Theory of Cognitive Dissonance. As has been reported, the
findings of the current study contradicted this hypothesis. Although these findings may have
many interesting implications, limitations in study design prevent more specific conclusions
from being drawn from the findings obtained. In their chapter on analogue methodology,
Heppner and colleagues (2008) note that researchers can “achieve a higher degree of specificity
in the operational definitions of a variable,” (p. 411) by creating vignettes which represent
varying levels of a variable of interest. The present study, which utilized one vignette shown to
all participants, did not capitalize on this useful feature of analogue design; the need to include
alternate vignettes was not foreseen, and would have required an exponential increase in sample
size with the addition of each subsequent vignette. Had the results of the present study been
consistent with the study’s primary hypothesis, the outcome variable – correct diagnosis of
cannabis use disorder based on the vignette, versus failure to make this diagnosis – would have
provided sufficient evidence that trainees’ personal cannabis use biased their clinical judgment.
In lieu of this result, additional vignettes – e.g., a vignette depicting recreational cannabis use
which did not meet criteria for cannabis use disorder – may have been helpful in establishing the
nature of the difference between current cannabis users and past or denied cannabis users.
Without the additional specificity afforded by the inclusion of additional vignettes (resulting in a
larger range of potential outcomes), the current study is limited in its conclusions.
Finally, it is necessary to acknowledge the limitations inherent in exploratory research.
As the present study was the first known to examine the influence of personal beliefs and
behaviors on the diagnosis of cannabis use disorder among doctoral psychology trainees, study
design was driven by theory and the findings of related research on healthcare professionals in
other disciplines. Ultimately, the current study found that many of the variables which were
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initially hypothesized to predict diagnosis of cannabis use disorder by doctoral psychology
trainees were not significant predictors of diagnostic decisions. In light of the finding that current
cannabis use among trainees predicted correct diagnosis of cannabis use disorder based on the
vignette employed by the present study, it has been argued that it is likely that current cannabis
use may be a proxy for a latent variable not measured in the present study. It is outside the scope
of the current study – or any exploratory study – to examine every possible predictor of a given
behavior, particularly a behavior as complex as diagnostic decision-making; thus, the current
study was unable to definitively determine the factor(s) which predict accurate diagnosis of
cannabis use disorder. Nonetheless, the current study is believed to provide critical initial data
which may inform the development of subsequent research aimed at identifying predictors of
diagnostic decision-making which have yet to be identified.
Future Directions for Research
The findings of the current, exploratory study have laid the groundwork for a number of
additional studies. As previously noted, the current study found that doctoral psychology
trainees’ beliefs about the risk of cannabis use and attitudes toward substance use varied by
history and recency of personal cannabis use. Despite this, and contrary to study predictions,
these attitudinal differences were not predictive of differences in diagnostic decisions among
trainees. Although the attitudes measured in the current study did not predict diagnosis of
cannabis use disorder, the observed differences in these attitudes may have an impact on
provision of care in ways which were not explored in the present study. As noted above,
diagnostic assessment is only one of many clinical behaviors involved in the treatment of
substance use disorders, including cannabis use disorder. Studies exploring the implications of
attitudinal differences on other clinician behaviors – i.e. provision of evidence-based
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interventions (e.g., use of motivational interviewing) and referral to specialized substance use
disorder treatment services – as well as core therapeutic processes, such as the development of
therapeutic alliance, would both determine the practical significance of these observed
discrepancies, as well as identify those attitudes which may impair the provision of these
services and accordingly require remediation. Similar studies exploring the impact of trainees’
personal cannabis use on the aforementioned clinical behaviors and therapeutic processes are
also called for.
Additionally, as discussed throughout this chapter, the current study found that current
cannabis use among doctoral psychology trainees predicted accurate identification of cannabis
use disorder. It has been theorized that this finding indicates that current cannabis use may be
beneficially linked to another factor which was unmeasured in the current study; for example, it
has been posited that current use experiences may serve as a barometer when assessing others’
use for evidence of addiction, resulting in increased sensitivity in the identification of cannabis
use disorder. Alternatively, it has been suggested that current cannabis use may act as a proxy for
a latent variable not explicitly measured in the current study. In contrast, whereas the
aforementioned theories posit that current cannabis use is beneficial, the possibility remains that
the diagnostic accuracy of current cannabis users is a benchmark, and past or denied cannabis
use is associated with latent factors which impair diagnostic accuracy; for example, it has been
hypothesized that individuals who do not currently use cannabis may minimize problem cannabis
use when assessing cannabis use. Limitations of current study methodology limit the extent to
which any of these theories can be verified; as such, future studies should seek to identify latent
characteristics of current cannabis using trainees versus past or denied users which may account
for the current study’s findings.
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In addition to clarifying the results of the present study, research targeted at identifying
factors which either impair or enhance diagnostic accuracy in the identification of cannabis use
disorder has important training implications. As noted in the “Implications” section of this
chapter, the results of the current study should not be interpreted as an endorsement of cannabis
use; however, it is apparent that individuals who endorsed current cannabis use were indeed
more likely to correctly diagnose cannabis use disorder. Identifying latent predictors for which
current cannabis use serves as a proxy (or, alternately, predictors of failure to diagnose cannabis
use disorder, for which denied or past use are proxies) would ultimately serve as a foundation for
the development of graduate training interventions which might enhance trainees’ identification
of cannabis use disorder. Indeed, improving training is the ultimate aim of the present study;
although the results of the current study shed light on factors which may influence accurate
diagnosis of cannabis use disorder, this information is only valuable to the extent to which it can
be utilized to improve doctoral psychology trainees’ competence in diagnosis and, in turn,
increase diagnosis and subsequent access to care for clients with cannabis use disorders.
Although the current study explored factors which may influence doctoral psychology
trainees’ diagnosis of cannabis use disorder, doctoral psychology trainees are only one group of
healthcare providers tasked with diagnosing cannabis use disorder; accordingly, consideration
should be given to replicating the current study with other healthcare professionals (and trainees
in these fields), particularly licensed psychologists, psychiatrists, psychiatric social workers,
substance abuse counselors, and mental health counselors, who are responsible for identifying
and treating psychiatric disorders including substance use disorders.
Finally, as noted previously, there is little data on the psychometric properties of
measures selected to assess trainees’ attitudes in the current study – the P-SAAS, NM-SAAS,
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and NS-SAAS (Chappel et al., 1985), and the PCURQ (adapted from Kondrad & Reid, 2013). In
light of the limitations of available measures, it is imperative that new or revised instruments be
developed, ideally in advance of any further research exploring attitudes toward cannabis use
among mental health professionals. Developing validated measures which capture contemporary
beliefs about cannabis use and substance use generally will enable researchers to more accurately
explore the influence of clinician attitudes on an array of clinical behaviors, including but not
limited to diagnosis of cannabis use disorder.
Conclusions
The incidence of cannabis use disorder is increasing across the United States as a
function of Americans’ increased cannabis use (Hasin et al., 2015). As such, it is critical that
mental healthcare professionals – particularly the next generation of mental healthcare
professionals, who may continue to witness increasing rates of cannabis use disorder – be able to
accurately identify problem cannabis use. In keeping with this imperative, the current study was
devised to explore potential barriers to diagnosing cannabis use disorder among one such group
of future mental healthcare professionals, doctoral psychology trainees. The goal of the current
study was twofold: First, the study examined whether doctoral psychology trainees’ personal
cannabis use predicted their perceptions of the risks of cannabis use and attitudes toward
substance use. Second, the study sought to explore whether doctoral psychology trainees’
personal cannabis use histories, perceptions of cannabis’ risks, and attitudes toward substance
use predicted whether they would correctly diagnose cannabis use disorder. Generally, results
suggested that trainees’ beliefs about the risks of cannabis use, as well as their permissiveness,
stereotyping, and moralism toward substance use, varied with history and recency of personal
cannabis use, suggesting that trainees’ personal behaviors may bias attitudes which may have
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some bearing on clinical judgment. Despite this, the study found that none of the attitudinal
factors explored significantly predicted diagnostic decisions among trainees. Perhaps most
surprisingly, findings suggest that endorsement of current cannabis use among doctoral
psychology trainees increased the likelihood that trainees would accurately make a diagnosis of
cannabis use disorder, contrary to study predictions. While it is apparent that diagnostic
decisions are complexly determined in ways in which the current study – an exploratory effort –
was ultimately unable to fully capture, the study nonetheless represents a crucial first step toward
identifying those personal characteristics of doctoral psychology trainees which predict whether
or not they will correctly identify and diagnose cannabis use disorder. The results of the present
study have numerous implications for graduate training, clinical practice, and public health, and
serve as a foundation for future studies to continue to identify those factors which may influence
clinical judgment, and ultimately, to develop and test the efficacy of curriculum which may
remediate barriers to accurate and efficient diagnosis of cannabis use disorder.
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Appendix A
Letter of Solicitation (for Snowball Sampling Distribution)
Dear fellow doctoral student,
Hello, my name is Alexandra Stratyner, and I am a student in Seton Hall University’s
Counseling Psychology Ph.D. program. I am currently collecting data for
my dissertation. My research examines possible factors that influence clinical judgment
among doctoral psychology trainees. As part of this research, I am seeking
psychology trainees enrolled in doctoral programs in clinical, counseling, or
school psychology or related disciplines (e.g., clinical developmental psychology,
clinical forensic psychology, clinical neuropsychology, etc.). The results of this study will
hopefully help psychology trainees and psychologists to better understand the role that
select individual qualities may play in case conceptualization and diagnosis.
Participation is a simple process: The study consists of an online survey that is easy to
fill out and which you can complete at your convenience from any device with internet
access. The survey should take no more than 15 minutes to complete. After consenting
to participate, you will be asked to answer a series of demographic questions. Next, you
will read a brief vignette about a hypothetical client and be asked to answer questions
based on your opinions about the vignette. You will then be asked to complete three
brief questionnaires. These questionnaires will ask you about your behavior, as well as
your thoughts and beliefs about yourself, others, and different situations and issues. It is
possible that some of the questions will ask you about sensitive topics. If completing
these questionnaires causes you any distress, you can find a psychologist in your area
at http://locator.apa.org. Participants will not be required to answer any questions that
they do not want to answer; however, I anticipate that the study questions will be
interesting to fellow doctoral psychology trainees. At the conclusion of the study,
participants will have the option of being entered into a drawing for one of six $50
Amazon e-gift cards as a token of my appreciation for their help with my dissertation
research.
Participation in this study is completely voluntary. You do not have to answer any
questions that you do not wish to answer, and you are free to withdraw at any time.
Additionally, participation in this study is anonymous. The survey will not ask you
for any identifying information, nor will any identifying information be collected by the
survey platform (e.g., IP addresses). If you choose to enter the drawing at the
conclusion of the study, you will be taken to a separate survey; no contact information
provided for these purposes will be associated with study data. Additionally, the study
will look at participants as a group, and no information you provide will be evaluated or
compared on an individual basis.
All survey data will be collected via Qualtrics, a secure server-based survey platform. All
data collected online will be subject to Qualtrics security and private policies to
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ensure that all information collected is encrypted and made available only to
authorized users. While the researchers take every reasonable step to protect your
privacy, there is always the possibility of interception or hacking of the data by third
parties that is not under the control of the research team.
To ensure the security and privacy of all information collected, all data will be kept on a
USB flash drive in a locked filing cabinet, which can only be accessed by Ms. Stratyner
and her academic advisor, Dr. Laura Palmer.
If you are at least 18 years old, are currently a doctoral student in a Ph.D., Psy.D., or
Ed.D. program, and are willing to participate in this study, please click on the following
link: https://shucehs.co1.qualtrics.com/SE/?SID=SV_0SVdIwnqQv6WBNz. Your
completing the survey will serve as your consent to participate in the study. The survey
will be open between April 1, 2015 and June 30, 2015. If you choose to participate,
please visit the website between those dates.
Students at any phase in their doctoral training, including current interns and
students who have already completed internship are eligible to participate.
In addition, I would greatly appreciate it if you would forward this e-mail to any
other doctoral students who you think might be interested in participating.
If you have any questions or concerns about this study, please feel free to contact me
(914-715-9346 or alexandra.stratyner@student.shu.edu) or my advisor, Dr. Laura
Palmer (973-275-2740 or laura.palmer@shu.edu). If you have questions regarding your
rights as a research participant, please contact Dr. Mary F. Ruzicka, Director of the
Seton Hall University Institutional Review Board (IRB), at irb@shu.edu or (973) 3136314.
Thank you for your consideration!
You may print this information for your personal records.
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Appendix B
Letter of Solicitation (for Distribution to Doctoral Program Training Directors)
Dear [TRAINING DIRECTOR],
Hello, my name is Alexandra Stratyner, and I am a student in Seton Hall University’s
Counseling Psychology Ph.D. program. I am currently collecting data for
my dissertation. My research examines possible factors that influence clinical judgment
among doctoral psychology trainees. As part of this research, I am seeking psychology
trainees enrolled in doctoral programs in clinical, counseling, or school psychology or
related disciplines (e.g., clinical developmental psychology, clinical forensic psychology,
clinical neuropsychology, etc.). The results of this study will hopefully help those
involved in the training of psychologists to better understand the role that select
individual qualities may play in trainees’ approaches to case conceptualization and
diagnosis.
As a training director, I would greatly appreciate it if you would forward information
about my research to your current students who may be interested in participating. I
have enclosed detailed information about the study below. In an effort to avoid potential
coercion, please ask your department secretary, graduate assistant, or an equivalent
staff member to distribute the information included below.
Thank you very much for your consideration. Should you have any questions about this
request or about my dissertation research, please do not hesitate to contact me (914715-9346 or alexandra.stratyner@student.shu.edu) or my advisor, Dr. Laura Palmer
(973-275-2740 or laura.palmer@shu.edu).
Again, my sincerest thanks,
Alexandra G. Stratyner, MA
_______________________________________
Dear [UNIVERSITY] students,
Hello, my name is Alexandra Stratyner, and I am a student in Seton Hall University’s
Counseling Psychology Ph.D. program. I am currently collecting data for
my dissertation. My research examines possible factors that influence clinical judgment
among doctoral psychology trainees. As part of this research, I am seeking
psychology trainees enrolled in doctoral programs in clinical, counseling, or
school psychology or related disciplines (e.g., clinical developmental psychology,
clinical forensic psychology, clinical neuropsychology, etc.). The results of this study will
hopefully help psychology trainees and psychologists to better understand the role that
select individual qualities may play in case conceptualization and diagnosis.
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Participation is a simple process: The study consists of an online survey that is easy to
fill out and which you can complete at your convenience from any device with internet
access. The survey should take no more than 15 minutes to complete. After consenting
to participate, you will be asked to answer a series of demographic questions. Next, you
will read a brief vignette about a hypothetical client and be asked to answer questions
based on your opinions about the vignette. You will then be asked to complete three
brief questionnaires. These questionnaires will ask you about your behavior, as well as
your thoughts and beliefs about yourself, others, and different situations and issues. It is
possible that some of the questions will ask you about sensitive topics. If completing
these questionnaires causes you any distress, you can find a psychologist in your area
at http://locator.apa.org. Participants will not be required to answer any questions that
they do not want to answer; however, I anticipate that the study questions will be
interesting to fellow doctoral psychology trainees. At the conclusion of the study,
participants will have the option of being entered into a drawing for one of six $50
Amazon e-gift cards as a token of my appreciation for their help with my dissertation
research.
Participation in this study is completely voluntary. You do not have to answer any
questions that you do not wish to answer, and you are free to withdraw at any time.
Additionally, participation in this study is anonymous. The survey will not ask you
for any identifying information, nor will any identifying information be collected by the
survey platform (e.g., IP addresses). If you choose to enter the drawing at the
conclusion of the study, you will be taken to a separate survey; no contact information
provided for these purposes will be associated with study data. Additionally, the study
will look at participants as a group, and no information you provide will be evaluated or
compared on an individual basis.
All survey data will be collected via Qualtrics, a secure server-based survey platform. All
data collected online will be subject to Qualtrics security and private policies to
ensure that all information collected is encrypted and made available only to
authorized users. While the researchers take every reasonable step to protect your
privacy, there is always the possibility of interception or hacking of the data by third
parties that is not under the control of the research team.
To ensure the security and privacy of all information collected, all data will be kept on a
USB flash drive in a locked filing cabinet, which can only be accessed by Ms. Stratyner
and her academic advisor, Dr. Laura Palmer.
If you are at least 18 years old, are currently a doctoral student in a Ph.D., Psy.D., or
Ed.D. program, and are willing to participate in this study, please click on the following
link: https://shucehs.co1.qualtrics.com/SE/?SID=SV_0SVdIwnqQv6WBNz. Your
completing the survey will serve as your consent to participate in the study. The survey
will be open between April 1, 2015 and June 30, 2015. If you choose to participate,
please visit the website between those dates.
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Students at any phase in their doctoral training, including current interns and
students who have already completed internship are eligible to participate.
In addition, I would greatly appreciate it if you would forward this e-mail to any
other doctoral students who you think might be interested in participating.
If you have any questions or concerns about this study, please feel free to contact me
(914-715-9346 or alexandra.stratyner@student.shu.edu) or my advisor, Dr. Laura
Palmer (973-275-2740 or laura.palmer@shu.edu). If you have questions regarding your
rights as a research participant, please contact Dr. Mary F. Ruzicka, Director of the
Seton Hall University Institutional Review Board (IRB), at irb@shu.edu or (973) 3136314.
Thank you for your consideration!
You may print this information for your personal records.

147
Appendix C
Demographic Information
For each of the items below, please select the response that best describes you.
1. Age: [Drop down menu with ages beginning at 18]
2. Sex: Male, Female, Other
3. Racial or Ethnic Background:
African American, Caribbean American, or Black
Asian American
Latina/Latino
Native American
White (non-Hispanic)
Biracial/Multiracial (Please specify: _____)
International Student (Please specify your national origin: _____)
Other (Please specify: _____)
4. Religious Preference:
Buddhist
Catholic/Christian
Hindu
Jewish
Muslim
Native American
Pagan
Sikh
Spiritualist
Unitarian/Universalist
Wiccan
Atheist
Agnostic
Humanist
No Religion
Multifaith (Please specify: _____)
Other (Please specify: _____)
5. Political Affiliation:
Democrat
Republican
Independent
Other (Please specify: _____)
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6. Doctoral Program Type:
Ed.D.
Ph.D.
Psy.D.
1. Doctoral Program Discipline:
Counseling Psychology
Clinical Psychology
Other (e.g., Clinical Developmental Psychology, Clinical Forensic Psychology,
Clinical Neuropsychology, etc. Please specify: _____)
2. Year in Doctoral Program:
1st
2nd
3rd
4th
5th
6th
7th year and beyond
3. Are you currently completing, or have you completed your pre-doctoral internship?
(Yes/No)
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Appendix D
Vignette Depicting Cannabis Use Disorder

John is a 21-year-old college junior who is majoring in psychology. He presents at the
counseling center, where you are an extern, after the resident assistant assigned to his dormitory
noticed the smell of marijuana coming from his room last Thursday and reported him for a
violation of the college’s drug and alcohol policy; as a condition of this violation, he is required
to meet with a therapist for a drug and alcohol use assessment.
John reports that he first tried marijuana when he was 18. John says that he has been smoking
marijuana most days of the week for “about a year,” although he notes that he always waits to
smoke until he is done with classes for the day. When you ask John what he likes about using
marijuana, he reports that marijuana helps him relax; he says that after he smokes, he spends the
rest of the afternoon and evening listening to music or watching television shows on Netflix with
friends who live in his dormitory, who sometimes smoke with him. John reports that his
marijuana use hasn’t impacted his grades or his relationships with his friends or family; however,
he notes that he doesn’t speak with his parents often anymore, because he will not answer his cell
phone if they call him when he is high. John also reports that his girlfriend of six months broke
up with him three months ago because she was unhappy with his marijuana use. John stated that
he sometimes gets into arguments with his roommate, who complains that John neglects to clean
up after himself and worries that their dorm room smells of marijuana. John is not involved in
any extracurricular activities. He reports that he is considering applying for internships this
summer, but is concerned because many employers require drug testing. John reports that he
consumes alcohol infrequently, stating that he “has a couple beers, maybe every few weeks, but I
don’t like drinking much.” He denies smoking cigarettes or using any other substances. John has
no history of significant medical illness or injury.

Does John have cannabis use disorder?
Yes
No
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Appendix E
Questions about Cannabis Use
1. Have you ever used cannabis? (Yes/No)
2. Have you used cannabis in the past 12 months? (Yes/No)
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Appendix F
Cannabis Use Problems Identification Test (CUPIT)
(Bashford et al., 2010)
The CUPIT is available as a free, downloadable PDF from the National Cannabis Prevention and
Information Centre (NCPIC) of Australia.
NCPIC
PO Box 684
Randwick NSW 2031
Australia
Telephone: +61 2 9385 0208
Website: https://ncpic.org.au
Direct Link to CUPIT PDF: https://ncpic.org.au/media/1591/updated-cupit-tool-may-2010.pdf
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Appendix G
Perceptions of Cannabis Use Risks Questionnaire (PCURQ)
(Adapted from Kondrad & Reid, 2013)
Please rate the extent to which you agree or disagree with the following statements.
1
Strongly
Disagree

1.
2.
3.
4.
5.

2
Disagree

3
Neither Agree
nor Disagree

4
Agree

Marijuana can be addictive.
Using marijuana poses serious physical health risks.
Using marijuana poses serious mental health risks.
There are significant physical health benefits to using marijuana.*
There are significant mental health benefits to using marijuana. *
*

= Reverse-scored item.

5
Strongly Agree
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Appendix H
Substance Abuse Attitude Survey (SAAS)
(Chappel et al. 1985)

The SAAS is available from the Ralph G. Connor Research Reference Files (CARRF) at Rutgers
University.
Ralph G. Connor Research Reference Files (CARRF)
Center of Alcohol Studies, Rutgers University
607 Allison Road
Piscataway, NJ 08854
Telephone: 848-445-2190
Fax: 732-445-3500
Website: http://library.alcoholstudies.rutgers.edu/resources/special/carrf
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Appendix I
Substance Use Disorders Training Survey Question
Which of the following substance use disorder treatment training experiences have you received?
(Please select all that apply.)
-

I have taken a graduate-level course (or multiple courses) on addiction or substance use
disorder treatment.

-

I have attended a workshop or conference on addiction or substance use disorder
treatment.

-

I am currently completing, or have previously completed, an externship, internship, or
similar clinical training experience in which substance use disorders treatment was a
primary focus.

-

I have worked with clients with problem substance use or substance use disorder
diagnoses.

-

I have conducted research on substance use/addiction.

-

I have completed training toward certification as a substance abuse counselor, or am
certified as a substance abuse counselor.

-

Other (Please specify: _____)

-

I have never received training in the treatment of substance use disorders.
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Appendix J
Demographic Variable Taxonomy
Demographic
Variables

Demographic
Categories

Agea
(N = 123)
Sex
(N = 123)

Male (n = 27)

Male (n = 27)

Female (n = 95)

Female (n = 95)

Dummy Coding

Sex (Male = 0, Female = 1)

Other b(n = 1)
African
American,
Caribbean
American, or
Black (n = 5)
Asian American
(n = 6)
Latina/Latino
(n = 6)

Race
(N = 123)

Collapsed
Categories

Native American
(n = 1)
Biracial/
Multiracial
(n = 8)

People of Color
(n = 32)

Race (White = 0, Other
Racial/Ethnic Identity = 1)

International
Student (n = 4)
Other (n = 2)
White (NonHispanic) (n =
91)
Catholic/
Christian (n =
42)
Buddhist (n = 3)

White (NonHispanic) (n = 91)

Catholic/Christian c
(n = 42)

Jewish (n = 18)
Native American
(n = 1)
Pagan (n = 1)
Religious
Affiliation
(N = 123)

Sikh (n = 1)
Spiritualist
(n = 4)

Other religious
affiliations (n = 40)

Unitarian/
Universalist
(n = 1)
Humanist (n = 4)
Multifaith
(n = 2)
Other (n = 5)

Political
Affiliation (N =
123)

Other Religious
Affiliations = 1
(Catholic/Christian OR NoReligious = 0)

Atheist (n = 15)
Agnostic (n =
13)
No Religion
(n = 13)
Democrat (n =
66)
Republican
(n = 9)
Independent
(n = 26)

Non-Religious = 1
(Catholic/Christian OR
Other Religious
Affiliations = 0)

Non-religious
(n = 41)

Democratc (n = 66)
Republican (n = 9)

Combinations of
continuous and/or
dummy coded
collapsed categorical
variables generated,
resulting in firstorder interactions for
combinations of all
demographics (e.g.,
Age*Counseling
Psychology).

Republican = 1 (Democrat
OR Other Affiliation = 0)

Other political
affiliation (n = 48)

Other Political Affiliation = 1
(Democrat or Republican = 0)

Ph.D. (n = 103)

Degree Type (Ph.D. = 0,
Psy.D. = 1)

Other (n = 22)
Degree Type
(N = 123)

Discipline
Years of
Traininga
(N = 123)

Internship Status

Ph.D. (n = 103)
Psy.D. (n = 20)
Clinical
Psychology
(n = 53)
Counseling
Psychology
(n = 61)
School
Psychology
(n = 4)
Other (n = 5)
Started/
Completed
(n = 25)
Yet to Start
(n = 98)

a

Psy.D. (n = 20)
Clinical Psychology = 1
(Counseling Psychology or
Other = 0)

Clinical Psychology
(n = 53)
c

Counseling Psychology
(n = 61)

Other discipline
(n = 9)

Other Discipline = 1
(Clinical or Counseling
Psychology = 0)

Internship (n = 25)
Internship (Yes = 1, No = 0)
No Internship
(n = 25)

Continuous variable. b Variable could not be meaningfully collapsed with other categories; due to low sample size (n = 1), this demographic category was
removed from further analysis. cReference group for category.
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Appendix K
Permission to Adapt Questionnaire Originally Used in Kondrad & Reid (2013)
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Appendix L
Permission to Reprint Items from Kondrad & Reid (2013)
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Appendix M
Permission to Use the Substance Abuse Attitude Survey (SAAS; Chappel et al., 1985)

